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Summary 
This thesis reports the study of fine-tuning the properties of ordered mesoporous 
silicas and their potential application in controlled drug delivery.  
The recent application of mesoporous silicas extended to controlled drug delivery 
has raised much interest due to their non-toxic nature, high surface area, large pore 
volume, tunable pore size and chemically modifiable surfaces, allowing them to be 
potential hosts for various drugs. In this research, ordered mesoporous silica SBA-15 
materials have been functionally modified and investigated as controlled drug delivery 
matrices for both small molecule model drug of ibuprofen (IBU) and large protein drug 
of bovine serum albumin (BSA).  
In the preparation of controlled drug delivery system for IBU, mesoporous SBA-
15 materials were functionalized with amine groups through post synthesis and one-pot 
synthesis. It is revealed that the adsorption capacities and release behaviors of IBU are 
highly dependent on the different surface properties of SBA-15 materials. The release 
rate of IBU from SBA-15 functionalized by post synthesis is found to be effectively 
controlled as compared with that from pure SBA-15 and SBA-15 functionalized by 
one-pot synthesis due to the stronger ionic interaction between carboxyl groups in IBU 
and amine groups on the surface of SBA-15 functionalized by post synthesis. 
In contrast to small molecular drug IBU, the fabrication of controlled drug 
delivery system for large protein model drug BSA is more complicated, as it involves 
not only the properties of drug matrix itself but also the stability of protein drug. In the 
first part of the work, the adsorption isotherms of BSA on SBA-15 were determined at 
various conditions in order to find the favorable conditions for large adsorption 
capacities. Based on their plateau adsorptions values, it is observed that higher BSA 
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adsorption capacities are obtained on SBA-15 with higher amine group content, larger 
pore size and near the isoelectric region of BSA. Electrostatic interaction is suggested 
to be the driving force that prompts mild BSA adsorption on hydrophilic surface of 
amine-functionalized SBA-15 and slower release rate on SBA-15 with higher amine 
group contents. Due to relatively larger amount of BSA adsorbed on the external 
surface of SBA-15 of smaller size, the overall release rate of BSA from SBA-15 with 
smaller pore size is faster than that with larger pore size.  
In the second part of the work, the conformational changes of BSA under various 
processing conditions were investigated. It is found that BSA displays reduced α-helix 
content when released from amine-functionalized SBA-15 prepared by post-synthesis, 
due to the hydrophobic interaction between BSA and the material which tends to 
induce conformational changes. In addition, BSA adsorption on SBA-15 of smaller 
pore size, adsorption process occurring at high temperatures and high pH values are 
found to induce more loss of α-helix, and the possible explanations for the results are 
proposed.  
Finally, a smart pH-controllable drug delivery system was prepared through 
encapsulation of amine-functionalized SBA-15 with poly(acrylic acid) by electrostatic 
assembly. Surface charge and hydrophilicity are found to be two important surface 
properties of SBA-15 determining the encapsulation process. It is shown the entrapped 
protein from the resulting system can be released at neutral medium (pH 7.4) rather 
than at acidic medium (pH 1.2). Cytotoxicity studies show that such pH-sensitive 
system has little toxicity effect even at a high particle concentration of 0.5 mg/ml. This 
novel drug delivery system is believed to have potential application in targeted oral 
delivery of therapeutic proteins, which can release drugs to the ideal site like small 
intestine or colon while protecting them from the acidic condition in the stomach. 
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CHAPTER 1 - INTRODUCTION 
1.1   Background 
Over the past three decades, there has been a rapid growth in the area of drug 
delivery which is due to the underlying principle that drug delivery technology can 
bring both commercial and clinical values to healthcare products. The innovative drug 
delivery technology has been proven to provide greater commercial opportunity in the 
development of new formulations of drugs with novel characteristics. Typically, drug 
development is a lengthy and enduring process that requires strict adherence to 
rigorous national and international regulations set by health authorities to ensure the 
safety and efficacy of marketed pharmaceutical products. This lengthy process 
includes the initial discovery, technical and analytical development, pre-clinical testing 
(in vitro and in animals), clinical evaluation of safety and efficacy (in volunteers and 
patients), and final file preparation for review and registration. Consequently, it takes 
12 years on average for an experimental drug to travel from the lab to the medicine 
chest. 
This development is also a risky and costly process: According to a recent study 
conducted by DiMasi et al. (2003), the estimated average out-of-pocket cost per new 
drug is US$ 403 million and capitalizing out-of-pocket costs to the point of marketing 
approval at a real discount rate of 11% yields a total pre-approval cost estimate of US$ 
802 million. The outstanding time and cost spent on marketing a new drug is sufficient 
to deter drug companies from further developing a new variety of drugs. However, by 
employing advanced drug delivery technology, which not only can prospectively 
deliver new chemical entities, but also retrospectively optimize the delivery systems of 
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approved drugs, it can provide new opportunity for “old” drugs whose patents have 
expired and present them with improved forms. Therefore, it can give benefits to drug 
companies by creating new forms of established drugs and offering improved versions 
of drugs. It has been shown that companies developing new drug delivery systems 
seem to enjoy a good return on their investment in the form of increased revenue and 
market share (Tyle, 1988).  
In its therapeutic aspect, the rationale for controlled drug delivery is to alter the 
pharmacokinetics and pharmacodynamics of pharmacologically active moieties by 
using novel drug delivery systems or by modifying the molecular structure and/or 
physiological parameters inherent in a selected route of administration. It is desirable 
that the duration of drug action becomes a more designed property of a rate-controlled 
dosage form, which is partly or totally different from the drug molecule’s inherent 
kinetic properties. However, the conventional instantaneously oral and parenteral 
routes of drug administration do not provide ideal pharmacokinetic profiles especially 
for drugs which display high toxicity and/or narrow therapeutic windows. For such 
drugs the ideal pharmacokinetic profile will be one that the drug concentration reaches 
therapeutic levels without exceeding the maximum tolerable dose and maintains these 
concentrations for extended periods of time till the desired therapeutic effect is reached 
as shown in Figure 1.1. Such a profile can be achieved in an ideal scenario through 
changing the pharmacokinetic and pharmacodynamic properties of drugs by the use of 
an appropriate controlled drug delivery system. This system involves the combination 
of a matrix with a biologically active agent in order to make the agent to be delivered 
in a predetermined manner, i.e. the drugs can be released in a constant rate over a long 
time. Practically, this system will improve efficacy of drugs, eliminate potentials for 
1 / Introduction 
    3









Figure 1.1  Drug concentrations in the blood. 
In recent years, controlled drug delivery systems have become much more 
complicated and sophisticated, with the ability to do more than simply extend the 
effective release period for a particular drug (Brannon-Peppas, 1997). For example, 
current controlled-release systems can respond to changing biological environments 
such as temperature (Dong and Hoffman, 1990), pH (Peppas and Peppas, 1989), or 
glucose concentration (Ishihara and Matsui, 1986), and the delivery or cease-delivery 
of the particular drug can be triggered by external environment changes. Therefore, 
materials that have been developed could lead to targeted delivery systems, in which a 
particular formulation can be directed to the specific cell, tissue, or site (Yamada et al., 
2004; McNamara II, 2006) where the drug it contains is to be delivered. The 
development of these kinds of responsive delivery systems is presumed to be where the 
most exciting opportunities for controlled drug delivery lie in, as they are possible to 
deliver drugs through implantable devices in response to a measured blood level or to 
deliver a drug precisely to a targeted site. While much of the related work is still in its 
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infant stages, emerging technologies offering possibilities have attracted increasing 
interests among scientists and formulation chemists.  
During the past three decades, much of the development of novel materials in 
controlled drug delivery for research and commercial applications has been focusing 
on the preparation and use of polymeric materials with specifically designed 
macroscopic and microscopic structural and chemical features. From the modest 
beginning in 1973 when drugs were simply mixed into a polymeric matrix (Woodland 
et al., 1973), an avalanche of theoretical and practical advances has led to the rapid 
development of a large number of distinct polymeric drug delivery system 
configurations and device designs. Polymers in the forms of membranes, envelopes or 
carriers for therapeutic agents have several advantages: their permeability can be 
modified and controlled, they can be shaped and applied by a large variety of methods, 
active ingredients and property modifiers can be incorporated either physically or 
chemically, and in general, polymers have little or no toxicity (Magda et al., 1993). 
However, beyond these beneficial properties, due to the nature of the materials 
themselves, it is difficult to control the homogeneity of pore size and swelling stability 
of polymers, which may affect the reproducibility and predictability of release rates. 
Additionally, the drug loading capacities of polymeric materials are generally small, 
mostly below 10%, which also is one of the factors limiting their applications. These 
obvious limitations of polymeric materials inspire the growing research efforts to 
develop a wide range of new materials, including inorganic nanoporous materials.  
Nanoprous materials are a subset of porous materials, which have 
crystallographically defined pores falling within the nanometer size range. Among 
various nanoporous materials, mesoporous materials are those with pores in the range 
2-50 nanometers in diameter. In the early 1990s, a family of highly ordered 
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mesoporous silicates M41S materials was first successfully prepared by Mobil 
researchers (Kresge et al., 1992), which involved the use of supramolecular templating 
combined with complicated sol-gel processes. In the following years, breakthroughs 
were further made in this area with a variety of novel catalyst supports, sorption agents, 
nanoreactors and separation media based on mesoporous materials coming into view 
due to their highly ordered structures, narrow pore size distribution and huge surface 
areas (Margolese et al., 1994; Raman et al., 1996; Sayari and Liu, 1997; Ying et al., 
1999). Most recently, the applications of mesoporous materials extended to drug 
delivery begin to attract much attention (Vallet-Regi et al., 2001; Lai et al., 2003; 
Cavallaro et al., 2004; Doadrio et al., 2004; Mal, et al., 2003; Xue and Shi, 2004). As 
an alternative drug carrier, they are inert, non-toxic, and biocompatible. Comparing 
with polymeric systems, they have higher mechanical strength and stability, which 
could avoid accidental release from drug matrices, and due to their large pore volume 
and surface area, a higher loading amount of drugs can be achieved. Additionally, 
these materials are easily fabricated and loaded with desired drugs. By making use of 
above properties, it has been shown that both small molecular and large molecular 
drugs can be hosted within the mesopores by impregnation techniques and released via 
a diffusion-controlled mechanism.  
 
1.2   Research Objectives 
SBA-15 is recently discovered mesoporous silica which has tunably large 
mesopores and well-defined 2D hexagonal structures (Zhao et al., 1998). Before its 
discovery, pore sizes of ordered mesoporous silica were limited to approximately 10 
nm and wall thickness was always found to be around 1 nm. The use of the triblock 
polymers of Pluronics type expanded the accessible range dramatically and 
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substantially larger pore size and wall thickness up to 6 nm could be obtained. The 
block polymer template can be easily removed by either extraction or calcination, and 
the resulting materials have good stability against water. The discovery of SBA-15 has 
opened up new application of mesoporous materials as its large pores can be hosts for 
large proteins or biomacromolecules (Washmon et al., 2000; Vinu et al., 2004; Hudson 
et al., 2005; Balas et al., 2006). One of the main purposes of this research is to explore 
the potential application of SBA-15 as drug delivery systems for both small molecule 
and large protein drugs, making them to be released over a prolonged time. For this 
purpose, ibuprofen (IBU) and bovine serum albumin (BSA) have been selected as 
model drugs. To control adsorption and release behaviors of the model drugs, different 
functional groups and functionalization methods are used in this study, and the content 
of functional groups and mesopore sizes have to be adjusted appropriately. The guest-
host interactions between the model drugs and SBA-15 materials are proposed in order 
to understand the mechanisms behind the adsorption and release of the model drugs. In 
addition, for protein model drug BSA, it is also important to know whether the protein 
drug still maintains its property stability after being incorporated into the delivery 
devices. Therefore the factors affecting BSA conformational changes in fabrication of 
the drug delivery systems have been investigated.   
Another goal is to develop a new kind of peptide and protein drug delivery system 
which could deliver peptide and protein drug molecules in a more controlled and 
localized manner. This system could successfully deploy the protein drugs intact to the 
desired targeted site of intestine (pH 6-8), and safely shepherd the drugs through the 
specific area of stomach, where low pH (pH 1-3) can destroy protein drugs. To achieve 
this goal, SBA-15 material is combined with a pH-sensitive hydrogel of poly(acrylic 
acid) (PAA), the pH-controlled release behaviors of BSA is to be examined. 
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1.3 Thesis Organization 
This thesis contains eight chapters. Following this Introduction Chapter, Chapter 
2 is a literature review in which a variety of drug delivery systems and their release 
mechanisms, including polymer, liposome, and activation-controlled devices are 
summarized. Further emphasis has been placed upon synthesis and application of 
ordered mesoporous materials, which is proposed as a novel drug delivery system in 
this research. Chapter 3 introduces the materials and experimental menthods employed 
in this thesis work. Chapter 4 describes the application of SBA-15 in the delivery of 
the small molecule model drug of ibuprofen (IBU), with emphasis on the influence of 
the different functional methods on the adsorption and release of IBU. Chapter 5 
discusses adsorption and sustained release of the large protein model drug of bovine 
serum albumin (BSA) on SBA-15. Chapter 6 covers the factors affecting stability of 
the released BSA in fabrication of drug delivery systems, including functionalization 
methods, pore size, temperature, and pH value. Chapter 7 deals with a new kind of 
smart pH-controllable drug delivery system which combines SBA-15 and polyacrylic 
acid (PAA), the pH-controlled release behaviors of BSA are studied. In Chapter 8, the 
important conclusions of the whole research work are summarized and the future 
research directions are recommended. 
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CHAPTER 2 - LITERATURE REVIEW 
Controlled drug delivery technology represents one of the most rapidly emerging 
areas of growth and importance which involves multidisciplinary scientific approaches 
contributing to human health care. A variety of classes of drugs can benefit from 
controlled delivery, including chemotherapeutical drugs, immunosuppressants, anti-
inflammatory agents, antibiotics, opioid antagonists, steroids, hormones, anesthetics, 
and vaccines (Uhrich et al., 1999). More recently, the need to develop new controlled 
release strategies has been intensified by development of solid-phase peptide synthesis 
and emergence of gene therapy. The revival of established drugs and clinical success 
of innovative drugs may be dependent on the design of controlled release systems that 
ensure that the drugs reach their desired sits precisely at the optimal dosage for optimal 
length of time. Therefore, there have been a lot of attempts to design various types of 
controlled drug delivery system. During the past three decades these systems have 
experienced massive advancement in terms of scope and sophistication. Broadly 
categorized based on the properties of materials and release mechanisms, different 
delivery systems including polymers, liposomes, activation-controlled devices, and 
mesoporous silicates are described in the subsequent sections. 
 
2.1   Polymers 
Polymers have gained importance in the pharmaceutical industry as both drug 
enclosures and vehicles of drug carriage: either controlling its release at a steady rate, 
or protecting an active agent during its passage through the body. The widespread 
application of polymer in formulations and devices for drug delivery is attributed to 
some of the unique characteristics of polymers (Noble et al., 2006), including: 
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¾ wide molecular weight distributions  
¾ variety of visco-elastic properties  
¾ special characteristics associated with phase transitions  
¾ ablility to contract when heated  
¾ variety of dissolution times  
¾ specialized chemical reactivities  
¾ tolerance of a variety of manufacturing methods  
Polymeric drug delivery systems under wide investigations are classified 
according to the mechanism controlling the release of the drug. Some of the basic 
systems are described as below.   
 
2.1.1 Reservoir Devices 
2.1.1.1 General Considerations 
Reservoir devices consist of a drug or other active agent enclosed within an inert 
controlling membrane which is incorporated into the systems as the rate control device 
(Figure 2.1). The rate of release in reservoir devices is strictly controlled by the rate of 
drug diffusion through the non-degradable polymeric membrane although convection 
or swelling may play some parts in the delivery of the drug, which can be 
mathematically expressed as: )(1 0ktf
Adt
dM
J t =−=  (Non-degradable polymer, here J- flux; 




J =−= (n- power, 0.5 < n <1, Non-Fickian). Both hydrophilic and hydrophobic 
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Figure 2.1  Reservoir devices have a membrane coating that controls the release rate. 
Table 2.1  Major non-degradable polymers for drug delivery systems. 







Ethylene-vinyl acetate copolymers 
Polyurethane elastomers 
 
According to their structural features, the following three types of polymeric 
membranes are generally important for the design of membrane-reservoir drug 
delivery systems (Langer and Wise, 1983): 
1. Amorphous and semicrystalline polymers above their glass transition 
temperatures: drug permeates through the system by first dissolving into the membrane 
at one interface followed by diffusion down a chemical potential gradient across the 
membrane and finally desorption from the downstream interface into the external 
releasing medium. Among this class of polymers, silicones (especially Medical Grade 
SilasticTM by Dow-Corning) are one of the earliest and have been one of the most 
successful polymers in medical applications (Hincal and Kaş, 1998). They are the 
major amorphous soft (rubbery) polymers used for controlled release of hydrophobic 
drugs. With high stabilities, biocompatibilities, and inertness, ethylene vinyl acetate 







 2 / Literature Review 
    11
(Ocak et al., 1999; Woofson et al., 2003). They are mainly amorphous polymers, but 
may have crystalline regions, which may further control the drug release rate. 
2. Glassy hydrogels which imbibe water to form swollen polymer gels: the drug 
permeation across such a membrane also follows the solution-diffusion mechanism as 
described in type 1. Contributions from convection may become important in 
hydrogels with high water content. The interaction or coupling between the transport 
of solvent and other permeating species may also be important, especially during the 
initial stage of swelling. Mainly hydrophilic, but also hydrophobic drugs can be 
incorporated within these polymers. Cross-linked hydrophilic polymers based on 2-
hydroxyethyl methacrylate are well-known examples of this type (Lehr et al., 1999; 
Ferreira et al., 2000; Lee et al., 2001);  
3. Microporous membranes with pore dimension comparable to the mean free 
path of the permeants: molecules transported through these membranes may interact 
strongly with the pore wall. The flow in such a system is governed by diffusion as well 
as convection. In contrast to the above two types of membranes, in which diffusion 
control depends on membrane-drug partitioning, this type of membranes have the 
advantage that drug diffuses through pores that are filled with the same medium as the 
reservoir. A good example of this type is the semipermeable cellulose acetate 
membrane (Makhija et al., 2003). 
2.1.1.2 Release Mechanisms 
Among the above three types of polymeric membranes, the release of drugs from 
membrane type 1 are controlled by so called “solution-diffusion mechanism” (Langer 
and Wise, 1983): the rate of drug permeation through these membranes is directly 
proportional to the product of the drug diffusion coefficient in the polymer, D, and the 
polymer/solution partition coefficient, K. The drug diffusion coefficient in the polymer 
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is a kinetic or nonequilibrium transport parameter, which would decrease with 
increasing drug molecular weight and molecular size, crystallinity of the polymer, the 
amount of filler, and increase with increasing plasticizer content and solvent swelling 
in the polymer. Other parameters such as copolymerization, grafting, crosslinking, as 
well as the distribution and orientation of crystallites may either increase or decrease 
the observed drug diffusion coefficient. The partition coefficient, defined as the ratio 
of the drug concentration in the polymer to the equilibrium drug concentration in the 
external solvent medium, is an equilibrium thermodynamic property. It is generally 
observed that the drug would be more soluble in the polymer phase as the difference in 
the solubility parameters of the drug and polymer becomes smaller. Therefore, for the 
design of a specific reservoir device, it is necessary to determine both the drug 
diffusion and partition coefficients experimentally.  
In addition to solution-diffusion mechanism, there are other two primary solvent-
controlled mechanisms of drug release include polymer swelling and osmosis. Most 
swelling controlled systems are hydrogels (Type 2). For cross-linked, hydrophilic 
hydrogels, which are quite glassy in the dry state and swell to form an elastic gel in the 
presence of water, the rate of swelling (and the rate of drug release) depends on the 
hydrophobic/hydrophilic balance of the polymeric matrix and the degree of 
crosslinking  (Brondsted et al., 1991). The release of water-soluble drugs from initially 
dry hydrogel membrane devices generally involves the swelling of the membrane and 
subsequent dissolution or swelling of the core. In the case of a membrane originally 
saturated with drug, a simultaneous adsorption of water and desorption of drug via a 
swelling-controlled mechanism is observed plus solution-diffusion mechanism. Thus, 
as water penetrates a glassy hydrogel membrane device, the polymer swells and its 
glass transition temperature is lowered. At the same time, the dissolved drug diffuses 
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through this swollen rubbery region into the external releasing medium. It should be 
mentioned that for hydrogels, the release of drug is more complicated and always 
controlled by the combination of two or three mechanisms. For example, Ulbrich et al. 
(1995) investigated the release of doxorubicin from hydrogels made of crosslinked N-
(2-hydroxypropyl)-methacrylamide copolymers. In these systems, release was 
controlled by the simultaneous swelling and erosion of the polymeric matrix. Once 
swelling begins, the crosslinks become accessible to specific colonic enzymes leading 
to the degradation of the hydrogel and the concomitant release of drug into the colon. 
This is an example for the use of both solvent control and chemical control (which will 
be discussed in 2.1.3) within the same system.  
Osmosis represents the second mechanism of solvent control. Osmotic systems 
are usually composed of a drug reservoir enclosed with a microporous membrane 
which is utilized to regulate the osmotic permeation of water. The polymeric 
membrane such as cellulose acetate (Type 3) has a small opening through which drug 
is released as a result of the built-up of hydrostatic pressure within the device. An 
example of this technology is a kind of osmotic system of verapamil (Gupta et al., 
1996). For a system of constant reservoir volume, the device delivers a volume of drug 
solution equal to the volume of osmotic water uptake within any given time interval. 
The rate of osmotic water influx and therefore the rate of drug delivery by the system 
will be constant as long as a constant thermodynamic activity gradient, usually derived 
from a saturated reservoir with excess solid, is maintained across the membrane, but 
the rate declines parabolically once the reservoir concentration falls below saturation. 
Such an osmotic delivery system is capable of providing not only a prolonged zero-
order release but also a delivery rate much higher than that achievable by the solution-
diffusion mechanism. The system is also applicable to drugs with a wide range of 
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molecular weight and chemical composition which are normally difficult to deliver by 
the solution-diffusion mechanism. 
2.1.1.3 Fabrication of Reservoir Devices 
The reservoir devices are fabricated starting with a suitable biodegradable 
polymer/solvent system in which the drug is either suspended or dissolved. As 
summarized by McHugh (2005), a membrane carrier is formed by the process known 








Figure 2.2 Schematic of phase inversion process showing transformation of solution 
consisting of polymer (P) and solvent (S), with dissolved or suspended drug (D), to a two-
phase membrane structure (McHugh, 2005).  
Fabrication involves casting, coating, injecting, or molding the polymer/solvent 
system. The initially homogeneous, viscous solution of polymer and solvent (or 
mixture of solvents) with drug (either suspended or dissolved) is induced to phase 
separate by evaporation of solvent in a quiescent or flowing atmosphere, or by 
solvent–nonsolvent exchange in a liquid quench environment. Liquid demixing results 
in a two-phase structure whose morphological details vary depending on the nature of 
the mass transfer and phase separation processes. The bulk morphology generally 
consists of interconnected solvent-non-solvent rich liquid droplets, dispersed in a 
polymer-rich matrix. Most often a skin forms on the topmost layer of the membrane 
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and the substructure may exhibit a honeycomb or finger-like appearance. Successful 
design of delivery devices requires control of the interplay between the dynamics of 
the phase inversion process, the resultant membrane morphology, and the state of 
dispersion of the drug in the multiphase matrix. 
2.1.1.4 Limitations 
Compared with other types controlled release devices which be discussed later, 
one of the potential disadvantages of reservoir systems is the danger of “dose 
dumping”. If the surrounding polymeric membrane holds become leaky due to cracks 
or sudden rupture, the entire drug core could be released into circulation within a very 
short of time. Therefore, the need to keep the polymeric membrane mechanically intact 
throughout the period of drug release requires a very careful optimization of the 
polymer properties so that the polymer membranes maintain enough mechanical 
strength during release process. 
 
2.1.2 Matrix (Monolithic) Devices 
2.1.2.1 General Considerations 
Matrix (monolithic) devices are the most common devices for controlling the 
release of drugs. This is because they are relatively easy to fabricate, and safer than 
reservoir devices, since no potentially lethal “drug pill” can occur even if the device 
would break into several pieces. In such a device, the drug species is homogeneously 
dissolved or uniformly dispersed in a non-biodegradable polymer matrix of either 
hydrophilic or lipophilic nature (Figure 2.3), which is typically formed by compression, 
dissolution or melting of a polymer/drug mixture, and the drug release rate can be 





J t =−= . 
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Figure 2.3 A schematic representation of the matrix devices. 
Matrix devices include the following formulations (Langer and Wise, 1983): 
1. Dissolved systems which are prepared from a matrix containing drug at or 
below the saturation solubility of the drug in the polymer; 
 2. Dispersed systems which contain drug dispersed within a matrix at a 
concentration that greatly exceeds the saturation solubility of the drug in the polymer. 
It is assumed that the drug is present as discrete solid particles. This implies that upon 
leaching of the drug, macroscopic channels or pores within the polymer matrix do not 
exist;  
3. Reservoir-dispersed matrix systems which are analogous to the dispersed 
system except that a barrier layer is present at the surface of the device which is of 
lower permeability to drug than the bulk polymer matrix;  
4. Porous matrix systems which are prepared from a dispersion of drug particles 
and preformed polymer. In porous matrix systems, it is assumed that upon leaching of 
the drug, continuous macroscopic pores or channels arise from the displacement of 
drug by solvent. 
2.1.2.2 Release Mechanisms 
The release of drugs from matrix devices is governed by the diffusion of solution 







Drug is dispersed uniformly in 
non-degradable matix. 
  Increasing time 
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equation is generated via solutions of Fick’s first and second laws of diffusion. In 
general, three limiting cases exist. First, when the initial drug load in equal to or less 
than the saturation solubility of the drug, the rate of release is dependent upon the 
diffusion coefficient of the drug in the polymer and upon the initial drug load. The 
diffusion coefficient is dependent upon the properties of the drug and the polymer 
matrix. Such a system can be described as a homogenous matrix containing dissolved 
drug. Second, when the initial drug load is greater then the saturation solubility but 
smaller relative to the total volume of the polymer, e.g. less than 10% w/w, drug 
release rates will also be dependent upon the diffusion coefficient of drug within the 
polymer matrix and the initial drug load. However, in such systems, a third variable 
becomes important, namely, the saturation solubility of drug in the polymer. Such 
systems should be described as a heterogeneous matrix or as a matrix system 
containing dispersed drug. Third, when the initial drug load is increased beyond about 
10% w/w, then a point will be reached when the solid drug particles will begin to form 
continuous pores or channels within the matrix. Under such circumstances the path of 
least resistance for the drug will be diffusion within channels formed from areas where 
drug has previously leached from the matrix. In this case, the rate of release will be 
governed by the elution medium. Such systems are termed “porous” or “granular” 
matrices.  
In view of the above classifications, it is apparent, for example, that as the initial 
drug load is increased, the matrix will become more porous as drug is leached from the 
polymer, In effect, the free volume for diffusion increases as a result of the voids 
created by the leached drug. This increase in void volume will be reflected by changes 
in the ‘effective’ diffusion coefficient of drug in the matrix phase. Such changes were 
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Figure 2.4 Schematic representation of the change in the dispersed and depleted zones 
of matrix devices with time (t1 > t0). For slab devices, the area of the zone of depletion is 
constant and the concentration gradient is linear. For cylindrical devices, the area at the 
zone of depletion decreases with time and concentration gradient is nonlinear. 
explicitly demonstrated for the release of progesterone from hydrogel matrices (Song 
et al., 1981). 
In addition to effects arising from the initial drug load, the release characteristics 
of a polymer matrix are also a function of the geometry of the matrix (Crank, 1975). 
This fact arises due to variations in the mature of the concentration gradient within the 
drug depletion zone of the matrix. For example, in a heterogeneous polymer matrix 
containing dispersed drug, a zone of depletion is formed as drug is released from the 
matrix. A pictorial representation of the changes in this zone with time has been given 
by Roseman and Higuchi (1970). If the matrix is best represented as infinite slab, the 
surface area at the receding boundary is constant. Therefore, from Fick’s first law it is 
apparent that the concentration gradient within the zone of depletion will be linear 
(Figure 2.4). For devices, e. g., cylinders or spheres, in which the area of the receding 
drug boundary decreases with time (Figure 2.4), the flux of the drug will again follow 
Dispersed Zone Depleted Zone 
Slab Devices 
t = t0 
Cs
t = t1
 Cylindrical Devices 
Cs 
t = t0 t = t1
  Cs Cs
Cs 
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a path which is perpendicular to the receding drug boundary. However, the volume of 
the depletion zone will increase radially from the surface and the concentration 
gradient is nonlinear within the zone of depletion. As a consequence, release-rate 
equations are dependent upon the geometry of the device. 
2.1.2.3 Fabrication of Matrix Devices 
As the composition of different polymers used as matrices can permit very 
different rates of diffusion, thus manipulating drug release rates extensively, there is a 
need to choose suitable polymer matrices based on the properties of the drug and the 
polymer. Among various polymeric (or wax) materials, the most important types of 
matrices include insoluble plastic matrices, hydrophilic matrices, and fatty matrices. 
Plastic matrices include methyl acrylate-methacrylate, polyvinyl chloride and 
polyethylene. Hydrophilic polymers include methylcellulose, hydroxypropyl-
methylcellulose (HMPC) and sodium carboxymethylcellulose. Fatty compounds 
include various waxes such as carnauba wax and glyceryl tristearate. These systems 
have been found many applications in the oral and transdermal delivery of biological 
agents and drugs (Ye et al., 1996; Falk et al., 1997; Conaghey et al., 1998; Devi et al., 
2003). 
The fabrication of polymeric matrix devices varies with different types of matrix 
devices. For dispersed-type matrix devices, the drug as a finely divided powder is 
generally mixed with the prepolymer. This polymer is then placed in an appropriate 
mold and allowed to cure. This technique is also useful for dissolved-type matrix 
devices provided that the initial drug load is below the saturation solubility of the drug 
in the cured polymer. For dissolved-type matrix devices, an alternative procedure is to 
first prepare the polymer matrix in an appropriate mold and then achieve the desired 
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drug load via sorption of the drug from a saturated solution of the drug in an 
appropriate solvent.  
The preparation of reservoir-matrix devices is more complicated due to the need 
to incorporate the barrier layer onto the matrix. For slab devices it is convenient to first 
prepare the inner-core matrix by the techniques described above. The barrier layer can 
then be placed on either or both sides of matrix by solvent casting (Olanoff et al., 
1979). For cylindrical devices, the inner-core matrix can also be prepared by the mold 
procedure described above and the barrier layer is then dip coated onto the matrix. To 
obtain a uniform coating, three alternative techniques are used: 1) It may be convenient 
to prepare a reservoir device from a polymer tube and fill the tube with the required 
materials to make the inner matrix followed by polymerization of the inner matrix 
containing the initial drug load. 2) The barrier layer may be formed by addition of a 
cross-linking agent to the outer regions of a preformed matrix devices. In this method a 
matrix device is first prepared by the usual techniques. Drug is then removed from the 
outer regions of this device by desorption in a good solvent. A cross-linking agent can 
be added to the outer regions by sorption from a good solvent followed by an 
appropriate methodology such as UV irradiation to initiate cross-linking. 3) It may be 
possible to form the barrier layer by directly cross-linking the outer regions of the 
device by an appropriate technique such as UV irradiation, exposure to an oxygen 
plasma, or by other techniques such as casting and etc. The method to achieve 
spherical-matrix devices are essentially formed by oil-soluble organic monomers 
dispersed in aqueous media (oil in water, O/W) or by water-soluble monomers 
dissolved in water dispersed in an organic medium (water in oil, W/O; Candau, 1985). 
The polymerization of dispersed monomers is achievable by various methods 
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including emulsion, suspension, and dispersion techniques (Piirma, 1985). With this 
method, uniform spherical particles can be prepared.  
Porous-type matrix devices can be prepared by a variety of techniques. In general, 
solid drug particles are mixed with a polymer or wax-matrix and the mixure 
compressed in tablet machines to provide the desired shape. 
2.1.2.4 Limitations 
One of the disadvantages with matrix devices is that, it can be quite difficult to 
formulate matrix devices that will exhibit constant drug release rates in a reproducible 
fashion over extended periods of time (Rhine et al., 1980). As the release continues, 
the drug diffusion rates from non-degradable polymers normally decrease for this type 
of device, since the active agent has a progressively longer distance to travel and 
therefore requires a longer diffusion time to release.  
 
2.1.3 Biodegradable Polymeric Devices 
2.1.3.1  General Considerations 
For the above two devices made of non-biodegradable polymers, a major 
disadvantage is their unsuitability as implants because the expanded device must be 
surgically removed. Biodegradable matrices, which are consumed or eroded during 
therapy, were first developed in 1970 by Yolles et al. (1970). Since then, a great deal 
of attention and research effort has being concentrated on biodegradable polymers. 
These drug devices degrade into biologically acceptable compounds and leave their 
incorporated medications behind, thus eliminating the need to remove a drug device 
after the release of the active agent has been completed. Most biodegradable polymers 
are designed to degrade as a result of hydrolysis of the polymer chains into 
biologically acceptable and progressively smaller compounds. In some cases, e.g, 
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polylactides, polyglycolides, and their copolymers, the degradation process itself 
involves the breakdown of polymers into lactic and glycolic acids. These acids are 
eventually reduced by the Kreb’s cycle to carbon dioxide and water, which the body 
can easily expel. Degradation may take place through bulk hydrolysis, in which 
polymer degrades in a fairly uniform manner throughout the matrix, as shown 
schematically in Figure 2.5a. For some degradable polymers, most notably 
polyanhydrides and polyorthoesters, the degradation occurs only at the surface of the 
polymer, resulting in a release rate that is proportional to the surface area of the drug 















Figure 2.5  The polymer degrades to release drug molecules in degradable devices. a- 
bulk-eroding and b- surface-eroding biodegradable systems. 
Drug-loaded 
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Bulk erosion occurs when water molecules are able to permeate into the bulk of 
the polymer matrix at a quicker rate than erosion. As a consequence, polymer 
molecules in the bulk may be hydrolyzed and the kinetics of polymer 
degradation/erosion are more complex than for surface eroding polymers. The majority 
of biodegradable polymers used in controlled drug delivery undergo bulk erosion, 
including the very important polyester materials. While the more limited predictability 
of erosion and the lack of protection of drug molecules are inherent disadvantages to 
bulk eroding devices, these properties do not inhibit their successful employment as 
drug delivery devices. In addition, many new applications in controlled release use 
nano- or microparticle formulations that possess massive surface areas resulting in 
bulk and surface eroding materials possessing similar erosion kinetics (Uhrich et al., 
1999). 
Surface erosion occurs when the rate of erosion exceeds the rate of water 
permeation into the bulk of the polymer. This is often considered to be a desirable 
mechanism of erosion in drug delivery because the kinetics of erosion, and hence the 
rate of drug release, are highly reproducible. Furthermore, the magnitude of erosion 
may be changed by simply changing the surface area of the drug delivery device. The 
slow rate of water permeation into surface eroding devices has a further beneficial 
effect of protecting water labile drugs up to the time of drug release. Examples of 
surface eroding polymers are polyanhydrides and polyorthoesters. Both of these 
classes of biodegradable polymers possess highly labile groups that ensure rapid 
hydrolysis of polymer chains when encountering water molecules. Water permeation is 
retarded by designing the polymers with hydrophobic monomer units. Alternatively, 
hydrophobic excipients can be added to stabilize the polymer bulk. In an ideal surface 
erosion, the erosion rate is directly proportional to external surface area. Surface 
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erosion can lead to zero-order drug release provided that diffusional release is limited 
and the overall shape remains constant (Uhrich et al., 1999). 
2.1.3.2  Polymer Erosion Mechanisms 
The various bioerosion mechanisms can be systematized into the three distinct 
types shown in Figure 2.6 (Heller, 1987).  
1. In system based on type I erosion, water-soluble macromolecules are 
crosslinked to form a three-dimensional network. As long as the crosslinks remain 
intact, the network is insoluble, and when placed in an aqueous environment, it can 
swell only to the extent allowed by the crosslink density. Erosion of these systems can 
occur by cleavage of cross-links (Type IA erosion) or cleavage of the water-soluble 
polymer backbone (Type IB erosion). As bond cleavage takes place, the matrix will 
begin to swell and eventually it will dissolve. Such a system has two inherent 
limitations. First, the progressive swelling of the matrix before dissolution will limit its 
use to applications where dimensional stability is of little importance. Second, because 
a system consisting of crosslinked water-soluble polymer is a hydrogel, it is 
completely permeated by water; therefore, the water solubility of the incorporated 
therapeutic agent becomes a very important consideration. Clearly, low molecular 
weight compounds with appreciable water solubility will be rapidly leached, 
independent of the matrix erosion rate. 
2. In systems based on type II erosion, water-insoluble macromolecules are 
converted to water-soluble macromolecules by hydrolysis, ionization, or protonation of 
a pendant group. Because no backbone cleavage takes place, the solubilization does 
not result in any significant change in molecular weight. However, unless the 
backbone is also degradable, polymers in this category are only useful in topical 
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applications in which elimination of high molecular weight, water-soluble 
macromolecules proceeds with no difficulty. 
3. In systems based on type III erosion, high molecular weight, water-insoluble 
macromolecules are converted to small, water-soluble molecules by a hydrolytic 
cleavage of labile bonds in the polymer backbone. Because these polymers are 
converted to small, water-soluble molecules, the principal application of these systems 
is for the systemic administration of therapeutic agents form subcutaneous, 
intramuscular, or intraperitoneal implantation site. Clearly, the development of a useful 
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Each type of polymer erosion has certain advantages and limitations, and the 
choice of a particular erosion mechanism is dictated by the specific application. In 
actual applications, the erosion is always the combination of two or three mechanisms. 
2.1.3.3  Biodegradable Polymeric Materials 
Biodegradable polymers can be either natural or synthetic. In general, synthetic 
polymers offer greater advantages over natural materials in that they can be tailored to 
give a wider range of properties and more predictable lot-to-lot uniformity in 
comparison with materials from natural sources. Synthetic polymers also represent a 
more reliable source of raw materials, one free from concerns of immunogenicity. The 
widely studied synthetic biodegradable polymers having been considered or used for 
controlled release applications are listed as below: 
1. Polyesters 
Polyesters are the best characterized and most widely studied biodegradable 
system. The predominant synthetic pathway for production of polyesters in a wide 
range of molecular weights is from ring-opening polymerization of the corresponding 
cyclic lactone monomer. The mechanism of degradation in polyester materials is 
classified as bulk degradation with random hydrolytic scission of the polymer 
backbone, forming naturally occurring non-toxic metabolities. The relative strength 
and the long-standing safe use and acceptance of the lactide/glycolide polymers as 
surgical sutures have encouraged the application of polyesters as drug carriers. 
2. Polyorthoesters 
The motivation for designing polyorthoesters for drug delivery was the need to 
develop biodegradable polymers that inhibited drug release by diffusion mechanisms 
and allowed drug release only after the hydrolysis of polymer chains at the surface of 
the device. Polyorthoesters are hydrophobic polymers which can be prepared by 
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transesterification (Heller, 1987) or by simple and rapid condensation of diketene 
acetals with diols (Baker, 1987). The orthoester bond is relatively stable in alkaline 
conditions but undergo hydrolysis in acidic environments. While the pure polymer 
exhibits bulk erosion, an initially surface erosion of polyorthoesters has been made by 
incorporating a stabilizing basic salt, such as sodium carbonate, into the polymer 
matrix (DeLuca et al., 1993). 
3. Polyanhydrides 
Polyanhydrides are prepared from easily available low cost resources and are 
generally considered as safe dicarboxylic acid building blocks (Kumar et al., 2002). 
Due to rapid degradation and limited mechanical properties, the main application for 
this class of polymers is in short-term controlled delivery of bioactive agents. The 
polymers are believed to undergo predominantly surface erosion due to the high water 
lability of the anhydride bonds on the surface and the hydrophobicity which prevents 
water penetration into the bulk. They have well-defined polymer structure with 
controlled molecular weight and degrade hydrolytically at a predictable nearly zero-
order rate. They are of great interest because they show no evidence of inflammatory 
reaction. 
4. Polyamides 
The most interesting class of polyamides for controlled release are the poly(amino 
acids). The synthetic ability to manipulate amino acid sequences has seen its maturity 
over the last two decades with new techniques and strategies continually being 
introduced. Poly(amino acids) have been used predominantly to deliver low molecular 
weight drugs, are usually tolerated when implanted in animals, and are metabolized to 
relatively nontoxic products. Although they have good biocompatibility, their mildly 
antigenic nature makes their widespread use uncertain. Another concern with 
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poly(amino acids) is the intrinsic hydrolytic stability of the amide bond which must 
rely upon enzymes for bond cleavage. The dependence on enzymes generally results in 
poor controlled release in vivo. 
2.1.3.4  Limitations 
In comparison with non-degradable polymers, biodegradable polymers is a more 
attractive and viable goal and have received extensive efforts in their syntheses and 
applications. However, at present there remains a scarcity of materials that can be 
evaluated in biomaterial applications for commercial purposes, which is due to some 
problems associated with the fabrication of drug/matrix. Currently, the drug/matrix is 
fabricated by compression molding, melting molding or solvent molding. Each 
molding process has its own problems. Such problems include: non-uniform 
distribution of drugs in the polymer matrices, heat inactivation of drugs, drug/polymer 
interaction at high temperature, use of organic solvents, and etc. 
 
2.2   Liposomes 
 
2.2.1 General Considerations 
First discovered in 1961 by Alec D. Bangham (Bangham and Horne, 1964) while 
studying phospholipids and blood clotting, soon after their discovery, liposomes were 
heralded as the answer to the quest for target drug delivery (Sessa et al., 1969). Over 
the past three decades, they have been investigated as carriers of various 
pharmacologically active agents such as anti-inflammatory drugs, antineoplastic drugs, 
polypeptides, vaccines and genetic materials (Juarez et al., 1989; Oberholzer et al., 
1999; Feng et al., 2002; Mamot et al., 2003; Alonso-Romanowski et al., 2003; Ewert et 
al., 2004). Liposomes are spherical microscopic or submicroscopic artificial vesicles of 
10 nm to 20 mm in diameters. They are made up of one or many concentrically 
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arranged lipid bilayers encapsulating an aqueous space. The basic components of 
liposomes are amphiphilic compounds having clearly separated hydrophilic and 
hydrophobic centers. Hydrophilic components of lipids of bilayer are directed towards 
aqueous phases (external and internal), whereas hydrophobic components of both lipid 
layers are directed towards one another, forming the internal layer of a membrane. In 
1997, the New York Academy of Science has distinguished three basic types of 
liposomes based on their size and number of bilayers (Betageri and Parsons, 1992; 
Kulkarni et al, 1995) (Figure 2.7): Small unilamellar vesicles (SUV) of 25–50 nm in 
diameter are surrounded by a single lipid layer. Large unilamellar vesicles (LUV) are a 
heterogeneous group of vesicles similar to SUVs and are surrounded by a single lipid 
layer. Multilamellar vesicles (MLV) consist of several lipid layers separated from one 










Figure 2.7  Types of liposomes depending on size and number of lamellae. 
Due to the following reasons, liposomes have been long standing as promising 
drug delivery devices: 
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¾ allow almost infinite possibilities to alter structural and physicochemical 
characteristics to be tailored to specific therapeutic needs ((Feng et al., 2004; 
Lukyanov et al., 2004); 
¾ able to encapsulate drugs with widely varying lipophilicities, either in the 
phospholipids bilayer, in the entrapped aqueous volume or at the bilayer 
interface (Figure 2.7) (Gregoriadis et al., 1980; Sharma, 1997); 
¾ can attach to cellular membranes or be taken up by the cell, releasing the 
entrapped active agents into the cell; 
¾ reduce systemic toxicity and prevent early degradation of the encapsulated 
drug after introduction to the target organism (Boulikas, 2004; Manosroi et al., 
2004). 
 
2.2.2 Classification of Liposomes 
On the basis of their composition and in vivo application, liposomes are broadly 
classified as the following four types (Storm and Crommelin, 1998): 
1. Conventional liposomes 
This type of liposomes is typically composed of only phospholipids (neutral 
and/or negatively charged) and/or cholesterol. Most early work on liposomes as a 
drug-carrier system employed this type of liposomes. Conventional liposomes are a 
family of vesicular structures based on lipid bilayers surrounding aqueous 
compartments. They can vary widely in their physicochemical properties such as size, 
lipid composition, surface charge and number and fluidity of the phospholipid bilayers. 
Although manipulation of these properties is a valuable tool to modify, to a certain 
extent, the in vivo behavior of conventional liposomes (i.e. stability, clearance and 
distribution), some in vivo behavioral features are very consistent among different 
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conventional liposome formulations. Conventional liposomes are characterized by a 
relatively short blood circulation time. When administered in vivo by a variety of 
parenteral routes (often by intravenous administration), they show a strong tendency to 
accumulate rapidly in the phagocytic cells of the mononuclear phagocyte system 
(MPS), also often referred to as the reticuloendothelial system (RES), therefore, 
conventional liposomes is thought to be attractive candidates for drug delivery to MPS 
macrophages. This macrophage targeting drug delivery system has also been applied to 
increase the capacity of macrophages to kill neoplastic cells and to increase resistance 
against infectious microorganisms.  
2. Long-circulating liposomes 
Although conventional liposomes have been found some valuable applications as 
mentioned above, however, due to their rapid clearance from the circulation by liver 
and spleen macrophages, their utilization for the treatment of a wide range of diseases 
remains a big doubt. The advent of new formulations of liposomes that can persist for 
prolonged periods of time in the bloodstream led to a revival of interest in liposomal 
delivery systems at the end of the 1980s. The emergence of the long-circulating 
liposomes opened a realm of new therapeutic opportunities that were up to then 
unrealistic because of efficient MPS uptake of conventional liposomes. At present the 
most popular way to produce long-circulating liposomes is to attach hydrophilic 
polymer polyethylene glycol (PEG) covalently to the outer surface (Figure 2.8). Such 
PEG-coated liposomes are also called ‘stealth’ or ‘sterically stabilized’ liposomes, the 
former term referring to their MPS-escaping capability, the latter term to the steric 
stabilization mechanism held responsible for the induction of long (half-life in humans 
~48 h) circulation times. Steric stabilization results from the local surface 
concentration of highly hydrated PEG groups that create a steric barrier against 
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interactions with molecular and cellular components in the biological environment 












Figure 2.8 Schematic representation of four major liposome types. Conventional 
liposomes are either neutral or negatively charged. Sterically stabilized (‘stealth’) 
liposomes carry polymer coatings to obtain prolonged circulation times. Immunoliposomes 
(‘antibody targeted’) may be either conventional or sterically stabilized. For cationic 
liposomes, several ways to impose a positive charge are shown (mono-, di- or multivalent 
interactions) (Storm and Crommelin, 1998). 
3. Immunoliposomes  
This type of liposomes have specific antibodies or antibody fragments on their 
surface to enhance target site binding (Figure 2.8). Although immunoliposome systems 
have been investigated for various therapeutic applications, the primary focus has been 
the targeted delivery of anticancer agents. As for any particle in the bloodstream, it is 
difficult for immunoliposomes to leave the blood compartment at sites other than the 
liver and the spleen. Therefore, to guarantee accessibility of the target receptors, local 
administration in body cavities has received some interest. Successful attempts have 
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been made to prolong the half-life of immunoliposomes after intravenous 
administration by coating with PEG, thus giving them a greater chance to reach target 
sites other than MPS macrophages. 
4. Cationic liposomes 
Cationic liposomes represent the youngest member of the liposome family 
(Figure 2.8). They are front-line runners among the delivery systems under 
development for improving the delivery of genetic material (Lasic and Templeton, 
1996; Mahato, et al., 1997). Their cationic lipid components interact with, and 
neutralize, the negatively-charged DNA, thereby condensing the DNA into a more 
compact structure. The resulting lipid–DNA complexes, rather than DNA encapsulated 
within liposomes, provide protection and promote cellular internalization and 
expression of the condensed plasmid. 
 
2.2.3 Methods of Preparation 
Liposomes of different sizes and features normally are fabricated by different 
methods. The simplest method to prepare large multilamellar liposomes is to hydrate a 
dry lipid film in aqueous solution at a temperature above the transition temperature of 
the lipid. Depending upon the thickness of the dry film, the temperature and the time of 
hydration, as well as lipid composition, liposomes differing in size and layer structure 
can be obtained (Szoka and Papahadjopoulos, 1980). By slow hydration of the dry 
lipid film, more multilamellar and larger liposomes can be made.  
Large unilamellar liposomes of large encapsulation volume can be obtained by 
evaporating the reversed phases or by removing the detergent from mixed, lipid-
detergent micelles. In the case of a method of slow rehydration, the size of liposomes 
depends to a great degree on lipid concentration in the initial organic solution as well 
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as on lipid composition (Szoka and Papahadjopoulos, 1980). In the second case, the 
size of the obtained vesicles depends on the kind of detergent used and, at least 
partially, on the rate of detergent elimination by dialysis (Wacker and Schubert, 1998).  
Another commonly used method of formation of large unilamellar liposomes is a 
reduction of size of large multilamellar vesticles (MLV) liposomes by their calibration 
achieved by pushing them through polycarbonate microfilters in extruders, which 
results in the narrow distribution in size of the liposomal population. The applied 
pressures may be as high as 100 atmospheres in the case of high concentration of 
liposomal lipid in the aqueous solution (Mayer et al., 1986).  
The small unilamellar liposomes are usually obtained by extrusion by pushing 
large multilamellar liposomes through pores of 100 nm or less in diameter. In some 
cases, a method of sonication is also used. This is applied using ultrasounds on large 
multilamellar vesicles (Almog et al., 1991). However, it causes some problems 
resulting from partial oxidation of lipids used for liposomes preparation and, in the 
case of the application of metal heads, the removal of small fragments of metal which 
became detached during the process is often necessary (Almog et al., 1991).  
 
2.2.4 Limitations of Liposomes 
As described above, liposomes have been studied as carriers of various 
pharmaceutical substances. However, so far liposome-based drug formulations have 
not entered the market in great numbers. Some of the inherent properties of liposomes 
limit their manufacture and development, including stability issues, batch to batch 
reproducibility, sterilization method, low drug entrapment, particle size control, 
production of large batch sizes, and short circulation half-life of vesicles.  
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2.3   Activation-Controlled Devices 
The controlled release devices described above are designed to make bioactive 
molecule to diffuse out of its original depot at a sustained rate, or ideally at a zero-
order constant rate. Indeed, the initial focus of drug delivery was placed on 
constructing various barriers to modify and manipulate the release rate over an 
extended period of time with minimal influence by outside environmental factors. 
However, in recent years, a more sophisticated series of controlled release technologies 
has been gradually developing, where the rate of release is influenced by 
environmental conditions or physicological stimuli, so that the bioactive agents are 
released only when they are required. Systems have also been designed to be 
manipulated by remote control, permitting non-invasive stimulation of release. There 
are many such ‘activation-controlled’ release mechanisms, in various stages of 
development, including (Duncan and Seymour, 1989): 
¾ Osmotic pressure-controlled 
¾ Vapour pressure-controlled 
¾ Chemical hydrolysis-controlled 
¾ Temperature-controlled 
¾ Enzymatic hydrolysis-controlled 
¾ Magnetism-controlled 
¾ Ion exchange-controlled 
¾ Radiation controlled 
¾ Photoactivation-controlled 
¾ Ultrasound-controlled  
¾ Optically controlled 
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There are some specially designed “hard” devices based on this type of release-
control, such as Alzet® pump, which uses osmotic pressure to determine the rate of 
release of the contained bioactive agent. Additionally, the activation controlled release 
can also be achieved by using “soft” hydrogels. The hydrogel described here is 
different from hydrogels mentioned in the previous section 2.1.1 in that it only swells 
under certain conditions triggered by external stimuli. For this type of hydrogel-based 
system, the triggered drug delivery occurs only when the hydrogel membrane or matrix 
swells by a change in the environment surrounding the delivery system. Depending 
upon the polymer, the environmental change can involve pH, temperature, or ionic 
strength, and the system can either shrink or swell upon a change in any of these 
environmental factors. A number of these environmentally sensitive or "intelligent" 
hydrogel materials are listed in Table 2.2. For most of these polymers, the structural 
changes are reversible and repeatable upon additional changes in the external 
environment. These responsive delivery systems represent the most exciting 
opportunities in controlled drug delivery, with which it will be possible to deliver 
drugs through implantable devices in response to a measured blood level or to deliver a 
drug precisely to a targeted site. Much of the development of controlled drug delivery 
will also be focusing on the preparation and use of these responsive systems and 
relevant novel materials with specifically designed macroscopic and microscopic 
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Table 2.2  Environmentally sensitive hydrogels for drug delivery (Dorski, 1997). 
Stimulus Hydrogel Mechanism 
pH Acidic or basic hydrogel Change in pH — swelling — release of drug 
Ionic strength Ionic hydrogel 
Change in ionic strength — change 
in concentration of ions inside gel 
— change in swelling — release of 
drug 
Chemical species Hydrogel containing electron-accepting groups 
Electron-donating compounds — 
formation of charge/transfer 
complex — change in swelling — 
release of drug 
Enzyme-substrate Hydrogel containing immobilized enzymes 
Substrate present — enzymatic 
conversion — product changes 
swelling of gel — release of drug 
Magnetic Magnetic particles dispersed in alginate microshperes 
Applied magnetic field — change 
in pores in gel — change in 





Change in temperature — change 
in polymer-polymer and water-
polymer interactions — change in 
swelling — release of drug 
Electrical Polyelectrolyte hydrogel 
Applied electric field — 
membrane charging — 
electrophoresis of charged drug — 






Ultrasound irradiation — 
temperature increase — release of 
drug 
 
2.4   Ordered Mesoporous Materials 
In view of polymeric and liposomal drug delivery devices described above, both 
of them have some limitations, suggesting that these materials may lack efficiency for 
certain bioactive agents. With the emerging of new therapeutic drugs, such as proteins 
and DNA drugs, there is also a need to discover new drug delivery systems. Recently, 
the application of ordered mesoporous materials extended to controlled drug delivery 
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has raised much interest due to their non-toxic nature, high surface area, large pore 
volume, tunable uniform pore size and chemically modifiable surfaces, allowing them 
to be hosts for various drugs, such as ibuprofen (Vallet-Regi, et al. 2001), amoxicillin 
(Vallet-Regi, et al. 2004), gentamicin (Lai, et al., 2003; Xue and Shi, 2004), captopril 
(Qu, et al., 2006), or even large protein drugs (Song et al., 2005) and DNA (Solberg 
and Landry, 2006). The results obtained in these studies show that mesoporous 
materials may open new applications in the area of controlled drug delivery and 
biomaterials aimed at the clinical field. The following sections will focus on the 
synthesis, properties and applications of mesoporous silica. 
 
2.4.1 Synthesis of Ordered Mesoporous Materials 
According to the IUPAC definition (Sing et al., 1985), porous materials are 
divided into three classes: microporous (< 2 nm), mesoporous (2–50 nm) and macro-
porous (> 50 nm) (Figure 2.9). Well-known members of the microporous class are the 
zeolites, which are crystalline alumosilicates with a framework structure consisting of 
cavities and channel systems of defined size and shape. Depending on the type of 
zeolite, the pore diameter is between 0.4 ± 1.5 nm. As a consequence of this structure, 
zeolites have particular properties, such as the ability to exchange ions and to 
reversibly desorb water. These properties made zeolites employed as ion exchangers 
and molecular sieves. Most important applications of zeolites are applied as catalysts, 
and in the area of petrochemistry alone (ZSM-5, zeolite Y), there is an annual turnover 
of more than US$ 30 billion (Förster and Plantenberg, 2002). However, their further 
applications are limited by the relatively small pore openings. Therefore, control of 
molecular sieve pore size, especially in the mesopore range, had been sought after 
from an applications standpoint, yet presented an elusive synthesis challenge.  
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Figure 2.9 Typical length scales of three-dimensional porous structures. 
The discovery of the first ordered, mesoporous molecular sieves (designated as 
M41S) has sparked interest throughout the scientific community (Kresge, et al., 1992; 
Beck, et al., 1992). These materials, which can be synthesized with pore sizes from 15 
to over 100 Å, have expanded the application of mesoposous molecular sieves to: 
shape-selective catalysis and sorption of large organic molecules, chromatographic 
separations, and uses as hosts to confine guest molecules and atomic arrays. The 
concept of ‘liquid crystal templating’ with molecular aggregations of surfactants, 
proposed as a key mechanistic step in the formation of these materials, has expanded 
the established idea of classical single molecular interaction in the formation of 
molecular sieves and provide new synthetic routes to engineer porous, inorganic solids. 
In the synthesis of mesoporous silica, four main components are a source of silica, 
structure-directing surfactants, a catalyst (an acid or a base) and a solvent. For example, 
the original M41S family of mesoporous molecular sieves was synthesized, in general, 
by the combination of appropriate amounts of a silica source (e.g. tetraethylortho-
silicate (TEOS), Ludox, fumed silica, sodium silicate), an alkyltrimethylammonium 
halide surfactant (e.g. cetyltrimethylammonium bromide (CTAB)), a base (e.g. sodium 
hydroxide or tetramethylammonium hydroxide (TMAOH)), and water. With MCM-41 
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(which has hexagonally packed cylindrical mesopores) as the representative of M41S 
materials, two mechanistic pathways based on ‘liquid crystal templating’ shown in 
Scheme 2.1 were postulated by the Mobil researchers (Beck at al., 1992; Kresge et al., 
1992): 
1) True liquid-crystal template mechanism: The aluminosilicate precursor species 
occupied the space between a preexisting hexagonal lyotropic liquid crystal (LC) phase 
and deposited on the micellar rods of the LC phase. 
 
Scheme 2.1 Formation of mesoporous materials by structure-directing agents: a) true 
liquid-crystal template mechanism, b) cooperative liquid crystal template mechanism. 
(Hoffmann et al., 2006). 
2) Cooperative liquid crystal template mechanism: The inorganics mediated, in 
some manner, the ordering of the surfactants into the hexagonal arrangement. In either 
case, the inorganic components (which were negatively charged at the high pH values 
used) preferentially interacted with the positively charged ammonium head groups of 
the surfactants and condensed into a solid, continuous framework. The resulting 
organic-inorganic mesostructure could be alternatively viewed as a hexagonal array of 
surfactant micellar rods embedded in a silica matrix; removal of the surfactants 
produced the open, mesoporous MCM-41 framework. It is now known that pathway 1 
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did not take place because the surfactant concentrations used were far below the 
critical micelle concentration (CMC) required for hexagonal LC formation (Vartuli, et 
al., 1994).  
Major advances in understanding and exploiting the synthesis protocols and 
mechanism of formation of these materials have allowed designed tailoring of 
composition, pore size, structure, texture and morphology. After MCM-41 (Kresge et 
al., 1992) as the hexagonal members and MCM-48 (Beck et al., 1992) as the cubic Ia3d 
member of the ordered mesoporous materials had been synthesized, a wide range of 
other structures became available quite rapidly, most of which had pure surfactant 
liquid crystal counterparts. For the hexagonally ordered mesoporous silicas the route 
leading to the formation of SBA-15 (Zhao et al., 1998) is the most exciting novel 
development after the discovery of the initial pathways. SBA-15, which has tunable 
large uniform pore sizes (up to ∼300 Å), two-dimensional (2D) hexagonal (p6mm) 
mesostructure and thick uniform silica walls (31 to 64 Å) is prepared by using 
amphiphilic block polymers as templates.  
As mentioned earlier, in preparing M41S mesostructured materials, ionic 
surfactants such as the cationic alkyltrimethylammonium (CnTA+, n = 8–18), anionic 
alkylsulfonates (CnSO32-, n = 12–18) or alkylphosphates were used as supramolecular 
templates. These syntheses were performed in extreme (acid or alkaline) pH conditions, 
yielding materials with controlled pore size (15–100 Å). However, two main 
limitations exist: (a) typical wall thickness of 8–13 Å, which is a serious limitation 
regarding stability for catalysis; (b) limited pore size offered by molecular surfactants. 
The only way to go beyond 50 Å pore size consisted in employing swelling agents 
(such as trimethylbenzene), involving complicated synthesis, and irreproducibility 
(linked to emulsion formation or phase separation). Thus, more versatile 
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supramolecular templates were needed. Amphiphilic block copolymers (BC) belong to 
an important family of surfactants, widely used in detergency, emulsifying, coating, 
thickening, etc. The self-assembly characteristics of these BC permit to control the 
superstructure, to vary the typical length scales and to add specific functions. Indeed, 
the properties of BC can be continuously tuned by adjusting solvent composition, 
molecular weight or polymer architecture. Table 2.3 compares the characteristics of 
BC vs. low-weight ionic surfactants.  
Table 2.3  Characteristics of surfactants and block copolymer (Soler-Illia et al., 2003). 
Surfactant block copolymer 
Solution and mesophase behavior 
Molecular/monodisperse 
Head+chain structure object shape controlled 
by the g packing parameter a 
Simple micelle-like or bicontinuous 
mesostructures 
Micellization driven by 
hydrophilic/hydrophobiccharacter 
Cosolvent swelling modifies curvature 
 
 
Use in the design of mesostructured materials
‘Hard’ well-defined HI 
Thin walls (1–1.5 nm) 
Walls not entangled with the 
template 
Pore size limited by micelle size 
 
Polymeric/can be polydisperse 
Enormous range of architectures: linear, 
branched, star, …shape controlled by xAB , N and 
f A, f B,b 
Possibility of complex multiscale mesostructures 
(e.g. ‘knitting patterns’) 
Micellization driven by 
Hydrophilic/hydrophobic character, block size 
and conformation 
Differential swelling of domains by cosolvents 
 
‘Blurry’ interface, swollen by the inorganic phase
Thick walls (2–10 nm) 
Walls entangled with the template (‘multiphase’) 
Pore size tailorable by modifying the 
polymerization degree, monomer nature or 
polymer fraction 
a g = V/Lc A0, according to (Israelachvili et al.,1976); see also (Soler-Illia et al., 2002). 
b xAB is the Flory–Huggins parameter; N = NA + NB +…is the total degree of polymerization 
(NA,NB,…are the respective degrees of polymerization of each block); f A, f B are the volume 
fractions of each block. 
 
Two main processes can be recognized in the formation of mesoporous silicas 
(e.g. SBA-15) templated by BC: 
1) The creation of an organized texture, due to the self-assembly properties of the 
template. This process results in a microphase separation, which divides the space in 
two domains: hydrophilic and hydrophobic, in the case of the simplest BC surfactants; 
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2) The formation of an inorganic network. The inorganic components are placed 
in one of the spatially separated parts of these nano-heterogeneous systems. 
Condensation reactions will give rise to an extended inorganic network; these reactions 
can be tuned to take place simultaneously or subsequently as organization proceeds. 
Three fundamental interactions that will control the final obtained structure: 
surfactant–surfactant (S–S), inorganic–inorganic (I–I) and surfactant–inorganic (S–I). 
These interactions take place in each of the microsegregated phases, or at the 
inorganic-template hybrid interface (HI). The solvent will also take part in mesophase 
formation. The most relevant thermodynamic aspects in the formation of a hybrid 
mesophase (∆Gms) have been defined by Huo et al. (1994) in their description of the 
cooperative assembly model.  
∆Gms = ∆Ginter + ∆Ginorg + ∆Gorg + ∆Gsol                                             (Equation 2.1) 
The central points to a well-defined mesophase formation are (1) the adequate 
segregation of hydrophilic and hydrophobic regions of the template (mainly ∆Gorg) (2) 
the selective positioning of the inorganic counterpart in one of these regions, without 
disrupting organization; this is related to the creation of a well-defined and compatible 
HI between the inorganic walls and the organic templates (i.e. ∆Ginter is important). In 
principle, |∆Ginorg| < |∆Ginter| or |∆Gorg| to permit the latter two terms to direct the 
formation of organized assemblies. 
An important advantage of BC compared to ordinary surfactants is that all 
relevant terms leading to order (i.e. ∆Ginter and ∆Gorg) can be pre-designed from the 
synthesis. The hydrophilic/lipophilic balance (HLB) and shape can be tuned by 
changing the polymerization degree. Moreover, the intrinsic chemistry of each block 
can be changed, modulating the interactions with the inorganic units that build up the 
framework. 
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The S–I interaction is particularly important in BC-metal oxide hybrids, 
especially in PEO–PPO based ones. Different possible interactions taking place at the 
HI are schematized in Figure 2.10. Most of the fine HI characterization has been 
performed on PEO-based (di- or tri-block) templates. Melosh et al. (1999) determined 
that in F127-templated silica monoliths, organization arose for polymer weight fractions 
higher than 40%. For lower polymer/silica ratios, non-ordered gels were formed. This 
lack of order was due to a relatively strong interaction (probably of H-bonding type) of 
the (Si-O–Si) polymers forming the inorganic skeleton with both PEO and PPO blocks, 
as demonstrated by CP-MAS NMR. These strong interactions extend the HI, hindering 
PPO segregation. For higher polymer concentrations, the PPO/PPO (S–S) attractions 
take over the Si–O/PPO (S–I) interactions, and microsegregation takes place, resulting 
in mesostructural order. In all examined cases, a strong interaction was observed 
between the PEO block and the silica polymer. A similar feature has been proposed to 
explain the microporosity of SBA-15. Quantitative XRD analysis of as-synthetized 
SBA-15 leads to a pore model where a low-density ‘corona’ (formed by 
interpenetrated PEO and silica, Figure 2.10b) is located between the pore center and 
the silica wall; this less dense zone can be held responsible for the observed 
microporosity. However, recent work by Haddad et al. (2002) suggests that 
microporosity is rather related to incomplete silica condensation. 
In summary, a thermodynamic point of view is extremely useful to understand the 
formation of BC-templated mesoporous materials, but the compatibility between two 
polymers (the BC and the inorganic part, which is a polymer itself) should be taken 
into account. Better order is related to an adequate balance of the S–S interactions 
(∆Gorg) that form the mesophase, with the S–I (∆G hybrid) interactions at the HI, via 
adjusting VTS, h or the HLB of the template and/or the inorganic precursor. Too strong 
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interactions at the HI can disrupt the formation of an organized mesophase, yielding an 
intimately mixed hybrid material, presenting no ordered segregation at the mesoscopic 
scale. Due to the crossed kinetic effects, temperature, an essential variable, should be 
more thoroughly explored before clear trends arise. 
 
Figure 2.10 (a) Schematic view of the (S0H+)(X-I+), S0I0, and (S0M+)(X-I0) HIs. (b) Three 
possible structures of a HI composed by a nonionic polymer and an inorganic framework. 
Left: a three-phase HI; the PEO block is completely segregated from the inorganic phase. 
Right: a two- phase HI, where the inorganic polymer is completely integrated into the PEO 
block. Center: an intermediate situation, where a fraction of the PEO is free (Soler-Illia et 
al., 2003). 
 
2.4.2 Applications of Ordered Mesoporous Materials 
2.4.2.1 Catalytic Applications 
The unique physical properties of mesoporous materials have made these 
materials highly desirable for catalytic applications. The extremely high specific 
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surface areas are conducive to high catalytic activity. The larger pore size (relative to 
that of microporous zeolites) allows for the fixation of large active complexes, reduces 
diffusional restriction of reactants, and enables reactions involving bulky molecules to 
take place.  
Many efforts have been taken to create solid-state acids based on mesoporous 
silica phases that could be used a heterogeneous acid catalysts, in analogy to Brønsted 
acidic zeolites, but as they possess larger pores they should be able to incorporate 
larger substrates. Among them, mainly sulfonic acid derivatives were anchored by 
using both one- and two-step functionalization strategies. Dufaud et al. (2003) 
discovered an interesting approach to the introduction of sulfonic acid groups into 
SBA-15 phases by functionalization with a bissilylated disulfide reagent followed by 
cleavage of the disulfide bridges and oxidation of the resulting thiols into sulfonic acid 
groups. The resulting material has two sulfonic acid groups which possess a specific 
spatial separation from one another. Mbaraka and Shanks (2005) anchored hydropho-
bic alkyl residues to the remaining free silanol groups so as to keep the disruptive 
water produced during esterification of fatty acids away from the immediate 
neighborhood of the catalytic center. Alvaro et al. (2004) lined MCM-41 and SBA-15 
phases with perfluorosulfonic acid groups in a single-stage functionalization reaction. 
These solid-state acids led to good yields and selectivities in the condensation of 
phenol and acetone to bisphenol A (Das et al., 2004; Dufaud and David, 2003) and 
high activities were recorded in the acetalation of acetophenone with ethylene glycol 
(Shimizu et al., 2005) as well as in the preparation of dibutyl ether from 1-butanol in a 
dehydration reaction. 
Organically functionalized mesoporous silica phases are believed to be suitable 
candidates for the creation of efficient heterogeneous catalysts. In addition to the 
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numerous studies on the catalytic properties of silica materials functionalized with 
metal salen complexes, there are purely organic studies involving functionalization 
with alkaloids and alkaloid derivates, amino alcohols, as well as proline and 
benzylpenicillin derivatives. Motorina and Crudden (2001) functionalized SBA-15 
with a cinchona derivative and used the resulting material for the asymmetric 
dihydroxylation of olefins under sharpless conditions. The obtained enantioselectivitie 
could reach up to 99%, almost identical to those that are obtained with the 
corresponding homogeneous system. In addition, the catalyst could be recovered 
without difficulty and used several times without critical loss in yield and selectivity. 
Lee et al. (2004) anchored a chiral bis(oxazoline) ligand onto SBA-15 samples and 
tested this catalytic species in the nitro-Mannich reaction of (E)-ethyl-2-(4-
methoxyphenylimino)acetate with nitroalkanes of differing chain lengths. They 
obtained enantioselectivities that, depending upon the chain length, were comparable 
to the analogous homogeneous system, and diastereoselectivities that were even higher. 
The pore systems of mesoporous silica phases have sizes that can accommodate at 
least small enzymes or proteins; this applies to a lesser extent for MCM-41/48-like 
phases and to a greater extent for SBA-15-like phases. Yiu et al. (2001a; 2005) used 
unmodified MCM-41/48 and SBA-15 phases as well as carboxy-, aminopropyl-, thiol-, 
cyano-, and phenyl-modified SBA-15 phases for the immobilization of trypsin. The 
activity of the trypsin was measured on the basis of the hydrolysis of N-a-benzoyl-
dlarginine-4-nitroanilide. They found that the thiol-functionalized phase was highly 
promising. Lei et al. (2002) successfully used amino- and carboxy-functionalized 
SBA-15 phases to immobilize the enzyme organophosphorus hydrolase, and found that 
in the adsorbed state, the activity was doubled than that in the free state. Ma et al. 
(2004) carried out studies on the activity of porcine pancreas lipase immobilized on the 
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surface of MCM-41 samples solely by hydrogen bonds. The strong decrease in activity 
following recovery (simply because of leaching of the enzyme from the pores) could 
not be prevented even by functionalization with vinyl groups after immobilization of 
the enzyme, which was anticipated to lead to stronger binding of the enzyme to the 
surface. Also, there are many other reports regarding the immobilization of 
conalbumin (Han et al., 1999), cytochrome c (Washmon-Kriel et al., 2000) subtilisin 
(Takahashi et al., 2001), (chloro-) peroxidases (Han et al., 2002), and lysozyme (Vinu 
et al., 2004) in SBA-15. 
2.4.2.2 Nanocasting 
Since many mesoscaled periodic materials can not be derived from sol–gel 
processes, nanocasting has brought forward incredible possibilities in preparing novel 
mesostructured materials (Schüth, 2001). Nanocasting is an extension of the 
templating concept in the preparation of zeolites and mesoporous materials (Scheme 
2.2). This nanocasting synthetic pathway was originally evolved from the porous 
Al2O3 membrane templating method (Martin, 1994). By using etching techniques, 
porous Al2O3 anodic membranes can be prepared, which can be further used as hard 
templates to prepare metal, metal oxide or metal sulfide nanostructures by 
electrodeposition or chemical vapor deposition (CVD) (Zelenski and Dorhout, 1998). 
Limited by the preparation process, the pore size of this kind of membrane is usually 
larger than 20 nm with a relatively broad pore size distribution and a poor pore 
structure regularity. Therefore, mesoporous silicate materials with highly ordered pore 
structures and uniform pore size are more ideal hard templates. Templated by 
mesoporous materials with different meso/micro structures, nanocasting can lead to 
nanowire arrays with a diameter smaller than 10 nm, or nanowire arrays that are inter-
connected by small pillars formed in the micro- or mesopores in the pore walls, which 
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will result in high surface area and narrow pore size distribution, or different 3-D 
frameworks with tunable mesostructures. The synthetic procedure is also simpler to 
carry out than the porous Al2O3 membrane templating method. With preformed 
mesoporous materials serving as a confined reactor or growing space, inorganic 
precursors are incorporated into the mesopores, and the unique, highly ordered 
nanorod or nanowire arrays can be prepared by further treatment, which cannot be 
obtained by other methods. In this method, instead of organic amines or surfactants, 
highly ordered mesoporous silicates are employed as templates, which are considered 
as hard templates. The precursors can be incorporated into the channels of mesoporous 
silicates by sorption, phase transition, ion exchange, complex or covalent grafting. 
Upon heat treatment, the precursors are thermally decomposed, and the nanoparticles 
derived grow larger and larger by interconnection to each other combined with a 
crystallization process. The byproducts generally leave the channels in the gas phase. 
If the loading rate of the precursors is high enough, during the annealing process, the 
nanocrystals may interlink with each other and form continuous frameworks. Even 
after the templates of the mesoporous silicates are dissolved, the mesostructures are 
fully copied by the nanocrystals, and replica materials such as unique nanorods or 
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There are many advantages for the nanocasting strategy using mesoporous 
silicates as templates: 1) Small size in the range of 2-10 nm can be achieved for the 
replica nanostructured arrays derived mesoporous silicates. This nanoscaled arrays 
make superior physical properties, such as quantum effects, possible (Scott et al., 
2001). 2) The obtained replica materials may show alternative topologies, such as 1-D 
nanowire arrays or 3-D bicontinuous nanowire arrays, which depends on the variable 
mesostructures of the silicate hosts. 3) The mesoporous silicate hosts can be prepared 
with different macroscopic morphologies, which will further control the morphology 
of the replica frameworks. 4) The chemical properties of the silicates are relatively 
stable during thermal or chemical treatments, and the precursors can be transformed 
into the nanocrystals by many different means. 5) The highly ordered mesostructures 
of the silicate templates provide the best mold to obtain highly ordered replicas. In 
many ways, the nanocasting method is quite effective and simple for the preparation of 
metal, metal oxide, metal sulfide and polymer replica mesostructures. Several 
pathways have been reported for the preparation of ordered mesoporous silicates, 
therefore, high-quality hard templates are easy to obtain. In addition, the sol–gel 
process is avoided, and there are more alternative choices for the precursors, such as 
metal chlorides, metal nitrates, metal acetates, organometallic complexes and so on.  
 
2.4.2.3 Sorption and Separate Applications 
The application of ordered mesoporous materials in the area of the separation and 
adsorption has also received a great deal of attention. The uniform pore structure 
within the mesopore range and the resultant high pore volume offer materials for 
separations that vary from the removal of organic and inorganic contaminants in waste 
streams to chromatographic media. Early work demonstrated the extraordinary high 
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sorption capacity of the mesoporous materials for hydrocarbon molecules such as 
benzene (Beck at al., 1992; Kresge et al., 1992). It was shown that modification of the 
pore walls by post functionalization could substantially alter the sorption capacity and 
behavior of these materials (Beck at al., 1992). Replacing the pore wall silanol groups 
with trimethylsilyl groups created a more hydrophobic environment within the pore 
structure which resulted substantial reduction in sorption capacity of polar molecules 
such as water.  
Some articles illustrated the use of functionalized MCM-41 or SBA-15 for 
solving environmental pollution by selective adsorption of heavy metals due to their 
high adsorption capacity and possible specificity for certain contaminant. These 
researchers functionalized the pore walls of silica with a mercaptopropylsilane or other 
groups. The resultant material demonstrated a high affinity to extract mercury and 
other heavy metals from both aqueous and nonaqueous waste streams. The pioneering 
work on SBA-15 is done by Liu et al. (2000), who prepared thiol- and amino-
functionalized SBA-15 silicas with uniform mesoporosities for removing heavy metal 
ions from waste water. In a most recent work, Yang et al. (2005) used thiol-
functionalized SBA-15 as adsorbents for heavy metal ions such as Hg2+, Cd2+, Zn2+, 
Cu2+ and Cr3+, and found SBA-15 had almost similar affinity to Hg2+, Cd2+, and Cr3+. 
And Antochshuk et al. (2002) attached 1-allyl-3-propylthiourea functionality into 
SBA-15 samples, and found they had promising properties towards mercury ion 
adsorption. Furthermore these researchers also demonstrated that this functionalized 
materials could be regenerated and reused. In addition to heavy metal adsorption, in 
several reports, enzymes or proteins have been attached to the pore walls of M41S 
materials or SBA-15, such as cytochrome C and trypsin (Diaz and Balkus, 1996; Yiu 
et al., 2001b; Vinu et al., 2004; Salis et al., 2005). In a recent article, Katiyar et al. 
 2 / Literature Review 
    52
(2006) proposed to apply SBA-15 for preparative chromatography of biomolecules. 
They investigated the adsorption of bovine serum albumin and lysozyme on SBA-15 
spheres, and a very high capacity of 700 mg/g of lysozyme were obtained on the 
spherical SBA-15 particles with pore diameter of 127 Å.  
Modification of the pore wall by coating the mesoporous structure can also alter 
the adsorption behavior of the material. Vartuli et al. (1998) produces an anionic-
exchange chromatographic material by using siliceous MCM-41 as the support media 
and coating it with a polyethyleimine. The coated material demonstrated excellent 
selectivity and high static adsorption of acidic nucleotides. This static capacity 
demonstrated by the MCM-41 material was higher than a comparable coated material 
prepared with amorphous silica.  
From a technological point of view, the preparation of uniform mesoporous 
materials in the form of thin films or membranes is often desirable, because they would 
have great utility for separation applications ranging from chemicals to pharma-
ceuticals. The performance of mesoporous membranes in gas separation processes can 
be improved by surface-derivatisation of the membrane by organic groups such as 
octadecyltrichlorosilane (Javaid and Ford, 2003). The gas separation by such modified 
membranes is thought to result from differences in solubility of the gases in the 
modified membrane. Other examples of applications of mesoporous inorganic 
membranes include the separation of supercritical CO2 (SCCO2) from mixtures 
containing caffeine (Tan et al., 2003) or the use of non-silicate yttria-zirconia 
membranes in solid-oxide fuel cells (Crepaldi et al., 2003) and for ultrafiltration in 
harsh environments (Kim and Lin, 1998). 
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2.4.2.4 Biomedical Applications 
Another important potential application of mesoporous silica that has attacted 
increasing interests in the last five years is their utilization in biomaterials science. Due 
to the outstanding features of surface and porosity, ordered mesoporous materials have 
shown to be excellent candidates for two biomedical applications: local drug delivery 
systems and bone tissue regeneration (Vallet-Regi, 2006). In fact silica-based 
mesoporous materials are able to incorporate high dosages of drugs into the mesopores 
(Vallet-Regi et al., 2001). Moreover, their silanol-containing surface can be 
functionalized, allowing a better control over the drug release, which depends on the 
chemical nature of the functional group attached to the surface (Horcajada et al., 2006) 
Because a well-ordered pore distribution in a ceramic matrix favors the 
homogeneity of the adsorption and release stages; thus, ordered silica mesoporous 
materials are potentially excellent candidates and can play a significant role in the field 
of controlled drug delivery systems. This fact was evidenced for the first time by the 
confinement of ibuprofen in two MCM-41 matrices with different pore diameters (1.9 
and 2.5 nm) (Vallet-Regi et al., 2001). The weight percentage of ibuprofen in MCM-41 
reached a value of about 30%; the drug was released from the MCM-41 matrix by 
immersion of the delivery system in a simulated body fluid. Working under optimum 
conditions, the full amount of ibuprofen loaded in the MCM-41 matrix was released to 
the external medium within three days. Following results found that the pore 
morphology, surface area, functionalized mesopore internal surfaces, hydrophobicities 
and even bulk morphology are all important factors determining drug adsorption and 
release behavior.  
The pore morphology and clearance determine the type of molecules that can fit 
into it and, therefore, those that are eligible for the adsorption process; however, the 
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maximum amount accepted depends on the pore volume, which is generally described 
in terms of cm3g-1 of material. In systems that only contain mesopores, the total pore 
volume is evidently equal to the mesopore total volume, but this is not generally the 
case. Frequently, there are also micropores or even macropores (pores with diameter 
larger than 50 nm) present; this last type of pore is usually associated to interparticle 
porosity, and its contribution to the total pore volume increases with a decreasing 
particle size in the material. Undoubtedly, the specific surface is a parameter that 
influences the adsorption properties of the material, since it is a surface phenomenon 
itself. The concept of surface encompasses not only the outer surface of the material, 
but also the inner surface of its cavities and channels, provided that the nitrogen-based 
molecules used in these measurements can pass freely through these inner areas. 
It seems reasonable to believe that the pore size must affect the amount of drug 
readily adsorbed. Horcajada et al. (2004) compared the amount of ibuprofen adsorbed 
on MCM-41 type mesoporous materials with different pore diameters (2.5, 1.9, 1.6, 1.5 
nm), they found that, the adsorption amount of ibuprofen depends on the matrix pore 
size, hence allowing the regulation of the amount of drug introduced. Besides, the 
release rate is directly proportional to the pore size, and it is feasible to predict such 
rates. 
The pore walls in ceramic matrices can be functionalized with a wide range of 
chemical species in order to modify their adsorption properties. These features make 
them suitable to host different pharmaceutical species and to release them in a 
sustained regime to the external medium, for long time periods, under appropriate 
conditions. The surface of MCM-41 material has been modified by reaction with the 
organosilanes Cl-Pr, NH2-Pr, Ph, Bz, SH-Pr, CN-Pr and Bu. This modification allows 
the selection of the appropriate group depending on the drug and its application. In the 
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case of ibuprofen, which has an acid group, different drug adsorption and delivery 
rates have been found depending on the functional groups. Thus, MCM-41 modified 
with polar groups show higher ibuprofen adsorption than that with nonpolar groups. 
Besides, the ibuprofen release is slowed down with SH-Pr and NH2-Pr groups. This 
study evidenced the possibility to design the matrices, according to the functional 
groups of the pharmacological molecule which will be inserted, allowing to choose the 
dosage and the release kinetics (Horcajada et al., 2006). 
Following the first publication in 2001, which utilize the new property of MCM-
41 as controlled release for ibuprofen, many other contributions have appeared to use 
other mesoporous materials like SBA-15 as controlled release drug matrices for 
various drugs and chemical species.  
In addition to their application for drug delivery, Vallet-Regi et al. (2006) found 
that the silanol groups located on the walls of silica mesoporous materials are not only 
useful to be anchor point for functionalization with various groups, they are also able 
to react with physiological fluids to produce nanometre-sized carbonated apatite. 
Izquierdo et al. (2005) studied in vitro bioactivity of SBA-15, MCM-48 and MCM-41 
by soaking these three different mesoporous materials into simulated body fluid. They 
revealed that an apatite-like layer is formed on the surface of SBA-15 and MCM-48 
materials after 30 and 60 days, respectively. Based on this observation, they described 
a new application of mesoporous materials in biomedical engineering for tissue 
regeneration such as bone regenerators. This group also found that, MCM-41 exhibited 
a bioactive behavior when its walls were doped with phosphorus (Vallet-Regi, 2005) 
or when small amounts of bioactive glasses were added (Horcajada et al., 2004). They 
concluded that the textural and structural properties of the mesoporous materials play 
an extremely important role in their bioactive behavior. The possibility to control the 
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periods of time needed for a positive response, together with the ability to 
functionalize the surface and the introduction of osteogenic substances inside the pores, 
open new expectations for designing novel mesoporous materials directed to specific 
medical applications. Their studies suggested that, taking into account the ability to 
introduce different species in the mesoporous matrices that can be subsequently 
released in a controlled fashion, combining this property with their inherent bioactivity 
could open new fields of application for these materials in tissue engineering, in which 
they can act as cellular scaffolds with embedded proteins, peptides or growth factors, 
that would be released to the medium promoting cell proliferation and differentiation. 
Currently, the use of such bioactive mesoporous silica as scaffolds for tissue 
engineering is still at a very preliminary stage of research; however, it may be 
predicable that their application in bioengineering will receive more and more interest 
in the next few years. 
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CHAPTER 3 - MATERIALS AND METHODS 
3.1   Materials 
3.1.1 Ibuprofen - a model drug 
The model drug, ibuprofen, is also known as 2-(4-isobutylphenyl)propionic acid 
and the chemical structure is shown in Figure 3.1. Ibuprofen is a weakly acidic non-
steroidal anti-inflammatory drug that is slightly insoluble in water. A pKa of about 3.6 






Figure 3.1 Chemical structure of ibuprofen or 2-(4-isobutylphenyl) propionic acid. 
The biological half-life of 1.8 to 2 hours means that an oral dosage formulation of 
this drug will be rapidly and almost completely absorbed from the gastrointestinal tract 
with peak plasma concentrations occurring within 1-2 hours. The main adverse effects 
of ibuprofen are gastrointestinal disturbances. In addition, poor solubility in water 
together with the short plasma elimination half-life affect its bioavailability hence 
ibuprofen’s suitability for modified release dosage forms. A wide therapeutic range or 
window of 1200 to 1800 mg/day up to a maximum of 3200 mg/day allows formulation 
into controlled release dosage forms with minimal risk of toxicity.  
 
3.1.2 Bovine Serum Albumin - a model protein drug 
Bovine serum albumin (BSA) is a large globular protein with a good essential 
amino acid profile. It has been well characterized and the physical properties of this 
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protein are well known [Table 3.1, (Peters, 1997)]. It has been commonly used as a 
model protein drug in various protein delivery systems.  
Table 3.1 Physicochemical properties of bovine serum albumin (Peters, 1997). 
Property Bovine Serum Albumin 
Molecular weight 66,500 daltons 
Sedimentation constant (S20,w x 1013) 4.5 (monomer), 6.7 (dimer) 
Diffiusion constant (D20,w x 107, dcm2/s) 5.9 
Partial specific volume (V20) 0.733 
Intrinsic viscosity 0.041 
Overall dimensions (Å), from physical chemistry 41.6 x 140.9 
Isoionic point 5.15 
Isoelectric point 4.7 
Net charge per molecule -17 
Optical absorbance at 279 nm, 1 g/L 0.667 
Estimated alpha helix, (%) 





The Bradford assay was frequently used in this thesis to determine the 
concentration of BSA in solution. The procedure is based on the formation of a 
complex between the dye (Brilliant Blue G) and proteins in solution. The protein-dye 
complex causes a shift in the absorption maximum of the dye from 465 to 595 nm. The 
amount of absorption is proportional to the protein present (Bradford, 1976). Two 
protocols were followed based on different protein concentrations: 1) Standard 3.1 ml 
assay, in which the protein concentration of 0.1-1.4 mg/ml was determined. 0.1 ml of 
the protein sample and 3 ml of the Bradford Reagent (Sigma, USA) were mixed 
together and the absorbance was measured at 595 nm. The protein concentrations were 
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determined by comparison of the unknown samples to the standard curve prepared 
using the protein standards; 2) Micro 2 ml assay, in which the protein concentration of 
1-10 µg/ml was determined. The assay used 1 ml of the protein sample and 1 ml of the 
Bradford Reagent (Sigma, USA). 
MTT assay was used to determine the cytotoxicity of SBA-15 materials. 3T3 
mouse fibroblasts cells (3T3-Swiss albino, ATCC) were selected for the assay as they 
are substrates-dependent, non-specific cell lines. These cells were cultured in a 
complete growth culture medium in a 5% CO2 incubator. The complete growth culture 
medium was prepared with Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum, 1mM L-glutamine and penicillin (100 
U/ml). Cell viability testing was carried out via the reduction of the MTT reagent (3-
[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyltetrazolium bromide, Sigma, USA). This assay 
provides a simple method for determining comparative cell viability using a standard 
microplate absorbance reader (Masmann, 1983). The MTT assay was performed with 
SBA-15 powders placed at the bottom of a 96-well plate following the standard 
procedure with minor modifications. Control experiments were carried out using the 
complete growth culture medium only (serving as non-toxic control) and 1% Triton X-
100 (Sigma) (as toxic control). 3T3 fibroblasts in the complete growth culture medium 
(100 ml) were seeded at a density of 104 cells/well in a 5% CO2 incubator for 24 h. The 
culture medium from each well was then removed and 100 ml of medium and 20 ml 
MTT solution (5 mg/ml in PBS) were then added to each well. After 24 h of incubation 
at 37˚C and 5% CO2, the media were removed and the formazan crystals were 
solubilized with 100 ml dimethyl sulfoxide (DMSO, Sigma) for 15 min. The optical 
absorbance was then measured at 570 nm on a microplate reader (Tecan, GENios).  
The data obtained were evaluated for statistical significance using the two sample t-test. 
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The results are reported as mean ±SD and the differences observed between samples 
were considered significant at P<0.05. 
Nitrogen adsorption/desorption isotherms of catalysts samples were determined 
using Autosorb-1 (Quantachrome, USA). About 0.1 g of sample was first outgassed at 
300°C for about 4 hours or 60°C for about 12 hours (For samples which may be 
decomposed at higher temperature). Nitrogen at 77.4 K was used as the adsorbate. The 
specific surface areas and the pore size distribution of supports were respectively 
calculated according to linear portion of the BET plot and Barrett-Joyner-Halenda 
(BJH) method. 
X-ray diffraction (XRD) analysis was carried out using a Shimadzu XRD-6000 
X-ray powder diffractometer (Shimadzu, Japan), where Cu target Kα-ray (operating at 
40 kV and 30 mA) was used as the X-ray source. The scanning range (2θ) was from 
0.7° to 7.0° with a scanning speed of 1.0°/min using a continuous scan mode.  
A high-resolution transmission electron microscopy (TEM, JEOL JEM-2010, 
Japan) with an electron kinetic energy of 300 kV was employed for scanning samples. 
The samples were prepared by dispersing the samples in deionized water or acetone 
via ultrasonic agitation. A drop of this well-dispersed suspension was placed on a 
carbon coated 300-mesh copper grid, followed by drying under ambient conditions 
before TEM scanning. 
X-ray photoelectron spectroscopy (XPS) was used to determine the chemical 
species C, O, S, or N. In this research, a Kratos AXIS XPS spectrometer (Kratos, 
England) was employed, using monochromatic Al Kα X-ray source (1486.6 eV, 225 
W) with a constant transmission pass energy of 80 eV. 
The infrared spectra characterizing surface groups of the materials were measured 
with Shimadzu FTIR-8700 spectrometer (Shimadzu, Japan) under a resolution of 2  
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cm-1. 10 mg of sample was pressed into self-supported wafer, degassed under vacuum 
(<10-5 mbar) and heated (120°С) or unheated for two hours prior to the IR 
measurements. 
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CHAPTER 4 - AMINE-FUNCTIONALIZED SBA-15 
MATERIALS AS CARRIERS FOR CONTROLLED 
DELIVERY OF IBUPROFEN 
4.1   Introduction 
Over the past three decades, there has been rapid growth in the area of drug 
delivery which is due to the underlying principle that drug delivery technology can 
bring both commercial and therapeutic values to health care products. Among the 
various materials employed in controlled drug delivery systems, polymeric materials 
provide the most important avenues for research and commercial applications. 
However, recently, there has been growing interest in the use of mesoporous materials 
as controlled drug delivery matrices because they have several attractive features, such 
as stable uniform mesoporous structures, high surface areas, tunable pore sizes with 
narrow distributions, and well-defined surface properties (Vallet-Regi et al., 2001; 
Muñoz et al., 2003; Tourné-Péteilh et al., 2003; Mal et al., 2003; Lai et al., 2003; 
Doadrio et al., 2004; Cavallaro et al., 2004; Xue and Shi, 2004), thus allowing them to 
adsorb certain kinds of drugs and release these drugs in a more reproducible and 
predicable manner. It has been shown that both small and large molecular drugs can be 
entrapped within the mesopores by an impregnation process and liberated via a 
diffusion controlled mechanism. The discovery of triblock copolymer templated SBA-
15 with large, controlled pore size and highly ordered hexagonal topology has opened 
the way to do intriguing experiments inside the resulting channel structures (Zhao et al., 
1998). By anchoring a variety of functional groups on the internal surfaces, the 
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sorption capacity and behavior of SBA-15 could be substantially altered. These 
properties have led SBA-15 to some intriguing applications, such as selective 
adsorption of heavy or noble metal (Liu et al., 2000; Kang et al., 2004), enzyme 
immobilization for biocatalysis (Lei et al., 2004; Deere et al., 2003; Vinu et al., 2004), 
and immobilization of large chelating groups (Corriu et al., 2002). In light of its 
potential application in the area of drug delivery, recently there have been attempts to 
apply pure SBA-15 as a drug host (Doadrio et al., 2004; Xue and Shi, 2004). However, 
for pure SBA-15, there exist only silanol groups on the channel walls, and these silanol 
groups simply form weak intermolecular hydrogen bonds with drugs; hence, they are 
not strong enough to hold drugs and allow them to be released in a sustained manner. 
The need to synthesize suitable carriers to have specific host-guest interactions with 
drugs led us to introduce functional groups on the surface of SBA-15. It has been 
reported that the organic functionalization of SBA-15 can be achieved via two 
different routes, i.e., one-pot synthesis (or co-condensation) (Yang et al., 2003; 
Mbaraka and Shanks, 2005) and postsynthesis (or silylation) (Yang et al., 2004; Chang 
et al., 2004; Choi et al., 2005). One-pot synthesis (OPS) is a one-step approach, in 
which SBA-15 is formed and at the same time functionalized by co-condensation of 
tetraethyl orthosilicate and triethoxysilane, while, in postsynthesis (PS), the 
functionalization is accomplished after the formation of stable SBA-15 structures. It 
would therefore be reasonable to presume that the functionalized SBA-15 synthesized 
through these two routes may have different surface properties, hence resulting in 
different applications of the material as hosts for various drugs. However, to our 
knowledge, there has been no detailed report till now that compares the surface 
performance of SBA-15 materials functionalized by the above two methods for their 
application as drug matrices. In this chapter, SBA-15 materials were functionalized 
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with amine groups by one-pot synthesis and postsynthesis. The surface physical and 
chemical properties of materials were investigated by FTIR, XRD, N2 
adsorption/desorption analysis, ζ potential measurement, nitrogen element analysis, 
XPS, and TEM. Ibuprofen (IBU), which was selected as a nonsteroidal anti-
inflammatory model drug, was loaded onto the SBA-15 materials and in vitro released 
in the medium of phosphate-buffered saline (PBS). The adsorption capacities and 
release behaviors of the drug on SBA-15 materials have been studied, with emphasis 
on the host (matrix)-guest (drug) interactions which determine the adsorption and 
release behaviors of drugs. 
 
4.2   Experimental 
4.2.1 Materials and Synthesis 
As-synthesized SBA-15 materials were prepared according to the procedure 
reported by Zhao et al. (1998) using Pluronic 123 triblock polymer 
[(EO)20(PO)70(EO)20, Mav = 5800, Aldrich, USA] as a structure directing agent and 
tetraethylorthosilicate (TEOS, Aldrich, USA) as silica source. The molar composition 
of the mixture was 1 SiO2: 0.017 P123: 2.9 HCl: 202.6 H2O. The mixture was first 
stirred to react at 40ºC for 24 h followed by hydrothermal treatment at 100ºC for 48 h 
under static conditions in a polypropylene bottle. All materials were filtered, washed 
with deionized water and dried at 60ºC overnight.  
To prepare functionalized SBA-15 by post-synthesis, the above materials were 
further calcined to remove the organic template. Then 1.0 g of pure calcined SBA-15 
reacted with 3-aminopropyltrimethoxysilane (APTMS, Sigma-Aldrich, USA) in 30 ml 
of 1, 4 dioxane (99%, Sigma-Aldrich, USA) under reflux for 24 h. The resultant white 
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solid was filtered off, washed with diethyl ether (3×20 cm3, Sigma-Aldrich, USA) and 
dried under vacuum. 
Functionalized SBA-15 prepared by one-pot synthesis was carried out using the 
same procedure as that used in the synthesis of as-synthesized SBA-15 except that 
APTMS was introduced together with TEOS. The surfactant template was removed by 
refluxing with ethanol (1 g of sample in 3×50 cm3 ethanol) for 10 h each time. It was 
reported that a maximum of 70% of surfactant could be removed by refluxing in 
ethanol (van Grieken et al., 2003). 
4.2.2 Drug Loading Procedures 
To load SBA-15 with ibuprofen (IBU, Aldrich, USA), 0.2 g of powder samples 
were added to 10 ml of ibuprofen-hexane solution (30 mg/ml) and soaked for 1 day 
under stirring until the concentration of solution did not significantly change; this was 
done by monitoring the ibuprofen concentration using a Shimadzu UV-3101 
spectrophotometer at a wavelength of 272 nm. The amount of drug loaded on the 
samples was determined according to the change of concentration before and after 
soaking. The powders were quickly and thoroughly washed with hexane and dried 
under vacuum. 
4.2.3 In vitro Drug Release Studies 
The release profiles of IBU were determined by soaking 0.2 g of samples into 100 
ml of PBS (Phosphate Buffer Saline, pH 7.4) under stirring at 100 rpm and the 
temperature was kept at 37 ± 0.1˚C. Samples of 5 ml were withdrawn at predetermined 
time, replaced by fresh medium and spectrophoto-metrically analyzed for IBU at 272 
nm.    
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4.2.4 Characterization Methods 
Nitrogen adsorption/desorption measurements were conducted using 
Quantachrome Autosorb-1 by N2 physisorption at 77 K. The BET specific surface 
areas of the samples were calculated in the range of relative pressures between 0.05 
and 0.25. The pore size distributions were calculated from the adsorption branch of 
isotherm using thermodynamic-based Barrett-Joyner-Halenda (BJH) method. The total 
pore volume was determined from the adsorption branch of the N2 isotherm at P/P0 = 
0.95. The FT-IR spectra were collected using a Shimadzu FTIR-8700 with a resolution 
of 2 cm-1. 10 mg of sample was pressed (under a pressure of 1 ton/cm2 for 10 sec) into 
a self-supported wafer 16 mm in diameter. Prior to analysis, the wafer was treated in 
an in-situ quartz cell equipped with CaF2 windows under vacuum (<10-5 mbar). Zeta 
potential measurements were performed using a ZetaPlus zeta potential analyzer 
(Brookhaven Instruments). High-resolution transmission electron microscopy was 
performed on JEOL JEM-2010 to examine the morphology of the samples. The total 
nitrogen content was determined by Perkin-Elmer Series II CHNS/O analyzer 2400. 
The small-angle XRD patterns were recorded under ambient condition on a Shimadzu 
XRD-6000 with Cu Kα radiation. The X-ray tube was operated at 40 kV and 30 mA, 
and a continuous 2θ scan mode from 0.7 to 5° was used with a resolution of 0.02°. X-
ray photoelectron spectroscopy was performed on Kratos AXIS HIS instrument to 
characterize surface nitrogen species. An Mg Kα X-ray source (hν = 1253.6) with 
analyzer pass energy of 40 eV was operated at 10 mA and 15 kV. All experiments 
presented here were performed in an untrahigh vacuum (UHV) chamber with a base 
pressure of less than 10-9 Torr.  In all cases, the binding energy of the C1s core levels 
(284.6 eV) was used as an internal standard to distinguish between band-bending and 
chemical shift.  
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4.3   Results and Discussion 
4.3.1 Characterization of Functionalized SBA-15 
FTIR is known to provide surface information of materials for identification of 
chemical groups. The incorporation of amine groups on the SBA-15 surface has been 
qualitatively confirmed by FTIR spectra as shown in Figure 4.1. Spectra a and b, 
which are related to the ethanol-extracted and calcined pure SBA-15, respectively, 
show the well-known IR adsorption bands due to the stretching vibrational mode of 
surface silanol groups in the range 3740-3500 cm-1 (Gallas and Lavalley, 1990; Gallas 
and Lavalley, 1991; Vrancken et al., 1992). The strong singlet peak at 2962 cm-1 in 
spectrum b is associated with the C-H stretching vibration, which arises from residual 
ethoxy groups due to incomplete hydrolysis (Nitta et al., 1999). The additional two 
peaks respectively centered at 2939 and 2908 cm-1 for spectra a and c can be assigned 
to the C-H stretching modes of CH2 and CH3 derived from the remaining surfactant 
template of (EO)20(PO)70(EO)20 (Su et al., 2003). For functionalized SBA-15 prepared 
by one-pot synthesis (shown as spectrum c), in addition to the above peaks, a new 
infrared absorption band assigned to NH2 asymmetric bending is observed at 1602   
cm-1 (Gianotti et al., 2002). This result shows that the surface has been successfully 
functionalized. The NH stretching, which normally appears at about 3380 and 3310 
cm-1, cannot be observed as it overlays with the broad band between 3500 and 3000 
cm-1 of surface hydroxyl groups (which were preserved during the ethanol extraction 
of surfactants). For spectrum d, which corresponds to functionalized SBA-15 prepared 
by post synthesis, a new band assigned to NH2 bending appears at 1595 cm-1 and two 
new bands assigned to CH2 stretching appear at 2935 and 2867 cm-1 due to the methyl 
groups introduced during silylation. Unlike spectrum c, the NH stretching mode can be 
clearly seen at 3386 and 3336 cm-1, and the bands assigned to silanol groups between 
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3740 and 3500 cm-1 are not present. The disappearance of silanol groups suggests an 











Figure 4.1 FTIR spectra of: a- ethanol-extracted SBA-15; b- calcined SBA-15; c- 
functionalised SBA-15 prepared by one-pot synthesis and d- functionalized SBA-15 
prepared by post-synthesis. 
The N2 adsorption/desorption data of functionalized SBA-15 prepared by one-pot 
synthesis (OPS1, OPS2, and OPS3) together with pure ethanol-extracted SBA-15 
(OPS0) are given in Table 4.1. For OPS1, OPS2, and OPS3 samples, their pore sizes 
are the same as that of OPS0. The result shows that there is no reduction in pore size 
for the functionalized samples prepared by one-pot synthesis compared to pure SBA-
15, suggesting that most of the functional groups have been distributed inside the 
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framework of inorganic materials and the low coverage of surface functional groups 
cannot significantly reduce the pore size (Kimura et al., 1999). 





















OPS0 0 - 602 86 0.96 0 
OPS1 4% - 571 86 0.93 0.69 
OPS2 5% - 590 86 0.95 0.89 
OPS3 6% - 570 - 0.73 1.09 
PS0 - 0 860 86 1.20 0 
PS1 - 8 473 78 0.76 2.35 
PS2 - 16 458 78 0.70 2.58 
PS3 - 24 469 78 0.75 2.77 
Figure 4.2 shows the N2 adsorption/desorption isotherms and pore size 
distribution for OPS1, OPS2 and OPS3 samples. The samples of OPS1 and OPS2 with 
molar ratio of APTMS/TEOS at 4% and 5% respectively show the typical IV 
isotherms with H1 hysteresis loops and moderate sharpness (Figure 4.2A). However, 
when the molar ratio of APTMS/TEOS is increased to 6%, the isotherm becomes 
distorted. This kind of distorted hysteresis loop is commonly found in some materials 
that are structurally disordered with a broad distribution of pore size (Figure 4.2B) and 
an ill-defined pore shape (Gregg and Sing, 1982). The adverse effect of functional 
agent can be explained as that, the amine groups of APTMS are readily protonated 
under acidic synthesis conditions as observed by Chu et al. (1993) and form 
zwitterions-like moieties (-SiO-···+H3NC3H6-Si≡) with silanol groups due to 
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hydrolysis of TEOS (Walcarius et al., 2003), which would disrupt the direct interaction 
















Figure 4.2 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- OPS0; b- OPS1; c- OPS2 and d-OPS3. (The isotherms are offset vertically by 300, 500 
and 800 cm3/g for samples OP1, OP2 and OP3, respectively. And the pore size 
distribution curves are offset vertically by 0.02, 0.04 and 0.06 cm3/Å/g for samples OPS1, 
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Figure 4.3 displays the powder XRD patterns of OPS1, OPS2 and OPS3 samples. 
For OPS1 and OPS2, both of which have a molar ratio of APTMS/TEOS below 6%, a 
well-resolved peak together with two small peaks can be indexed as the diffraction 
planes (100), (110), (200) due to the hexagonal array of SBA-15 mesopores, indicating 
that well-ordered mesoporous structures have been formed after functionalization by 
one-pot synthesis. However, when the molar ratio of APTMS/TEOS is increased to 6% 
(corresponding to nitrogen content in the sample around 1.09%, these peaks disappear, 
indicating that the ordered hexagonal structures cannot be obtained under this 
condition. TEM images (Figure 4.4) also show clearly that only amorphous or disorder 
structures can be observed on OPS3 (having APTMS/TEOS = 6%), while highly 
ordered mesostructures still exist for the other two samples with APTMS/TEOS below 
6%. All these results show that one-pot synthesis works well with APTMS/TEOS ratio 









Figure 4.3 Powder XRD pattern of: a- OPS0; b- OPS1; c- OPS2 and d- OPS3. 
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Figure 4.4 TEM images of: a- OPS0; b- OPS1; c- OPS2 and d- OPS3. 
Table 4.1 (page 69) also lists the N2 adsorption/desorption data of functionalized 
SBA-15 prepared by post-synthesis (PS1, PS2 and PS3) together with the pure SBA-15 
(PS0) and Figure 4.5 shows their isotherms. The pore size of PS1, PS2 or PS3 is 
around 78 Å, which is smaller than that of PS0, which has a pore size around 86 Å. 
This result suggests that the grafting of functional groups on the internal surface of 
pure SBA-15 has occurred, with the reduction of surface areas as well. Ryoo et al. 
(2000) Preported that the large mesopores of SBA-15 are generally accompanied by a 
certain amount of significantly smaller pores with a broad distribution primarily in the 
micro/small-mesopore range. The loss of surface area may be largely attributed to the 
disappearance of these complimentary smaller pores. Compared with the 
functionalized samples prepared by one-pot synthesis, the isotherms of those prepared 
by post-synthesis show a very sharp increasing step with a typical H1 hysteresis loop 
(Figure 4.5A) corresponding to the highly-ordered mesostructures and narrow pore 
size distribution (Figure 4.5B) even when APTMS/SBA-15 has been increased to 24 
mmol/g (which corresponds to the nitrogen element content in the sample around 
2.77%).  
d 
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Figure 4.5 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- PS0; b- PS1; c- PS2 and d- PS3. (The isotherms are offset vertically by 500, 800 and 
1000 cm3/g for samples PS1, PS2 and PS3, respectively. And the pore size distribution 
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Figure 4.6 shows the X-ray diffraction of PS1, PS2, PS3 and PS0. As illustrated 
in the figure, the mesoporous architecture remained intact after post functionalization, 
exhibiting a very intense diffraction peak at 2θ = 0.8-1° and two other weak peaks at 
2θ < 2°; these peaks can be indexed to (100), (110) and (200) planes, respectively, 
which are characteristic of the well-ordered hexagonal structure. This ordered array 
can also be seen directly from TEM images in Figure 4.7. All these results show that 
the uniformity of the functionalized mesopores of SBA-15 under high loading of 
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Figure 4.7 TEM images of: a- PS0 and b- PS3. 
4.3.2 Loading SBA-15 with IBU 
All SBA-15 samples were soaked into solutions containing drug molecules in 
order to entrap drug molecules into “nano-reservoirs”, i.e. the highly-ordered 
hexagonal nanoporous channels. Table 4.2 displays the adsorption capacities of model 
drug IBU on OPS and PS samples. The result shows that increasing quantity of 
functional agents (which would normally lead to high loading of functional groups) 
generally increases the loading amount of IBU, except for the OPS3 sample, which has 
amorphous, disordered structures. This result indicates that both functional groups and 
a 
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ordered structures play some roles in influencing the adsorption amount of drugs on 
the surface. A higher loading of amine groups would generally lead to a higher loading 
amount of drugs. However, for the amorphous structures, since the pore size 
distribution is broader, there are a large amount of micropores which are inaccessible 
to drugs. Hence, although OPS3 has a higher loading of amine groups, the amount of 
loading of IBU on this sample is relatively smaller, suggesting the influence of 
amorphous structures on the loading amount of IBU. For PS0 which has a higher 
surface area, larger pore size and more silanol groups on pore wall, since it is liable to 
form hydrogen bonding with the carboxyl group of IBU, a significant amount of IBU 
can also be loaded on pure SBA-15.  
Table 4.2 The loading amount of IBU on different SBA-15 samples. 
One-pot synthesis Post-synthesis 
Sample ID Loading amount of IBU (w/w) Sample ID 
Loading amount of 
IBU (w/w) 
OPS0 21.3% PS0 25.6 % 
OPS1 16.9% PS1 20.6 % 
OPS2 23.8% PS2 29.9 % 
OPS3 17.5% PS3 37.2 % 
The mesoporous structures of SBA-15 after being loaded with the drug molecules 
have also been characterized by powder XRD and TEM. The XRD pattern (not shown) 
shows that the hexagonal mesoporous structure loaded with drug molecules are similar 
to that of the unloaded samples. The three main XRD peaks are still observed, showing 
that the hexagonal mesopores of SBA-15 are stable during the entrapment of drug 
molecules inside the mesopores. TEM images (not shown) also directly show well-
ordered hexagonal arrays of mesopores, further confirming that highly-ordered 
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mesoporous structures of SBA-15 are stable during drug loading process. This stability 
of SBA-15 mesopores thus has potential application as a drug host, since the unique 
mesoporous structures of SBA-15 can be expected to keep stable under other harsh 
conditions, such as in the GI tract of human body. 
4.3.3 In vitro Release Studies  
Since in vitro dissolution testing is important for drug development and quality 
control, it was used in this study to investigate the difference of the release rate of 
model drugs from SBA-15 samples into PBS medium in order to evaluate best 
formulations. To minimize the effect of IBU loading amount on the release rate, 
functionalized SBA-15 samples prepared by post-synthesis (PS2), functionalized SBA-
15 prepared by one-pot synthesis (OPS2) and pure calcined SBA-15 (PS0) were 
selected for in vitro release studies of IBU as the drug loading amounts of these 
samples have no much difference, around 25 %. Figure 4.8 shows the in vitro IBU 
release profiles of these three samples. It can be observed that the release profiles of 
IBU from PS0 and OPS2 are similar, and IBU could be completely released in only 10 
hours. However, the release profile of IBU from PS2 is evidently different from PS0 
and OPS2: in the release of IBU from PS2, there is an initial burst release of 50% in 10 
hours followed by a slow release, with 100% complete release reached in 3 days. The 
initial burst release may be due to the excessive drugs which were weakly entrapped 
inside the mesopores, and the slow release of the rest of IBU from PS2 is attributed to 
the strong interaction between IBU molecules and the functionalized mesopore surface 
(this interaction – in the form of “ionic” interaction - between IBU drug molecule and 
functionalized surface will be discussed in detail later).  
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Figure 4.8  In vitro release of IBU from PS0, PS2 and OPS2. 
4.3.4 Surface Interaction between SBA-15 and IBU  
The above adsorption and release results of IBU from either OPS or PS samples 
suggest that there is a different binding affinity between IBU with pure SBA-15 and 
with functionalized SBA-15 prepared by two synthesis routes. FTIR and XPS spectra 
are used to further understand this binding affinity between IBU drug molecules with 
mesoporous matrix.  
FTIR spectra of functionalized SBA-15 (i.e. PS2 and OPS2) with and without 
IBU, pure SBA-15 (PS0) with IBU, and pure IBU are shown in Figure 4.9. PS2 
without IBU shows N-H deformation vibration at 1595 cm-1; this peak is assigned to 
the free NH2 groups present on the surface of functionalized SBA-15. Pure IBU shows 
a strong carboxyl band at 1707 cm-1, which corresponds to the carboxyl group (COOH) 
present in IBU. PS2 loaded with IBU shows the disappearance of the strong carboxyl 
band at 1707 cm-1 and the NHB2 band at 1595 cm-1; instead, a new peak at 1558 cm-1 is 
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observed and this new peak may be attributed to the asymmetric stretching vibration of 
COO -, since carboxylic acid salts exhibit a strong characteristic COO - asymmetric 
stretching band in the range of 1650-1550 cm-1 (Socrates, 1994) However, for PS0 and 
OPS2 both loaded with IBU, strong carboxyl peaks can be clearly observed at 1730 
cm-1 and 1720 cm-1, respectively, but they show a slight blue shift from 1707 cm-1 due 
to the hydrogen bonding of Si-OH with the carboxyl groups of IBU. This observation 
is consistent with the result reported by Vallet-Regi et al. (2003) that there is a 
culombic interaction between IBU and MCM-41, which has similar hexagonal 










Figure 4.9 FTIR spectra of: a- PS2 without IBU; b- PS2 loaded with IBU; c- OPS2 loaded 
with IBU and d- PS0 loaded with IBU and e- IBU. 
Furthermore, our XPS spectra also provide evidence of this ionic interaction. 
Figure 4.10 shows the N 1s XPS spectra of functionalized SBA-15 before and after 
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being loaded with IBU. Four N 1s spectra (a, b, d and e) show two clear peaks at about 
399 and 401 eV, which can be attributed respectively to the free amine groups and 
protonated amine groups (Moses et al., 1978; Vandenerg et al., 1991; Kallury et al., 
1994). The appearance of these two peaks can be explained as follows. For OPS2, the 
formation of protonated amine group is due to the protonation of aminopropyl groups 
of APTMS under acidic condition as stated before and the free amine groups are 
attributed to the APTMS that have not been protonated during one-pot synthesis. 
Whereas for PS2, since the free amine groups interact with surface silanol groups, 
some of these free amine groups were protonated to form protonated amine species 
≡SiO-···+H3NC3H6-Si≡ and the rest of the free amine groups are in the form of ≡Si- 
C3H6NH2 species; the ratio of these protonated to free amine groups for post-synthesis 
functionalization was always found to be about 40:60 by Walcarius et al. Similar result 
was observed in our XPS study for PS2 samples before being loaded with IBU, with 
the ratio of protonated to free amine groups to be around 0.63 (spectrum a).  For OPS2 
sample the ratio of protonated to free amine groups is around 0.95 (spectrum d). This 
result shows that, before loaded with IBU, the ratio of protonated to free amine groups 
is always lower than 1 for either PS2 or OPS2 samples. However, after IBU has been 
adsorbed onto both PS2 and OPS2 samples, the amount of protonated species becomes 
dominant due to the formation of –NH3+···-OOC- as a result of the ionic interaction 
between surface amine groups and carboxyl groups of IBU. The ratios of protonated to 
free amine groups on PS2 and OPS2, which can be obtained from spectra b and e, can 
remarkably increase to 1.89 and 1.17, respectively. 
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Figure 4.10 XPS spectra of: a- PS2 without drug; b- PS2 loaded with IBU; c- OPS2 
without drug and d- OPS2 loaded with IBU. 
A further investigation of the intensity of these two XPS peaks observed on PS2 
and OPS2 samples clearly shows that OPS2 has a lower amount of amine groups than 
PS2. This result is also in reasonable agreement with nitrogen elemental analysis 
shown in Tables 4.1 and 4.2. It is found that the maximum amount of nitrogen content 
on ordered SBA-15 prepared by one-pot synthesis (OPS2) is 0.89 wt.% (corresponding 
to 0.73 mmol/g SiO2 ); this nitrogen content on OPS2 is much less than the PS samples, 
which can have a nitrogen content up to 2.77 wt.% (corresponding to 2.21 mmol/g 
SiO2). The elemental analysis result is also consistent with the data reported earlier 
(Yiu et al., 2001b). From above results, it can be concluded that for SBA-15 to be used 
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as a matrix for IBU, post synthesis is a suitable method since it can easily provide a 
higher amount of functional groups than one-pot synthesis method. By having a larger 
amount of amine functional groups, the PS samples have stronger affinity with the 
adsorbed IBU than the OPS samples, and hence IBU can be released in a more 
sustained manner from PS samples than OPS samples. 
 
4.4   Conclusions 
  Mesoporous SBA-15 materials were functionalized with amine groups through 
post synthesis and one-pot synthesis, and the resulting functionalized materials were 
investigated as controlled drug delivery matrices for ibuprofen. The materials were 
characterized by FTIR, N2 adsorption/desorption analysis, potential measurement, 
XRD, XPS, and TEM. It was revealed that the adsorption capacities and release 
behaviors of ibuprofen were highly dependent on the different surface properties of 
SBA-15 materials. The release rate of ibuprofen from SBA-15 functionalized by post 
synthesis is found to be effectively controlled as compared to that from pure SBA-15 
and SBA-15 functionalized by one-pot synthesis. Through investigation by FTIR and 
XPS spectra, it has been found that the ionic interaction between carboxyl groups in 
ibuprofen and amine groups on the surface of SBA-15 played an important role in 
determing the release rate of ibuprofen from amine-functionalized SBA-15. 
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CHAPTER 5 - ADSORPTION AND SUSTAINED 
RELEASE OF BOVINE SERUM ALBUMIN ON 
FUNCTIONALIZED SBA-15 
5.1   Introduction 
The development of solid-phase peptide synthesis in the early 1960s and 
subsequent recombinant DNA technology in the 1970s have boosted increasing 
interest of employing peptides and proteins as potential drug candidates. Unfortunately, 
the rapid progress of synthesis technology has not been coupled with the advancement 
of peptide and protein delivery systems. This is largely due to the complexity and 
fragility of peptides and proteins posing to the formulation chemist compared with the 
conventional drug compounds, such as large molecular size, susceptibility to 
enzymatic degradation, rapid plasma clearance, as well as the liability of undergoing 
aggregation and adsorption followed by denaturation. Nonetheless, the demand for 
effective delivery systems for peptides and proteins has inspired a great breakthrough 
in drug delivery technology in terms of their scope and complexity during the past 
decades. A variety of both natural and synthetic materials including polymers and 
liposomes have been investigated for the controlled release of peptides and proteins 
(Cohen et al., 1991; Langer and Moses, 1991; Baldwin and Saltzman, 1998; Johnson 
and Tracy, 1999; Boulmedarat et al., 2005; Gorodetsky et al., 2004; Lu and Hickey, 
2005). Polymeric matrices are shown to increase circulation half-life of encapsulated 
proteins or peptides and maintain their biologically active for a prolonged period, thus 
helping ensure improved utilization of the protein drugs and resulting in more cost-
 5 / Adsorption and Sustained Release of Bovine Serum Albumin on Functionalized SBA-15 
 85
effective formulations. However, many procedures involved in the incorporation of 
proteins into polymeric matrices pose concerns as the structural and chemical integrity 
of proteins would be deteriorated in the harsh admixing or encapsulation conditions, 
such as elevated temperatures, high concentrations of surfactants, or organic and 
aqueous solvent mixtures (Cleland and Langer, 1994; Schwendeman et al., 1996; 
Carpenter and Chang, 1996; Dong et al., 1996; Bartus et al., 1998). Besides, polymeric 
matrix normally has a low protein loading capacity (Ramkissoon-Ganorkar, 1999). 
Compared with polymers, liposomes are made up of one or many concentrically 
arranged lipid bilayers constituting an envelope that can be “stuffed full of drug,” thus 
allowing higher drug loading and offering higher protection against enzymatic 
degradation because the lipid layers can isolate drug molecules from the in vivo 
environment. However, lipids tend to undergo degradation due to oxidation and 
hydrolysis in vivo (Kemps and Crommelin, 1988), resulting in poor stability of 
liposomes; this is one of the critical issues associated with liposomes as drug matrices, 
especially for large volume liposomal formulations. 
Recently, the application of non-toxic mesoporous silica materials to controlled 
drug delivery has attracted much interest due to their high surface area, tunable large 
pore size, and chemical modifiable surface. There are several research groups working 
on this area: Vallet-Regi et al. investigated the use of MCM-41 and SBA-15 for 
sustained release of ibuprofen, amoxicillin, gentamicin, and erythromycin (Vallet-Regi 
et al., 2001; Vallet-Regi et al., 2004; Doadrio et al., 2004; Doadrio et al., 2006); Mal et 
al. (2003) attached coumarin derivatives to the pore outlets of  MCM-41 to render it 
with the reversibly photo-controlled property; and Lai et al. (2003) studied the stimuli-
responsive release of vancomycin- and adenosine triphosphate using surface-
derivatived cadmium sulfide nanocrystals as chemically removable caps on MCM-41. 
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All these studies showed that mesoporous silica materials are expected to open up 
possible applications in the area of drug delivery. Herein, we propose to utilize SBA-
15 as an alternative vehicle for protein controlled delivery as it has the potential to 
overcome the constraints associated with polymers or liposomes as stated earlier. 
SBA-15 also has unique properties such as large pore size and high hydrothermal 
stability, which can be a safe storage to large protein molecules. In addition, previous 
studies showed that the stability of enzymes adsorbed on mesoporous solid is possible 
to be maintained or even enhanced (Thomas, 1994; Deere et al., 2001; Takahashi et al., 
2000; Aburto et al., 2005). In this chapter, SBA-15 materials were functionalized with 
amine groups by one-pot synthesis (also called co-condensation). The surface physical 
and chemical properties of the resulting materials were investigated by N2 
adsorption/desorption analysis, ζ-potential measurement, and nitrogen element analysis. 
Bovine serum albumin (BSA) was selected as a protein model drug and loaded into the 
SBA-15 materials and in vitro released in the media of phosphate buffered solution 
(PBS). To determine the optimum conditions favoring high BSA loading amount, a 
series of adsorption isotherms for BSA on SBA-15 materials were investigated at four 
different pH values. The influences of amine group content and pore size of 
functionalized SBA-15 on the adsorption capacities and release rates were studied. 
Finally the conformational changes of the released BSA from amine-functionalized 






 5 / Adsorption and Sustained Release of Bovine Serum Albumin on Functionalized SBA-15 
 87
5.2   Experimental 
5.2.1 Materials and Synthesis 
Amine-functionalized SBA-15 materials were prepared according to the 
procedure reported by Zhao et al. (1998), using Pluronic 123 triblock polymer 
[(EO)20(PO)70(EO)20, Mav = 5800, Aldrich, USA] as structure directing agent, and 
tetraethylorthosilicate (TEOS, Aldrich, USA) as silica source. For one-pot synthesis of 
functionalized SBA-15, functional agent was introduced together with TEOS. The 
molar composition of the mixture was 1 TEOS: 0.05 X-TES: 0.017 P123: 2.9 HCl: 
202.6 H2O. (X-TES refers to 3-aminopropyltriethoxysilane, mercaptopropyl- 
triethoxysilane, or 4-triethoxysilylbutyronitril). The mixture was first stirred to react at 
40ºC for 24 hrs followed by hydrothermal treatment for 48 hrs under static conditions 
in a polypropylene bottle (at 100ºC) or a Teflon-lined autoclave (at above 100ºC). 
After reaction, the resulting white solids were washed with the deionized water, 
filtered and dried at 60ºC overnight. The surfactant template was removed by refluxing 
2 g of sample with 100 cm3 ethanol) for 24 hrs. All materials were filtered, washed 
with ethanol and deionized water alternately for several times, and then dried at 60ºC.  
5.2.2 Adsorption Isotherms 
The adsorption isotherms of BSA on amine functionalized SBA-15 samples were 
obtained at 22ºC in citrate-phosphate buffer solutions. 10 mg of powder sample was 
added to 5 ml of desired BSA phosphate-citrate buffer solution and soaked for 24 hrs 
in a water-bath shaker (GFL 1092, Germany). (Preliminary kinetic results were 
conducted to confirm that equilibrium conditions could be reached within 24 hrs). The 
amount of drug loaded on samples was determined based on the BSA concentration 
difference before and after soaking which were analyzed with Bradford assay using a 
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Shimadzu UV-3101 spectrophotometer (Shimadzu, Japan) operating at a wavelength 
of 595 nm.  
5.2.3 In vitro Drug Release Studies 
The BSA release profiles were determined by soaking 0.1g of BSA-loaded SBA-
15 samples into 50 ml of PBS (Phosphate Buffered Saline, pH 7.4, I = 0.25 M) in a 
shaking water bath with a shaking speed of 100 rpm at temperature of 37 ± 0.1ºC. 
Samples of 1 ml were withdrawn at predetermined time, replaced by fresh medium and 
BSA concentrations were spectrophotometrically analyzed with Bradford assay at 595 
nm using a Shimadzu UV-3101 UV-Vis spectrophotometer.  
5.2.4 Characterization Methods 
Nitrogen adsorption/desorption measurements were conducted using 
Quantachrome Autosorb-1 (Quantachrome, Boynton Beach, FL, USA) by N2 
physisorption at 77 K. The BET specific surface areas of the samples were calculated 
in the range of relative pressures between 0.05 and 0.30. The pore size distribution was 
calculated from the adsorption branch of isotherm using thermodynamic-based Barrett-
Joyner-Halenda (BJH) method. The total pore volume was determined from adsorption 
branch of the N2 isotherm at the P/P0 = 0.95. ζ potential measurements were performed 
by ΖetaPlus potential analyzer (Brookhaven Instruments, Holtsville, NY, USA). Total 
nitrogen contents of the samples were determined by Perkin-Elmer Series II CHNS/O 
analyzer 2400 (Perkin-Elmer, Norwalk, CT, USA). The FTIR spectra were collected 
using a Shimadzu FTIR-8700 (Shimadzu, Japan) with a resolution of 2 cm-1. 10 mg of 
solid sample was pressed (under a pressure of 1 ton/cm2 for 10 sec) into a self-
supported wafer of 16 mm in diameter. Prior to analysis, the wafer was treated in an 
in-situ quartz cell equipped with CaF2 windows under vacuum (<10-5 mbar) for 1 hr. 
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Circular Dichroism (CD) spectra on the released BSA were collected from a Jasco-810 
spectropolarimeter over the range 200-250 nm at 22ºC. The scan rate was 30nm/min, 
with a response time of 8 s and 3 accumulations per sample. The α-helix content of 
proteins was evaluated using K2d algorithm (Andrade et al., 1993). Before evaluation, 
the recorded ellipticity data θ (mdeg) were converted to mean molar ellipticity [θ] 
(deg·cm2/dmol) using the equation [θ] = θ/(10×C×L), C = C0/M0, where L is the 
optical pathlength in cm, C is the mean residue molar concentration, C0 is the surface 
concentration (µg/ml), and M0 is the mean residue molecular weight (=118 for BSA). 
 
5.3    Results and Discussion  
5.3.1 Characterization of Materials 
The surface chemical composition determines the availability of certain functional 
species to interact with proteins. The effects of exposed surface functional species on 
protein adsorption have been observed for amine, thiol or methyl groups, and protein 
molecules or particular regions of the molecules may have different affinities for 
various surface functional species (Yiu et al., 2001c; Han et al., 2005; Clare et al., 
2005; Mansur et al., 2005). The SBA-15 materials were functionalized in this study by 
one-pot synthesis, which basically involve co-condensation of tetraethylorthosilicate 
and organotriethoxysilane in the presence of the surfactant template. One-pot synthesis 
is used because it allows a better control of the functional group amount, and provides 
homogenous surface coverage (Lim and Stein, 1999) and favorable hydrophilic surface 
for maintaining protein conformation (Song et al., 2005). Table 5.1 summarizes the 
physicochemical properties of functionalized SBA-15 samples together with pure 
SBA-15 (S-1 and S-2). It is found that the hydrothermal treatment temperature has a 
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more significant effect on enlarging the pore sizes of NH2-SBA-15 (NH2-S-1 to NH2-
S-5) than other functionalized SBA-15, i.e. COOH-SBA-15 (COOH-S-1 and COOH-
S-2) and SH-SBA-15 (SH-S-1 and SH-S-2). It should be noted that the advantage of 
one-pot synthesis of COOH-SBA-15 is that no further hydrolysis step is required 
during the synthesis as the intermediate -CN group could be directly converted to -
COOH group in the highly acidic hydrothermal treatment condition.  






















content   
(wt %)
S-1 40, 100 - 602.3 86.2 1.12 - - 
S-2 40, 130 - 439.1 110.8 1.27 - - 
COOH-S-1 40, 100 - 475.2 84.2 1.02 - - 
COOH-S-2 40,130 - 437.3 86.1 0.99 - - 
SH-S-1 40,100 - 559.4 71.5 1.04 - 1.31 
SH-S-2 40,130 - 512.8 86.7 0.94 - 1.13 
NH2-S-1 40, 140 3 % 453.3 109.0 1.32 0.18 - 
NH2-S-2 40, 140 4 % 421.8 108.1 1.19 0.35 - 
NH2-S-3 40, 140 5 % 405.0 106.1 1.03 0.58 - 
NH2-S-4 40, 120 5 % 433.5 96.7 1.16 0.61 - 
NH2-S-5 40, 100 5 % 424.7 86.8 1.10 0.56 - 
* Reaction at 40 ºC for 24 hours, then under hydrothermal treatment at higher temperature for 48 hours. 
 
The incorporation of functional groups can be confirmed from FTIR, XPS spectra 
or elemental analysis results. Figure 5.1 shows the FTIR spectra for NH2-SBA-15, SH-
SBA-15 and COOH-SBA-15, and for all of the samples, a broad band centered at 
around 3000-3600 cm-1 can be observed at the high frequency side, which corresponds 
to free Si-OH groups. On the lower frequency side of the broad band, there exists a 
strong and sharp band at 1719 cm-1 corrseponding to -C=O stretching vibration mode 



















for COOH-SBA-15, indicating the presence of carboxyl groups on the surface of SBA-
15. For NH2-SBA-15, the FTIR spectra showed that there is a peak appearing at 1602 
cm-1, which is attributed to -NH2 bending mode. And for SH-SBA-15 sample, a weak 













Figure 5.1  FTIR spectra of: a- COOH-SBA-15; b- NH2-SBA-15 and c- SH-SBA-15. 
 
Figure 5.2A shows C1s XPS spectra for COOH-SBA-15. It can be seen that there 
is a peak at 286 eV due to -COO-, revealing the presence of carboxyl groups. Figure 
5.2B (N1s XPS spectra for NH2-SBA-15) shows two clear peaks at about 399 and 401 
eV, which can be attributed respectively to the free amine groups and protonated 
amine groups (Karllury et al., 1994). The appearance of thiol groups on SH-SBA-15 
can be seen in Figure 5.3C, as there is a peak located at 164 eV, which is assigned to 
HS-C3H6- (Bain et al., 1989). Additionally, for NH2-SBA-15 and SH-SBA-15, 
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elemental analysis by CHNS (Table 5.1) further confirms the presence of the 
























Figure 5.2 XPS spectra of: (A) COOH-SBA-15; (B) NH2-SBA-15 and (C) SH-SBA-15. 
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Table 5.1 (page 90) also gives the physicochemical properties of amine-
functionalized SBA-15 samples with different amine group contents. Our previous 
study (Song et al., 2005) has shown that the increase of molar ratio APTES/TEOS 
from 3% to 5% resulted in the increase of nitrogen content in the material. For the 
samples studied in this chapter, with the increase of molar ratio APTES/TEOS from 
3% to 5%, the nitrogen content is increased from 0.18% to around 0.58%, revealing 
the incorporation of amine-groups into the materials. However, when the molar ratio of 
APTES/TEOS is increased to 5%, the highly ordered mesoporous structure shows 
some disruption. As it can be seen from Figure 5.3, the adsorption isotherm for NH2-S-
3 is distorted as compared with other samples which have sharp adsorption and 




















































Figure 5.3 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- S2; b- NH2-S-1; c- NH2-S-2; d- NH2-S-3; e- NH2-S-4 and f- NH2-S-5. (The isotherms are 
offset vertically by 300, 600, 1000, 1500 and 1800 cm3/g for e, d, c, b and a, respectively. 
And the pore size distribution curves are offset vertically by 0.05, 0.10, 0.15, 0.20 and 
0.25 cm3/Å/g for e, d, c, b and a, respectively.) 
In addition to the changes of physicochemical properties as shown in Table 5.1, 
the introduction of amine groups has also significantly altered the ζ potential of 
materials at a solid-liquid interface as shown in Figure 5.4. The ζ potential, which is a 
pH-dependent value of surface charge, is believed to be one of the important properties 
which can influence the adsorption of protein on solids in an aqueous solution. In 
Figure 5.4, the ζ potential of pure silica SBA-15 (S-2) is negative at the pH value 
above 3.5, as surface silanol groups (Si-OH) lose a proton and form Si-O- species. 
However, in the case of amine-functionalized SBA-15, only a small amount 
introduction of amine groups has remarkably altered the surface charge of SBA-15. 
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functionalized SBA-15 materials became negative at the pH value above around 6-7. 
Furthermore, increasing the content of amine group on functionalized SBA-15 from 












Figure 5.4 ζ potential of SBA-15 samples as a function of pH value. 
In this study, hydrothermal treatment temperatures were adjusted over a range of 
temperature from 100ºC to 140ºC in order to change the pore size of NH2-SBA-15 
materials. It can be seen from Table 5.1 and Figure 5.3 that increasing hydrothermal 
treatment temperature resulted in the enlargement of pore size. This shows that raising 
hydrothermal treatment temperatures to enlarge pore size can also be applied to one-
pot synthesis of amine-functionalized SBA-15. The observed result is believed to arise 
from the specific property of non-ionic triblock copolymer EO20PO70EO20 (Pluronic 
P123), which is employed as the template for SBA-15 synthesis. In the aqueous solution 
the copolymer forms the micelle, which consists of a core and a shell built up by the 


























 5 / Adsorption and Sustained Release of Bovine Serum Albumin on Functionalized SBA-15 
 96
With the increase of temperature, the block copolymer aggregation in the micelle, the 
hydrophobicity of the EO block in the copolymer, and the density of the core of the 
micelle increase accordingly (Yamada, 2002), leading to the enlargement of the 
micelle core radius Rc. The empirical scaling relationship between the micelle core 
radius and temperature has been mathematically described by Mortensen and Brown 
(1993) as: Rc ∝ (T - Tcmt) 0.2 (Where T stands for the temperature of the aqueous 
solution and Tcmt stands for the critical micellization temperature). It can be inferred 
from the equation that raising the temperature results in the increase of the template 
micelle core radius, which ultimately leads to the enlargement of pore size of SBA-15. 
5.3.2 Effects of Different Functional Groups on BSA Adsorption and Release 
Figure 5.5 shows the adsorption isotherms of BSA (in phosphate-citrate buffer 
solutions having ionic strength of 0.16 M at pH 4.69 at 22ºC) on S-1, COOH-S-2, SH-
S-2 and NH2-S-5, all of which have similar pore sizes. A higher loading amount of 
BSA is obtained on SH-S-2 and NH2-S-5 than on S-1 and COOH-S-2. The initial slope 
of the adsorption isotherm of BSA on NH2-S-5 is steeper than that on SH-S-2. Based 
on the pseudo-Langmuir model, the result suggests that there is a stronger binding 
affinity between BSA and NH2-S-5 (Haynes and Norde, 1994).  
The BSA release studies were conducted in phosphate buffered saline solutions 
(PBS, pH 7.4, I = 0.25M) at 37ºC. Figure 5.6 shows the release profiles of BSA from 
SH-S-2 and NH2-S-5. BSA is immediately released from SH-S-2 (within 30 min) but 
sustainedly released from NH2-S-1 (within 480 min) due to the stronger interaction 
between BSA and NH2-S-1. Based on these results, amine-functionalized SBA-15 is 
the most favorable material for BSA adsorption and release. Accordingly, the detailed 
study following this section will be mainly focused on amine-functionalized SBA-15.   
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Figure 5.6 Release profiles of BSA from NH2-S-5 and SH-S-2. 
 
5.3.3 Effects of pH Values and Amine Group Contents on BSA Adsorption 
In order to identify the determining factors that allow for the maximum BSA 
loading amount either in the sorbent surfaces or in the bulk solutions, a series of 


























 5 / Adsorption and Sustained Release of Bovine Serum Albumin on Functionalized SBA-15 
 98
isotherms for BSA adsorption on amine-functionalizaed and unfunctionalized SBA-15 
materials were investigated at 22ºC  at four pH values of 3.26, 4.72, 5.61 and 6.36. 
These selected pH values are either below, or close to, or above the isoelectric point of 
BSA (pI 4.7) (Peters, 1995). Since ionic strength is generally believed to have 
influence on protein adsorption at solid-liquid interfaces (Daly et al., 2005; Can and 
Güner, 2006), and in order to exclude the effect of ionic strength on BSA adsorption, 
all the isotherm experiments were performed in buffer solutions at an identical ionic 
strength of 0.16 M by adding a corresponding amount of NaCl. The resulting 
adsorption isotherms are shown in Figure 5.7. It can be seen that the isotherms exhibit 
Langmuir-like patterns, whereby the amount of adsorbed proteins increases 
continuously until a well-defined plateau value corresponding to the maximum amount 
of BSA is reached. As Langmuir theory is not strictly applied in protein adsorption 
(Haynes and Norde, 1994) (thus the derived parameters in Langmuir equation have no 
physical meanings), and based on previous well-established studies (Haynes and Norde, 
1994; Norde, 1986; Norde, 1992; Norde, 1997; Bremer et al., 2004), it seems more 
reasonable to qualitatively (instead of quantitatively) judge the adsorption isotherms 
based on their plateau values and initial slopes and this qualitative judgment will be 
used in this study. 
There are three main factors related to the surface properties of SBA-15 which 
can influence BSA adsorption: geometric, electrical, and chemical. From a 
topographical point of view, SBA-15 has a high surface area and tunable large pore 
size, making it potential host for proteins (The effect of pore size will be discussed in 
section 5.3.4). We focus here the influence of electrical and chemical factors of SBA-
15 surface. Figure 5.7 shows the adsorption isotherms obtained under four different pH 
values. At the pH of 3.26 (Figure 5.3A), BSA is positively charged and amine-
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functionalized SBA-15 is also positively charged, while unfunctionalized SBA-15 is 
negatively charged. It is known that protein adsorption at a charged surface involves 
overlapping of the electric double layers, resulting in electrostatic attraction if the 
protein and the sorbent are of opposite charge and in electrostatic repulsion if they are 
of similar charge. Therefore, due to the electrostatic attraction, a higher plateau 
adsorption Γpl was obtained on unfunctionalized SBA-15 compared with amine-
functionalized SBA-15. For an adsorption isotherm characterizing a high affinity, the 
initial part of the isotherm merges with the Γ axis (Norde, 1992). Therefore, the finite 
initial slopes for all of adsorption isotherms suggest a mild interaction between the 
charges of BSA and SBA-15 surfaces. Furthermore, the steeper initial slope observed 
on the isotherm of unfunctionalized SBA-15 than those of amine-functionalized SBA-
15 indicates a higher affinity induced by electrostatic attraction. In addition, it is found 
that the plateau adsorption Γpl decreased with the increase of the content of amine 
group. As higher amine group content resulted in more positive charges on the surface 
of amine-functionalized SBA-15 (Figure 5.4), this result further confirms that the 
electrostatic interaction is the main driving force for BSA adsorption on SBA-15 
materials of hydrophilic natures. 
The influence of electrostatics is further investigated by varying the pH values of 
BSA solutions. At the pH of 5.61 and the pH of 6.36 above isoelectric point of BSA 
(Figure 5.7C and 5.7D), BSA and unfunctionalized SBA-15 are of negative charge and 
amine-functionalized SBA-15 is of positive charge. Therefore, due to the electrostatic 
attraction, higher plateau adsorptions Γpl for BSA were obtained on amine-
functionalized SBA-15 than on unfunctionalized SBA-15. Furthermore, since NH2-S-3 
is more positive charged than NH2-S-2 and NH2-S-1, higher plateau adsorption was 
prompted on NH2-S-3. Similar to the adsorption isotherms obtained at pH 3.26, the 
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finite initial slopes observed for all of adsorption isotherms suggest that there is a mild 
interaction between the charges of BSA and hydrophilic SBA-15 surfaces. Comparing 
Figure 5.7C with Figure 5.7D, it is noticed that the plateau adsorption Γpl obtained at 
the pH of 5.61 for each sample is higher than that obtained at the pH of 6.36. The 
result is due to the fact that excess negative charge of BSA at the pH of 6.36 is higher 
than that at the pH of 5.61, leading to a larger intramolecular repulsion and thus 



















(B) pH = 4.72 



































































(D) pH = 6.36 
Figure 5.7 Effect of pH on the adsorption isotherms of BSA in phosphate-citrate buffer 
solutions with an ionic strength of 0.16 M: a- NH2-S-3; b- NH2-S-2; c- NH2-S-1 and d- S-2 
at different pH values: (A) pH = 3.26; (B) pH = 4.72; (C) pH = 5.61 and (D) pH = 6.36. 
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Based on the plateau adsorptions Γpl, it is obvious that for all the samples, the 
highest BSA loading amount is obtained at pH 4.72 (Figure 5.7B), which is in the 
vicinity of BSA isoelectric point. And the maximum BSA loading amount of ca.350 
mg/g (Figure 5.8) is obtained on the SBA-15 sample which has a higher amount of 
amine groups and a larger pore size (i.e. NH2-S-3 which has nitrogen content of 0.58% 
and pore size of 107 Å). In the vicinity of isoelectric region, the protein adsorption 
become more complex, as it may involve both the interaction between the protein and 
the surface as well as the properties of the protein molecules. Similar to the adsorption 
isotherms obtained at the pH of 5.61 and the pH of 6.36, the highest plateau adsorption 
Γpl for BSA at pH 4.72 were observed on NH2-S-3 due to the electrostatic attraction 
between the negative region of BSA and the positive surface of SBA-15. For BSA 
molecule in its pI region, the positive and negative charges are more or less evenly 
distributed over the protein molecule, resulting in intramolecular electrostatic 
attraction, and thus favoring a more compact conformation (Norde, 1986). Therefore, 
the volume occupied by BSA molecules adsorbed at pH 4.72 is less than that adsorbed 
at the pH values away from the pI value of BSA. Furthermore, since globular BSA 
molecules have no net charge in the isoelectric region, the intermolecular repulsion 
between the adsorbed molecules (lateral repulsion) is also smaller. Consequently, a 
larger amount of BSA molecule could be adsorbed onto SBA-15. This tendency of 
BSA adsorption into mesopores is also similar to that onto the planar surfaces or 
nanoparticle surfaces (Peng et al., 2004; Katiyar, 2005). Because the surface chemical 
composition determines the availability of certain functional species to interact with 
proteins, in addition to electrostatic interaction, surface amine groups may also play a 
role in the adsorption of BSA on amine-functionalized SBA-15 (Mansur et al., 2005).  
 











Figure 5.8 BSA loading amount based on plateau adsorptions Γpl of BSA on S-2, NH2-S-1, 
NH2-S-2 and NH2-S-3 in phosphate-citrate solutions with an ionic strength of 0.16 M at pH 
4.72. 
5.3.4 Effect of Pore Size on BSA Adsorption 
Pore size is another factor to be investigated in this part of thesis as it decides the 
accessibility of mesopore internal space to large protein molecules. SBA-15 has 
tunable large pore sizes, rendering its possibility to host large molecules of biological 
interest. Although ethanol-extracted SBA-15 may still contain some surfactant 
template retained inside the complementary pores, the primary mesopores are fully 
accessible as reported by Kruk et al. (2000). Therefore, proteins are expected to enter 
into the mesopores as long as the pore size is large enough to host these protein 
molecules. Figure 5.9 shows the adsorption isotherms obtained at pH 4.69 on NH2-S-3, 
NH2-S-4 and NH2-S-5 with pore sizes of 106.7 Å, 96.7 Å and 86.8 Å, respectively. 
Based on the plateau adsorptions Γpl in the isotherms, it is observed that the maximum 
BSA loading amount is increased when the pore size is enlarged. In the case of NH2-S-
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Figure 5.9 Effect of pore size on the adsorption isotherms of BSA on: a- NH2-S-3; b- NH2-
S-4 and c- NH2-S-5 in BSA phosphate-citrate solutions with an ionic strength of 0.16 M at 
pH 4.69 
 
maximum BSA loading for NH2-S-4 with pore size of 96.7 Å or NH2-S-3 with pore 
size of 106.7 Å is increased to ca.300 mg/g or ca.350 mg/g respectively (Figure 5.10). 
Katiyar et al. (2005) investigated the adsorption of BSA on calcined SBA-15 at pH 5.0 
and found that higher loading of ca.450 mg/g was obtained on the sample having pore 
size of 240 Å and the loading on the sample of pore size 77.3 Å was reported to be 
ca.100 mg/g; their result on the smaller pore size is similar to our study. However, in 
our study, a higher BSA loading amount of ca.350 mg/g has been obtained on the 
amine-functionalized sample of pore size 106.7 Å, suggesting that the attractive 
interaction between amine-functionalized SBA-15 and BSA can prompt BSA 
adsorption. It is worth mentioning that sample NH2-S-4 has a BSA loading of ca.300 
mg/g, which is much higher than NH2-S-5. The reason behind this sharp increase may 
be due to the presence of secondary macro/mesopores in NH2-S-4 as indicated by a 
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pronounced high pressure hysteresis loop at relative pressures between 0.85 and 0.98 
(Sayari et al., 1997; Kruk et al., 1997). The effect of pore size was also investigated by 
Horcajada et al. (2004) for ibuprofen adsorption on MCM-41, and ibuprofen loading 









Figure 5.10 BSA loading amount based on plateau adsorptions Γpl of BSA on NH2-S-3, 
NH2-S-4 and NH2-S-5 in phosphate-citrate solutions with an ionic strength of 0.16 M at pH 
4.69. 
The presence of BSA on amine-functionalized SBA-15 is qualitatively observed 
from the FTIR spectra shown in Figure 5.11. Compared with the sample without BSA, 
an intensified broad peak centered at 3300 cm-1 and two newly-appeared intense peaks 
respectively centered at 1650 and 1550 cm-1 are clearly observed in the FTIR spectrum. 
These three peaks are associated with N-H stretching vibration (amide A), C=O 
stretching vibration (70-85%) (amide I) and N-H bending (40-60%) combined with C-
N stretching (18-40%) (amide II) of structural repetitive peptide group of proteins, 
respectively (Chittur, 1998; Wright and Thompson, 1997). These peaks clearly indicate 
the existence of BSA on NH2-SBA-15, among which amide I band can provide the 
information of protein secondary structures, such as contents of α-helix, β-sheet in 

























 5 / Adsorption and Sustained Release of Bovine Serum Albumin on Functionalized SBA-15 
 106
centered at 1650 cm-1, as shown in Figure 5.11, seems to indicate high content of α-
helix in BSA, implying that the adsorption of BSA into mesopores is possible not to 
cause significant denaturation of BSA. Although the state of BSA adsorbed on the 
solid is different from its released state in aqueous solution, the high α-helix content 
revealed by FTIR may suggest higher α-helix content in solution. This is because that 
the altered structure of BSA induced by adsorption may undergo reversible 
conformation change after its desorbed from the solid surface, resulting a higher α-
helix percentage. The exact percentage of α-helix in BSA has been estimated by CD 
spectra after the absorbed BSA has been released to the buffer solution. (The detailed 












Figure 5.11 FTIR spectra of: a- amine-functionalized SBA-15 (NH2-S-3) with BSA; b- 
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Figure 5.12 Release profiles of BSA from SBA-15 having different amount of amine groups 
in PBS with an ionic strength of 0.25 M at pH 7.4. 
5.3.5 In vitro Release Studies 
The samples for in vitro release studies were prepared based on the experimental 
results from the adsorption isotherms. To minimize the effects of the different drug 
loading on the release rates, all samples were specifically chosen to have similar BSA 
loading amounts (S-2: 132 mg/g, NH2-S-1: 143 mg/g, NH2-S-2: 150 mg/g, NH2-S-3: 
135 mg/g for studying the effect of amine group; NH2-S-3: 129 mg/g, NH2-S-4: 142 
mg/g, NH2-S-5: 139 mg/g for studying the effect of pore size).  
Figure 5.12 shows the BSA release profiles from SBA-15 with different amine 
group contents. It can be observed that BSA is quickly released from unfunctionalized 
SBA-15 (PS-2) within a few minutes, with about 85% of BSA released within 30 
minutes. In comparison with unfunctionalized SBA-15, the release rates of BSA from 
amine-functionalized SBA-15 materials are slower and the initial bursts are also 
reduced. Furthermore, with the increase of amine group content, there is a stronger 
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electrostatic attraction between BSA and amine-functionalized SBA-15, causing the 
release rates of BSA from amine-functionalized SBA-15 to become slower, and the 
initial bursts to become smaller. The initial bursts are believed to be triggered either by 
the high concentration gradient of BSA at the early stage, or by the loosely adsorbed 
BSA both on the external and internal surfaces, or by some weak interaction between 
released BSA and SBA-15 matrices.  
Figure 5.13 displays the release profiles of BSA from SBA-15 materials with 
different pore sizes. It is observed that the overall release rate is faster for the sample 
of smaller pore size; this result seems to be in contrary to the literature result 
(Horcajada et al., 2004). In order to explain the abnormal results, the release profiles 
are divided into two regions as shown in Figure 5.9. In region I, BSA is released with 
the fastest rate from the sample of the smallest pore size (NH2-S-5) and with an initial 
burst of around 85% within 30 minutes. The result may be largely caused by the 
adsorbed BSA on the external surfaces. Assuming that the external surface of SBA-15 
is 50 m2/g (Kruk et al., 2000) and the calculated area of BSA molecule on a surface is 
7070 Å2 (Peters, 1995), the estimated maximum loading amount of BSA on the 
external surface is around 78 mg/g. For SBA-15 with a smaller pore size, BSA seems 
to be preferably adsorbed on the external surface instead of inside the mesopores due 
to the pore diffusion resistance. Consequently, the relatively larger amount of BSA on 
the external surface resulted in the larger initial burst and fast release rate. Comparing 
with the release rates in region I, the release result in region II is just the opposite: the 
sample with the largest pore size (NH2-S-3) has the fastest released rate of BSA. The 
release tendency in this region is thought to be mainly affected by BSA diffusion from 
mesopores, and BSA tends to diffuse faster from the larger pores. It should be 
mentioned that the initial bursts are observed on all the samples in this study. This 
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diffusion-controlled initial burst effect is common to several mesoporous-silica-based 
drug delivery systems and is difficult to manage unless there is a very strong 
interaction between drugs and matrices (Doadrio et al., 2004; Lai et al., 2003; 
Cavallaro et al., 2004). However, in the case of protein delivery system, the strong 
interaction is unfavorable as entrapped protein or peptide drug can not be completely 
released from the matrices and the strong interaction may also induce irreversible 
conformational change of the protein drugs. In order to better control the release rate, 
additional processing needs to be applied, such as using specific polymer coatings. It 
has been reported that such kind of coatings was stimuli-responsive and the release rate 











Figure 5.13 Release profiles of BSA from SBA-15 with different pore sizes in PBS with an 
ionic strength of 0.25 M at pH 7.4. 
As the functions and structures of proteins are inherently correlated, there is a 
need to assess structural changes of the peptide or protein-based drugs after their 
release. Hence, UV-CD has been employed in this study to estimate the secondary 
structure present in the released BSA. Figure 5.14 shows the CD spectra of the native 
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BSA and the released BSA from NH2-S-3, whereby the largest loading amount and the 
slowest release of BSA were obtained (Detailed studies on BSA conformation changes 
on different SBA-15 samples will be presented in Chapter 6). It shows that the CD 
spectrum of the released BSA is similar to that of the native BSA. In addition, the 
calculated percentage of α-helix in the native BSA and the released BSA are 67% and 
65%, respectively, indicating that BSA conformation has not been severely or 
irreversibly altered by the adsorption. Therefore the protein matrix as discussed in this 
study shows the advantage of not only maintaining the conformation of the model 
protein drug but also prompting a higher protein adsorption capacity as well. It is 
interesting to note that, since the adsorption interaction between BSA and amine-
functionalized SBA-15 is not very strong, as observed in the previous release kinetics 
study, this rather weak interaction does not lead to the destabilization of protein. 
Although strong adsorption interaction is possible to better control the release rate, it 
may compromise the integrity or conformational stability of protein structures. For 
instance, hydrophobic force tends to bind more protein as well as bind them more 
tenaciously, but most proteins are liable to undergo irreversible adsorption and lose 
integrity. Therefore, for a proper protein delivery system, the preservation of integrity 
and conformation is the primary consideration. In this study, as the amine-
functionalized SBA-15 prepared by one-pot synthesis is of hydrophilic nature, BSA 
conformation can be well-maintained after adsorption and subsequent release. This 
result is also consistent with the previous result reported by Norde and Giacomelli 
(2000), who found that BSA adsorption is reversible on hydrophilic surfaces and 
irreversible if the surface is hydrophobic. 
 
 









































Figure 5.14 CD spectra of released BSA from NH2-S-3 and native BSA. 
 
5.4  Conclusions 
Functionalized SBA-15 materials have been investigated as matrices for 
adsorption and sustained release of BSA. For SBA-15 functionalized with different 
groups, i.e. –SH, -COOH or –NH2, the highest BSA loading amount and the slowest 
BSA release rate are found to be obtained on the amine-functionalized SBA-15. The 
adsorption isotherms of BSA on different amine-functionalized SBA-15 materials have 
been determined at various pH conditions. Generally higher BSA adsorption capacities 
could be obtained on SBA-15 with higher amine group content, larger pore size and at 
the isoelectric region of BSA. Electrostatic interaction is suggested to be the driving 
force that prompted mild BSA adsorption on hydrophilic surface amine-functionalized 
SBA-15. In vitro release studies conducted in phosphate buffered saline (PBS, pH 7.4, 
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ionic strength 0.25 M) show that the amine group content and the pore size of 
functionalized SBA-15 could also affect the release rates. The release rates slow down 
when BSA are adsorbed on SBA-15 of higher amine contents due to the stronger 
electrostatic interaction between BSA and amine-functionalized SBA-15. For SBA-15 
of smaller pore size, a relatively larger amount of BSA is believed to be adsorbed on 
the external surface instead of inside the mesopores, hence the overall release rates of 
BSA from smaller pores are faster than the larger pores. CD spectra show that BSA 
conformation on the optimized sample (NH2-S-3, whereby the largest loading amount 
and the slowest release of BSA were obtained) could be well-maintained after 
adsorption and subsequent release from amine-functionalized SBA-15 due to the 
hydrophilic nature of amine-functionalized SBA-15 prepared by one-pot synthesis. 
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CHAPTER 6 - FACTORS AFFECTING THE STABILITY 
OF BOVINE SERUM ALBUMIN IN FABRICATION 
OF DELIVERY SYSTEMS 
6.1   Introduction 
As it has been mentioned in Chapter 2, since the discovery of the first member 
(MCM-41) of M41S family in 1992 (Beck et al., 1992), ordered mesoporous materials 
have always been the attractive subject in nanoporous materials due to their large pore 
size, high surface areas and tunable surface properties. Enormous efforts have been 
taken to explore their potential applications, from the early stage in catalysis, 
separation to recent development in nanotemplating and biomedical materials (Yiu et 
al., 2001a; Byambajav and Ohtsuka, 2003; Newalkar et al., 2003; Liu et al., 2000; 
Fuertes, 2004; Yang and Huang, 2005; Vallet-Regi, 2006). After the first publication 
reported by Vallet-Regi et al. (2001) who found a new property of mesoporous 
material (MCM-41) as controlled drug delivery device in 2001, the past five years 
have seen the burgeoning growth in applications of various mesoporous materials 
(MCM-41, MSU, SBA-15) to different drugs, including anti-inflammatory drug 
(Munoz et al., 2003; Tang et al., 2006), antibiotic drug (Doadrio et al., 2004),  
angioteusion-converting enzyme (ACE) inhibitor of captopril (Qu et al., 2006), and 
anticonvulsive agents (Lopez et al., 2006). Among these studies, most of them are 
concerned with the preparation and properties of materials or the interaction betweens 
the drugs and the materials. To our best knowledge, there are few reports regarding the 
investigation of property changes of drug itself after its release from mesoporous 
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matrix. However, the properties of released drug may decide whether the drug still has 
sufficient therapeutical effect after being incorporated into the delivery devices. This is 
one of important considerations to evaluate drug delivery devices, especially for those 
drugs which are liable to undergo structure change during fabrication of drug loaded 
matrix, such as protein drug. A protein may undergo a number of chemical or physical 
alterations under different processing conditions and these alterations are possible to 
affect the safety and efficacy of the protein as a drug. It is therefore necessary to 
investigate these alterations for a particular protein pharmaceutical formulation.  
As our previous work has shown that BSA loading amount can be increased if 
amine-functionalized mesoporpus material SBA-15 is used (Song et al., 2005), hence, 
in this study, amine-functionalized SBA-15 has been selected as the drug matrix, and 
model protein drug - bovine serum albumin (BSA) is incorporated into the matrix by 
immersion of SBA-15 into BSA aqueous solution, which is the most commonly used 
method to immobilized protein on solid interfaces. The structure of a globular protein 
molecule like BSA in aqueous solution is only marginally stable. Therefore, the 
protein structure may be readily perturbed by changing the environmental conditions, 
such as pH or temperature. Protein structure stability may also be affected by 
introducing a foreign interface because protein tends to rearrange, thus changing its 
conformation upon adsorption. Herein, BSA adsorptions at different temperatures, pH 
values and on various amine-functionalized SBA-15 materials are studied. Since 
Circular Dichroism (CD) is one of the most powerful techniques to evaluate protein 
secondary structures, thus giving information on protein conformational changes in 
aqueous solutions, it is used in this study to investigate the conformational change of 
BSA after its adsorption and subsequent release from SBA-15 materials. 
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6.2   Experimental  
6.2.1 Materials and Synthesis 
Either one-pot synthesis or post modification was used to functionalize SBA-15 
with amine groups. In one-pot synthesis, Pluronic 123 [(EO)20(PO)70(EO)20, Mav = 
5800, Aldrich, USA] was fully dissolved in deionized water at room temperature, 
followed by slowly adding 37% concentrated HCl solution and pre-mixed TEOS 
(tetraethylorthosilicate, Aldrich, USA) and APTES (3-aminopropyltriethoxysilane, 
Sigma-Aldrich, USA) under stirring. The molar composition of the mixture was 0.95 
TEOS: 0.05 APTES: 0.017 P123: 2.9 HCl: 202.6 H2O. The resultant was allowed to stir 
at 40°C for 24 h and then transferred into a polypropylene bottle (100°C) or a Teflon-
lined autoclave (>100°C) and reacted under static condition for 48 h. The solid product 
was recovered by filtration and dried at 50°C overnight. The template was removed 
from the as-synthesized material by refluxing in ethanol for 24 h. Then the material 
was filtered, washed with water and ethanol for several times and dried at 50°C. 
In post modification, P123/H2O solution was sequentially added 37% concentrated 
HCl solution and TEOS under stirring. The molar composition of the mixture was 1 
TEOS: 0.017 P123: 2.9 HCl: 202.6 H2O. The resultant was stirred at 40°C for 24 h and 
then transferred to a Teflon-lined autoclave and reacted at 140°C under static condition 
for 48 h. The solid was then filtered off, washed three times with deionized water, and 
calcined at 550°C for 8 h. 1.0 g of the obtained SBA-15 was reacted with 4 mmol of 3-
aminopropyltrimethoxysilane (APTMS, Sigma-Aldrich, USA) in 30 ml of 1, 4 dioxane 
(99%, Sigma-Aldrich, USA) under reflux for 24 h. The resultant white solid was 
finally filtered off, washed with diethyl ether (3×20 cm3, Sigma-Aldrich, USA) and 
dried under vacuum. 
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6.2.2 Adsorption Isotherms 
10 mg of synthesized SBA-15 was added to 5 ml of BSA phosphate-citrate buffer 
solutions and the mixture was shaken for a designated length of time (24 hrs for 
adsorption isotherms) with a shaking water bath (GFL 1092, Burgwedel, Germany). 
The amount of BSA loaded on solid samples was determined from the concentration 
difference of the BSA buffer solutions before and after immersion which were 
analyzed using Bradford assay by a Shimadzu UV-3101 spectrophotometer (Shimadzu, 
Japan) at 595 nm. 
6.2.3 Determination of Conformational Changes of BSA by CD 
The conformations of BSA released from amine-functionalized SBA-15 materials 
were analyzed by the circular dichroism (CD) method. The CD spectra were recorded 
using a Jasco-810 spectropolarimeter over the range 200-240 nm, with a 5 mm quartz 
cuvette at 22°C. The scan rate was 30 nm/min, with a response time of 8 s and 10 
accumulations per sample. 
The solid samples loaded with BSA were first washed 3 times with PBS (pH 7.4, 
ionic strength 0.25 M) solution under vigorous shaking to remove away loosely bound 
BSA from the surfaces of SBA-15. Fresh PBS solution was then placed in the tube and 
incubated at 37 ± 0.1°C for 24 h. The obtained solution samples after incubation were 
used for the CD spectroscopic measurements. The α-helix content of proteins was 
evaluated using K2d algorithm (Yang, 1986; Chang et al., 1978). Before evaluation, 
the recorded ellipticity data θ (mdeg) were converted to mean molar ellipticity [θ] 
(deg·cm2/dmol) using the equation [θ] = θ/(10×C×L), C = C0/M0, where L is the 
optical pathlength in cm, C is the mean residue molar concentration, C0 is the surface 
concentration (µg/ml), and M0 is the mean residue molecular weight (= 118 for BSA). 
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6.2.4 Characterization Methods 
Nitrogen adsorption/desorption measurements were conducted using 
Quantachrome Autosorb-1 (Quantachrome, Boynton Beach, FL, USA) by N2 
physisorption at 77 K. The BET specific surface areas of the samples were calculated 
in the range of relative pressures between 0.05 and 0.30. The pore size distribution was 
calculated from the adsorption branch of isotherm using thermodynamic-based Barrett-
Joyner-Halenda (BJH) method. The total pore volume was determined from the 
adsorption branch of N2 isotherm at the P/P0 = 0.95 signal point. The FTIR spectra 
were collected using a Shimadzu FTIR-8700 (Shimadzu, Japan) with a resolution of 2 
cm-1. 10 mg of solid sample was pressed (under a pressure of 1 ton/cm2 for 10 sec) into 
a self-supported wafer 16 mm in diameter. Prior to analysis, the wafer was treated in 
an in-situ quartz cell equipped with CaF2 windows under vacuum (<10-5 mbar) before 
analysis. ζ potential measurements were performed by ΖetaPlus potential analyzer 
(Brookhaven Instruments, Holtsville, NY, USA). The total nitrogen content was 
determined by Perkin-Elmer Series II CHNS/O analyzer 2400 (Perkin-Elmer, Norwalk, 
CT, USA). Thermogravimetric analysis was carried out in nitrogen atmosphere on a 
Shimadzu DTG-60 Simultaneous DTA-TG analyzer.  
 
6.3   Results and Discussion 
6.3.1 Effect of Functionalization Methods 
Figure 6.1 shows the N2 adsorption/desorption isotherms and pore size 
distributions of OPS1 and PM1, which are the amine-functionalized SBA-15 samples 
prepared by one-pot synthesis and post modification, respectively. It can be seen that 
both these two samples exhibit typical irreversible type IV adsorption isotherms with 
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H1 hysteresis loops as defined by IUPAC, which is the characteristic of ordered 
mesoporous materials. The pore size distribution curves reveal that they have similar 














Figure 6.1 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- OPS1 and b- PM1. (For b, the isotherm is offset vertically by 500 cm3/g for b. And the 


























Figure 6.2 FTIR spectra of: a- OPS1 and b- PM1. 
 
The incorporation of amine groups on the two samples can be confirmed by FTIR 
spectra as shown in Figure 6.2. For PM1, two peaks assigned to NH stretching 
vibration and one peak assigned to NH2 bending vibration can be clearly seen at 3386, 
3336 and 1595 cm-1. Unlike PM1, in case of OPS1, only one peak assigned to NH2 
bending vibration appears at 1602 cm-1. The NH stretching, which normally appears at 
ca. 3380 and 3300 cm-1, can not be observed as it overlays with the broad band of 
hydroxyl groups. This obvious variation also reveals the different hydrophobicity of 
the two materials. For unmodified periodic mesoporous silicas, there exist three types 
of surface silanols, that is, single, hydrogen-bonded, and geminal hydroxyl groups 
(Moller and Bein, 1998). It is well recognized that in post modification, the free (≡
SiOH) and geminal (=Si(OH)2) silanol groups would be consumed through the 
silylation reaction between APTES and surface silanol groups (Sayari and Hamoudi, 
2001). Because of such consumption, as well as the loss of surface hydroxyl groups in 
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condensation reaction at higher calcinations temperature and the loading of nonpolar 
and hydrophobic triethoxy groups in Si-CH2-CH2-CH2-NH2 chains, PM1 is more 
hydrophobic than OPS1. In case of OPS1, which is prepared by co-condensation of 
TEOS and APTES, however, the copolymer template was removed by ethanol 
extraction instead of calcination, therefore more surface hydroxyl groups could be 
preserved, which can be directly seen from FTIR spectrum as shown in Figure 6.2a.  
The different hydrophobicity of OPS1 and PM1 can also been studied by 
thermogravimetric weight loss curves as shown in Figure 6.3. It can been seen that 
PM1 exhibits less weight loss at temperatures up to ca. 100˚C, which can be attributed 
to the release of physically adsorbed water (Jaroniec et al., 1997) and therefore 
indicates a relatively hydrophobic character of its surface. Such a difference in 




















































Figure 6.4 BSA adsorption isotherms on (A) OPS1 and (B) PM1 in phosphate-citrate 
buffer solutions (ionic strength 0.16 M) at different pH values: a- pH = 4.72; b- pH = 5.61 
and c- pH = 3.26. 
Figure 6.4 shows BSA adsorption isotherms on OPS1 and PM1 at three different 
pH values of 3.26, 4.72 and 5.61. The isoelectric point (pI) of BSA is around 4.7 
(Peters, 1995), hence the protein is positively charged at pH < 4.7 and negatively 
charged at pH > 4.7. Both of OPS1 and PM1 are positively charged under the studied 































 6 / Factors Affecting the Stability of Bovine Serum Albumin in Fabrication of Drug Delivey Systems 
 122
pH range as shown in Table 6.1. At pH 4.72 in the vicinity of pI, a maximum plateau 
adsorption is obtained on either of two samples, which is attributed to the compact 
protein structures and the reduced lateral interactions between the protein molecules. 
Compared with OPS1, the plateau adsorption values of BSA on PM1 at these three pH 
values are much higher than those on OPS1. At pH 5.61 above its pI, BSA is 
negatively charged, as expected, a large amount of BSA can be adsorbed on positively 
charged PM1 and OPS1. However, it is interesting to note that, at pH 3.26 below its pI 
whereby BSA is positively charged, only a low degree of BSA adsorption, Γpl < 0.2 
mg/m2 is observed for positive-charged OPS1, while a high degree of BSA adsorption, 
Γpl ≈ 1.0 mg/m2 is still observed positive-charged PM1. Such a difference suggests that 
the adsorption driving force for BSA adsorptions on two materials may not be the 
same. Similar adsorption behaviors also have been observed in the adsorption of 
myoglobin onto porous hydrophilic zirconium phosphate and hydrophobic zirconium 
benzenephosphonate (Bellezza et al., 2006).  
Table 6.1 Physicochemical characteristics of pure and 
amine-functionalized SBA-15 samples. 


















content    





PM1 40, 140 227.1 107.6 0.88 1.23 44.5 32.8 26.7
OPS1 40, 140 405.0 106.1 1.03 0.58 35.3 28.4 20.0
OPS2 40, 120 433.5 96.7 1.16 0.61 - - - 
OPS3 40, 100 424.7 86.8 1.10 0.56 - - - 
* Reaction at 40 ºC for 24 hours, then hydrothermal treatment at higher temperature for 48 hours. 
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It is known that adsorption of proteins is the net result of an interplay of various 
interactions, among which electrostatic and hydrophobic interactions are the most 
important ones (Norde, 1997). As mentioned earlier, the surface of OPS1 is more 
hydrophilic, and very small amount of BSA is absorbed on like-charge surface of 
OPS1, therefore, it suggests that BSA adsorption is resisted if electrostatically repulsed 
and global electrostatic interaction thus is the dominant factor that promotes or resists 
BSA adsorption on OPS1 surface. However, in case of PM1, as Figure 6.4(B) shows, a 
large amount of BSA can be absorbed on the surface either of similar or of opposite 
charge. This happens if the surface is more hydrophobic and the hydrophobic 
interaction overrules the electrostatic interaction. Hence, BSA adsorption on PM1 is 
more hydrophobically driven. In addition, such hydrophobic force also results in BSA 
adsorption in larger amount at more hydrophobic surface of PM1; this is a general 
trend observed on proteins adsorptions (Gőlander et al., 1990; Van den Berg et al., 
1991). 
However, it is generally believed that hydrophobic interaction between proteins 
and sorbents tends to induce the structural alteration of proteins because of the 
tendency to force proteins to expose internal, hydrophobic residues. Figure 6.5 shows 
CD spectra of native BSA, the released BSA from OPS1 and PM1. Compared with 
native BSA, which has α-helix percentage of 67%, the α-helix percentage of BSA 
released from OPS1 is 65% and that released from PM1 is 59%. This indicates that 
BSA secondary structure has been altered to a larger extent after its adsorption and 
subsequent release from PM1 whose surface is more of hydrophobic nature. 
 
 






































Figure 6.5  CD spectra for BSA released from a- OPS1; b- PM1 and c- native BSA. 
Considering from the thermodynamic point of view, at constant temperature and 
pressure, protein adsorption occurs only if the Gibbs energy G of the system decreases: 
∆adsG = ∆adsH – T∆adsS < 0 (where H, S and T are the enthalpy, entropy and absolute 
temperature respectively, and ∆ads refers to the change in the thermodynamic functions 
of state resulting from the adsorption process). Based on such thermodynamic analysis 
of the adsorption of HPA (helix pomatia agglutinin) on hydrophobic and hydrophilic 
oxide surfaces, Norde (1986) indicated that for protein adsorption at the hydrophobic 
oxide surfaces that have the same charge sign as the protein molecules, the entropy 
gain resulting in the decrease of the Gibbs energy must originate from the protein 
molecule itself. This can occur either from the dehydration of hydrophobic patches, or 
from structural changes, or both. If the α-helix content in the adsorbed state is assumed 
to be comparable to that calculated from the desorbed material, then the entropy 
increase for the loss of α-helix content largely compensates for the positive heat of 
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adsorption. Wu et al. (1993) employed CD, ellipsometry and radio labeling techniques 
to study the induction of changes in the secondary structure of BSA by a hydrophobic 
surface. They also observed the changes of secondary structure of globular protein 
induced by a hydrophobic surface and they attributed this change to the steric 
interaction between adsorbed proteins as well as by hydrophobic interactions during 
the adsorption process. In addition, they found that there is obviously an intermediate 
stage in which the protein molecules are mainly in the β-structure, indicating that for 
certain proteins, the β-structure may be a more stable secondary structure than α-helix 
on the hydrophobic surface. 
6.3.2 Effect of Pore Size 
Figure 6.6 shows the N2 adsorption/desorption isotherms and pore size 
distributions and Table 6.1 (page 122) lists physicochemical characteristic data for 
OPS1, OPS2 and OPS3 samples. All three samples exhibit type IV adsorption 
isotherms with a H1 adsorption–desorption hysteresis loop, indicating their ordered 
mesoporous structures. OPS1, OPS2 and OPS3 show a narrow pore size distribution at 

















Figure 6.6 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- OPS1; b- OPS2 and c- OPS3. (The isotherms are offset vertically by 300 and 600 
cm3/g for b and a respectively. And the pore size distribution curves are offset vertically by 
0.05 and 0.10 cm3/Å/g for b and a, respectively.) 
Figure 6.7 shows the adsorption isotherms of BSA on OPS1, OPS2 and OPS3 in 
BSA phosphate-citrate solutions at 22 ˚C (pH 4.69, ionic strength 0.16 M). It can be 
seen with the decrease of the pore size from 106Å to 87Å, the plateau adsorption of 
BSA drop from ca. 0.90 mg/m2 (350 mg/g) to ca. 0.35 mg/m2 (150 mg/g). Based on the 
calculated area of BSA molecule on a surface (7070 Å2) (Peters, 1995), the external 
surface of SBA-15 (50 m2/g) (Kruk et al., 2000) and the overall adsorbed amount of 
BSA (150 mg/g), it can be estimated that a large percentage of the adsorbed BSA (78 
mg/g out of 150 mg/g) is most likely on the external surface of OPS3 rather than inside 
the mesopores. Assuming that BSA is of heart-shaped structure with dimensions of 84 
× 84 × 84 × 35 Å (Ferrer et al., 2001),  the results of the loading amount of BSA on 
these three samples suggest that when the pore size of adsorbent is larger than 87Å, 
more BSA molecules could enter into the mesopores. Hence, compared with OPS3 (87 
B 
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Å), on which the loading amount of BSA is ca.150 mg/g, the loading amount of BSA 








Figure 6.7 Effect of pore size on the adsorption isotherms of BSA on: a- OPS1; b- OPS2 
and c- OPS3 in BSA phosphate-citrate solutions with an ionic strength of 0.16 M at pH 
4.69, 22 ˚C. 
Figure 6.8 shows the CD spectra of BSA released from the above three samples. 
It can be observed that the conformations of the released BSA from these three 
samples seem to be similar to each other. However, further analysis of the molar 
ellipticity from CD spectra found that the α-helix content of the released BSA from 
OPS1, OPS2 and OPS3 is 65%, 62% and 60%, respectively. It suggests that BSA tend 
to undergo slightly more conformational change when adsorbed into the mesopores of 
smaller pore size. As CD is an average of the entire molecular population, which 
includes BSA both adsorbed on the external surface and inside the mesopores, and 
fewer BSA molecules are absorbed inside the smaller mesopores, hence, at 22˚C, CD 
resultes show that the stability of BSA is not severely affected when adsorbed on the 
material of small pore size, i.e. 87 Å. However, this scenario becomes quite different 

















































when the adsorption process of BSA on such material is conducted at higher 
temperatures which will be discussed later. It should be mentioned here that previous 
experimental and Monte Carlo simulation studies on protein stabilities in confined 
spaces found that confining a protein to a small inert space could stabilize the 
encapsulated protein against unfolding, thus enhance its stability against the changes of 
temperature, pH and ionic strength. In addition, the thermal stability of protein, e.g. 
horseradish peroxidase, increased as the pore size of the silica matrix was decreased 
(Zhou and Dill, 2001; Eggers and Valentine, 2001; Ping et al., 2003). In these studies, 
the pore size is large enough to encapsulate the protein molecules; therefore the 
stabilities of encapsulated protein molecules can be enhanced. However, in the present 
study, as the pore size is so closed to protein molecular size, the protein molecules may 
undergo some irreversible conformational changes in order to enter the small 









Figure 6.8 CD spectra for BSA released from: a- OPS1; b- OPS2 and c- OPS3. 
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6.3.3 Effect of Temperature 
Figure 6.9 shows the adsorption kinetics of BSA on OPS1 at 22˚C, 31˚C, 37˚C 
and 45˚C. Kinetics of BSA binding to OPS1 at these four temperatures all display an 
initial rapid phase followed by a slow approach to equilibrium, and rising temperature 
results in more rapid process in the initial phase and BSA adsorption on OPS1 
approached equilibrium more quickly. Lei et al. (2004) have observed the similar 
trends in the immobilization of lysozymes on mesoporous silicas, and they ascribed 
such result to the endothermic process of protein migrating into the inner space of 
mesopores. However, Damodaran and Song (1988) found that the kinetics of 
adsorption of proteins at interface is highly complex: it is governed not only by 
diffusion and the energy barrier at the interface, but also by the conformational states 
of the proteins. Predenaturation or unfolding of the protein molecule could accelerate 
the initial phase of the kinetics. Therefore, the faster adsorption kinetics with rising 
temperature as shown in Figure 6.9 may be accompanied by the structural alteration of 







Figure 6.9 BSA adsorption kinetics on OPS1 a- 22˚C; b- 31˚C; c- 37˚C and d- 45˚C. 
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Figure 6.10 (A) and (B) shows the adsorption isotherms of BSA on OPS1 (106 Å) 
and OPS3 (87 Å) at 22˚C, 31˚C, 37˚C and 45˚C. It can be seen that these two groups of 
isotherms all follow Langmuir-like patterns: the adsorbed amount increases 
continuously until it reaches a well-defined plateau value corresponding to the 
maximum adsorbed amount. Adsorptions conducted at higher temperatures lead to 
steeper initial slopes and larger plateau adsorption values. However, there is an 
obvious difference between these two groups of isotherms: Rising temperature can 
significantly increase the plateau adsorption on OPS3 than on OPS1. The plateau 
adsorption Γpl for BSA adsorption on OPS1 only slightly increased from ca. 0.85 
mg/m2 to ca. 0.92 mg/m2 when adsorption temperature is increased from 22 ˚C to 45 
˚C, while the plateau adsorption Γpl for BSA adsorption on OPS3 dramatically 
increased from ca. 0.38 mg/m2 to ca. 0.84 mg/m2 under the same condition.  
Assuming BSA is heart-shaped with dimensions of 84 × 84 × 84 × 35 Å (Ferrer et 
al., 2001), it is therefore more difficult for BSA molecules enter into OPS3 (87 Å) than 
OPS1 (106 Å) due to the higher pore diffusion resistance of the smaller pore size. At 
the lower temperatures, as the molecule size of BSA is so closed to the pore size of 
OPS3, such resistance may impede the migration of BSA into the mesopores. Hence, a 
large percentage of BSA may be adsorbed on the external surface of OPS3 instead of 
the internal mesopores, resulting in the lower adsorbed amount of BSA (ca. 0.38 
mg/m2) on OPS3 at 22 ˚C. However, at the same temperature, BSA molecules could 
easily enter into the larger pore of OPS1. It is interesting to find that at the temperature 
above biological temperature 37˚C, i.e. 45˚C, the absorbed amount of BSA on OPS3 is 
significantly increased to 0.84 mg/m2, very closed to that on OPS1 (0.92 mg/m2), 
indicating that BSA can also be adsorbed into the mesopores of smaller pore size at 
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higher temperature. This suggests that there may exist additional adsorption driving 














Figure 6.10 BSA adsorption isotherms on (A) OPS1 and (B) OPS3 in phosphate-citrate 
buffer solutions (pH 4.69, ionic strength 0.16 M) at different temperatures: a- 22˚C; b- 
31˚C; c- 37˚C and d- 45˚C. 
Based on Le Chatelier’s principle, an increase of Γ with increasing T implies an 
endothermic adsorption process (Norde, 1986). Consequently, an increase of entropy 
(i.e. ∆adsS > 0) must be the driving “force” behind such adsorption process. According 
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to Haynes and Norde (1994), large positive ∆adsS values could arise from sorbent 
surface dehydration, or the unfolding of protein molecules upon adsorption. However, 
because BSA and OPS samples both are primarily hydrophilic, dehydration would 
oppose adsorption, therefore, in this adsorption process, the increase of entropy should 
result from the unfolding of BSA molecules upon adsorption. Haynes and Norde also 
inferred that the entropy drives protein adsorption in systems where the rotational 
freedom of the polypeptide backbone is significantly greater in the adsorbed state than 
in the native state. Such increased rotational freedom may be the reason behind BSA 
adsorption into the smaller pore size at higher temperatures.  
To exclude the possible influence of smaller pore size (i.e. OPS3, 87 Å) and get 
the unbiased result of the effect of temperature on protein adsorption, the released BSA 
from SBA-15 of larger pore was analyzed by CD to study the conformation change of 
BSA. Figure 6.11 shows the CD spectra of released BSA from OPS1. It can be 
observed that the magnitude of the ellipticity at 205-240 nm decreases with the rise of 
temperature, which indicates irreversible conformational changes in the secondary 
structure of BSA. The calculated α-helix percentage at 22°C, 31°C, 37°C and 45°C is 
63%, 60%, 58% and 47%, respectively. This result indicates that the stability of BSA 
can be severely affected if the adsorption experiments have been carried out at higher 
temperature, and the thermal stability of native BSA can not been maintained upon 
adsorption.  
Temperature is known as one of major factors affecting protein conformational 
changes seen with other denaturing conditions. With elevated temperature there is 
increased intramolecular motion, allowing facile jumping of protein over free-energy 
hurdles to numerous structural variations. If the protein encounters liquid-solid 
interface, such structural variations may result in the reversible or irreversible 

































structural alterations upon its adsorption on the interface. Albumin is known for its 
amazing tolerance of high temperature under certain conditions. All commercial 
human (even bovine) albumin preparations have been “pasteurized” by heating at 60˚C 
for 10 h to inactivate pathogenic viruses, and appear essentially unchanged by this 
treatment (Peters, 1995). And Takeda et al. (1989) found that the effect of heat up to 
45˚C for native BSA appear to be fully reversible. However, our above results revealed 
that such high thermal stability of native BSA cannot be maintained after its adsorption 
and subsequent desorption from the interface. Similarly, Czeslik and Winter (2001) 
found that in the adsorbed state the temperature of unfolding of lysozyme is lower than 








Figure 6.11 CD spectra for BSA released from OPS1, adsorption occurred in BSA 
phosphate-citrate solutions (pH 4.69, ionic strength 0.16 M) at different temperatures: a- 
22˚C; b- 31˚C; c- 37˚C and d- 45˚C. 
6.3.4 Effect of pH Value 
Figure 6.12 shows the plateau adsorption value for BSA on OPS1 as a function of 
pH. It exhibits that the maximum plateau adsorption is obtained near the isoelectric 
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point (pI) of BSA; such pH-dependent tendency of Γpl is commonly observed in 
protein adsorption on solid surfaces (Bagchi and Birnbaum, 1981; Katiyar et al., 2005). 
According to Haynes and Norde (1994), in the system displaying such tendency, it 
reveals that driving force for protein adsorption is determined by the competition 
between protein-protein and protein-surface electrostatic interactions. As discussed 
previously, electrostatic interactions between BSA and OPS samples is the adsorption 
driving force in the hydrophilic surface. In the vicinity of the isoelectric point, due to 
the compact protein structures and the reduced lateral interactions, highest BSA 








Figure 6.12 Plateau values for the adsorption of BSA on OPS1 in BSA phosphate-citrate 
solutions (ionic strength 0.16 M, 22˚C) at different pH values. 
Figure 6.13 shows the CD spectra of the released BSA from OPS1 at pH 4.01, 
4.72, 5.61 and 6.89 and Table 6.2 summarizes the α-helix percentage of the released 
BSA together with the dissolved (native) BSA at pH 4.0, 4.7 and 7.0 (Norde, 1997). 
For the dissolved BSA, the α-helix content does not change much in the pH range of 
4.0-7.0. In contrast, in case of the adsorbed and subsequently released BSA moelecules, 

































both CD spectra and calculated α-helix content indicate that their structural states vary 
as a function of solution pH and the adsorption of BSA in buffer solution of higher pH 
results in larger structure perturbation and lower α-helix percentage. When adsorption 
is carried out in the buffer solution of pH 4.72, the α-helix percentage of the released 
BSA is 65%, however, when adsorption is carried out in the solution of pH 6.89, the α-
helix percentage of the released BSA is reduced to 57%, suggesting more structural 
alteration at higher pH values. Similarly, based on their observations, Haynes and 
Norde (1994) found that at 22˚C the protein is more unfolded on the surface at pH 7.0 
than at its pI. These results also are consistent with the protein’s lower structural 









Figure 6.13 CD spectra for BSA released from OPS1, adsorption occurred in BSA 
phosphate-citrate solutions (ionic strength 0.16 M) at different pH values: a- 4.01; b- 4.72; 
c- 5.61 and d- 6.89. 
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There are two reasons that may account for such conformational change in the 
adsorption process: 1) It is believed that the stability of a globular protein structure 
decreases with increasing net charge on the molecule, 2) The non-ionized forms of the 
residues originally buried in the folded protein are ionized due to the change of 
external pH environment. For example, the non-ionized form of Tyr residue, which is 
commonly found in the interior of globular proteins, if ionized, could prompt 
unfolding at alkaline pH values (Antosiewicz, 1994). Hence, the unstable protein 
molecules more likely undergo structural changes when adsorption occurs at a pH 
away from pI. In addition to the results obtained in this study, there has been 
increasingly convincing evidence that pH environment of bulk protein solution affects 
the adsorbed amount and the level to which native-state proteins undergo 
conformational alterations upon adsorption to solid surfaces (Haynes and Norde, 1994). 
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6.4  Conclusions 
The model protein drug - bovine serum albumin (BSA) has been loaded onto 
different amine-functionalized mesoporous silica (SBA-15) materials under various 
process conditions. It is found that BSA has reduced α-helix content after it has been 
released from amine-functionalized SBA-15 prepared by post-synthesis. This result is 
resulted from the hydrophobic interaction between BSA and the hydrophobic surface 
of the material. For SBA-15 of different pore sizes, the percentage of α-helix of BSA 
secondary structure is more likely to be reduced on those of smaller pore size. For 
adsorption process occurred at different temperatures, it is found that the high thermal 
stability of native BSA can not be preserved after its adsorption and subsequent 
desorption from SBA-15, which is attribute to entropically driving adsorption resulting 
from the unfolding of protein molecules. In BSA adsorption process, the pH value of 
buffer solution is also observed to be one of important factors affecting the 
conformational change; the results show that there is more loss of α-helix at higher pH 
values.   
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CHAPTER 7 – A SMART PH-CONTROLLABLE DRUG 
DELIVERY SYSTEM BASED ON REMOVABLE 
POLY(ACRYLIC ACID) ENCAPSULATED SBA-15 
7.1   Introduction 
During the past three decades, materials science has evolved into an 
interdisciplinary field which encompasses organic, polymeric, and even biological 
components in addition to the classic metals and inorganics. Such multicomposites 
make it possible to combine two or more desirable properties together to endow the 
materials with new functionalities. As it has been frequently mentioned in the previous 
chapters, mesoporous silica has several advantages such as: higher surface area, 
tunable large pore size and mechanical stability, which can make it a secure and high 
content drug-loaded reservoir. Recently, in combination with organic matters or 
nanoparticles, studies in mesoporous silica based delivery have been evolved to 
responsive carrier systems in which the release of drugs can be triggered by external 
stimuli (Lai et al., 2003; Mal et al., 2003; Yang et al., 2005; Giri et al. 2005; Zhu et al., 
2005). For example, Mal et al. (2003) reported coumarin modified MCM-41 in which 
the uptake, storage and release of guest molecules can be regulated through the 
photocontrolled and reversible intermolecular dimerization of coumarin derivatives 
attached to the pore outlet; Lin and coworkers (Lai et al., 2003; Giri et al. 2005) 
synthesized controlled release system based on mesoporous silica capped with 
nanoparticles which can be chemically removed by using release triggers (e.g. cell-
produced antioxidants or disulfide-reducing agents); Zhu et al. (2005) designed a 
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stimuli-responsive controlled drug-release system by using PAH/PSS multilayers as a 
coating to cap the mesopore openings of drug-loaded hollow mesoporous silica spheres 
and the drug release can be controlled by changing the pH value (or the salt 
concentration) of the release medium. In our research, we propose to combine 
mesoporous silica and hydrogel together to make a pH controllable drug delivery 
system which could have potential application for targeted oral delivery of protein 
drugs. 
Hydrogels, which belong to one category of widely employed polymer-drug 
matrices, are three-dimensional, hydrophilic, macromolecular networks capable of 
imbibing large amounts of water or biological fluids (Peppas and Mikos, 1986; 
Brannon-Peppas, 1990). Due to their high water content and rubbery nature which is 
similar to natural tissue, as well as their good biocompatibility and sensitivity in the 
physiological or biological environment (Peppas et al., 2000), hydrogels have been 
found in numerous applications in the fields of biology and medicine including 
ophthalmological devices, biosensors, scaffold, and controlled drug delivery systems 
(Heller at al., 1990; Lendlein and Kelch, 2002; Song et al., 2003; Suri et al., 2003; Kim 
et al., 2006). Poly(acrylic acid) (PAA) is known as a common pH responsive hydrogel 
polymer, bearing carboxylic groups which have a tremendous impact on the swelling 
ratio at various pH values. PAA has some beneficial properties which are critical for 
use in drug formulations. For instance, PAA can stick to the mucosal lining of the 
upper small intestine, allowing it to anchor drug-laden matrices to the intestinal wall, 
while swelling and releasing therapeutic agents (Chen and Hoffman, 1995). 
Additionally, PAA was found to be able to protect some protein drugs from 
degradation by inhibiting the hydrolytic activity of gastrointestinal enzymes (Bai et al., 
1995). The aim of this chapter is to prepare a pH-controllable drug delivery system by 
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encapsulating mesoporous silica SBA-15 with PAA. Such a pH-sensitive drug delivery 
system could hold a mode protein drug BSA in a low-pH environment as in the 
stomach and release the protein drug in a high-pH environment as in the intestine. 
7.2   Experimental  
7.2.1 Materials 
Ethanol-extracted unfunctionalized SBA-15 (S-15), amine-functionalized SBA-15 
prepared by one-pot synthesis (OPS-15), and amine-functionalized SBA-15 prepared 
by post-synthesis (PS-15) were prepared according to the procedure described in the 
previous chapters. 
7.2.2 BSA Loading  
200 mg of SBA-15 sample was soaked into 100 ml of BSA citrate-phosphate 
buffer solution for 24 hrs (3 mg/ml, pH 4.7) and BSA was then loaded on SBA-15. The 
powders were then separated by centrifugation and freeze-dried. 
7.2.3 PAA Encapsulation 
200 mg of PAA (Mw = 130,000) were dissolved into 100 ml of 8 mM NaOH 
solution. 50 mg of SBA-15 samples loaded with BSA was then added to 25 ml of the 
resulting PAA solution and the mixture was vigorously shaken at 250 rpm for 10 mins. 
Finally, the material was separated from the solution by centrifugation and freeze-dried. 
The above procedures were repeated once again to make SBA-15 samples densely 
coated with PAA.  
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7.2.4 In vitro Release Studies 
The release profiles of BSA were determined by soaking 40 mg of samples into 
20 ml of HCl-KCl buffer solution (pH 1.2) or PBS (Phosphate Buffered Saline, pH 7.4) 
under shaking at 100 rpm and the temperature was kept at 37 ± 0.1ºC. Samples of 1 ml 
were withdrawn at the predetermined time, replaced by fresh medium and 
spectrophotometrically analyzed by Bradford assay at a wavelength of 595 nm. After 
completing the release test, the solid samples were separated from the release media by 
centrifugation and dried for later TGA analysis. 
7.2.5 Characterization Methods 
Nitrogen adsorption/desorption measurements were conducted using 
Quantachrome Autosorb-1 by N2 physisorption at 77 K. The BET specific surface 
areas of the samples were calculated in the range of relative pressures between 0.05 
and 0.30. The pore size distributions were calculated from the adsorption branch of 
isotherm using Barrett-Joyner-Halenda (BJH) method. The total pore volume was 
determined from the adsorption branch of the N2 isotherm at P/P0 = 0.95. High-
resolution transmission electron microscopy (TEM) was performed on JEOL JEM-
2010 at 200 kV to examine the morphology of the samples. The morphologies of the 
powder samples were visually observed using field emission scanning electron 
microscopy (FESEM, JEOL JSM-6700F). Thermal gravimetric analysis (TGA) was 
performed using a Shimadzu DTG-60 simultaneous DTA-TG analyzer. The cyto-
toxicity of SBA-15 materials was evaluated using 3T3 mouse fibroblasts and 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide thiazolyl blue (MTT) assay, 
and the cell viability was expressed as % of the corresponding control values. 
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7.3   Results and Discussion 
7.3.1 Surface Properties of Materials on PAA Encapsulation 
Scheme 1 is a schematic representation of the pH-sensitive drug delivery system 
under investigation. In this system, the model protein drug BSA is first loaded onto 
ordered mesoporous silica (i.e. SBA-15) and the resulting material is then encapsulated 
with PAA by electrostatic assembly. Due to the pH-dependent property of PAA, the 
entrapped protein can be released in response to certain pH conditions, e.g. pH 7.4, 
while retained at other pH conditions, e.g. pH 1.2. For the fabrication of such a kind of 
pH-sensitive drug delivery system, the most important step is to effectively 
encapsulate SBA-15 with PAA coatings. It is found that the surface properties of SBA-
15, i.e. hydrophobicity and surface charge, could significantly affect the encapsulation 























at pH 7.4 at pH 1.2 
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Table 7.1 summarizes the textural parameters and Figure 7.1 gives the N2 
adsorption/desorption isotherms and pore size distributions of unfunctionalized SBA-
15 (S-15), amine-functionalized SBA-15 prepared by one-pot synthesis (OPS-15) and 
amine-functionalized SBA-15 prepared by post synthesis (PS-15). The three samples 
have similar pore size, but in comparison with S-15 and OPS-15, PS-15 has smaller 
surface area. However, the loading amount of BSA on PS-15 is the highest compared 
with that on the other two samples. This is due to the fact that the adsorption driven 
force for BSA adsorption on PS-15 is hydrobobic force, which generally tends to 
induce a larger amount of protein adsorption. As mentioned earlier in Chapter 6, based 
on FTIR spectra and TGA analysis, PS-15 (amine-functionalized SBA-15 prepared by 
post-synthesis) is believed to be more hydrophobic than OPS-15. It is found that such 
hydrophobicity not only affects the loading amount of BSA, but also influences on 
encapsulation process. Due to its highly hydrophobic nature, the powders of sample 
PS-15 were observed to agglomerate together and float on the surface of PAA solution 
(rather than homogenously dispersed inside the solution) when they are in contact with 
an aqueous PAA solution, thus making encapsulation process unsuccessful. 
















S-15 446.8 109.0 1.27 0 9.1 
OPS-15 405.0 106.1 1.03 0.58 20.5 
PS-15 228.2 108.6 0.89 1.25 23.1 
 


























Figure 7.1 (A) Nitrogen adsorption/desorption isotherms and (B) Pore size distributions of: 
a- S-15; b- OPS-15 and c- PS-15. (The isotherms are offset vertically by 500 and 1000 
cm3/g for b and c respectively. And the pore size distribution curves are offset vertically by 

































Figure 7.2 ζ potential of SBA-15 samples as a function of pH value. 
Figure 7.2 shows the ζ potential as a function of pH value for S-15, OPS-15 and 
PS-15. From ζ potential curve it can be observed that surface charge has been 
remarkably changed when SBA-15 was functionalized by amine groups. The ζ 
potential of pure silica SBA-15 is positive only at pH value below 3.5, as surface 
silanol groups (Si-OH) tend to lose a proton and form Si-O- species. Due to the 
dissociation of the surface amine groups, the ζ potential of amine-functionalized SBA-
15 is positive at the pH value below around 6.7 (OPS-15) or 7.4 (PS-15). Because 
PAA is a weak polyelectrolyte whose repeating units bear pendant carboxylic groups 
with pKa values in the range of 4.5-5.0, in 8 mM of NaOH solution, PAA (Mw = 
130,000) can be dissolved and partially dissociated to be negatively charged, and the 
final pH value of the solution (2 mg/ml) is pH 5.35. Hence for hydrophilic 
unfunctionalized SBA-15 (S-15) which is negatively charged above pH 2-3, the relese 
study shows that the negatively charged SBA-15 cannot be encapsulated with PAA at 
pH 5.35 due to the electrostatic repulsion. It is worth mentioning that although PS-15 
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is positively charged (as revealed in the ζ potential curve) due to its hydrophobic 
nature, PAA also can not be coated onto its surface as mentioned earlier. Since amine-
functionalized SBA-15 prepared by one-pot synthesis (OPS-15) is of hydrophilic 
nature and positively charged, PAA could be assembled onto the outer surface of 
BSA/OPS-15 within only 10 minutes by electrostatic assembly (ESA).  
7.3.2 Characterization of Materials  
Figure 7.3 shows C1s XPS spectra for PAA, BSA/OPS-15 and PAA-encapsulated 
BSA/OPS-15. PAA (Figure 7.3a) reveals two peaks at 284.6 and 288.6 eV, which are 
assigned to C-C and O-C=O bonds in PAA chain, respectively. After BSA/OPS-15 
was encapsulated with PAA (Figure 7.3c), there is a broad O-C=O peak appearing at 
288.6 eV, which is attributed to the increase of carboxyl groups on the surface as a 
















Figure 7.3 C1s XPS spectra of: a- PAA; b- BSA/OPS-15 and c- PAA-encapsulated 
BSA/OPS-15. 
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Figure 7.4 shows FESEM images for S-15 (for comparison) and OPS-15 before 
and after coated with PAA. During the encapsulation process, for both S-15 and PS-15, 
it has been observed that the powders were well dispersed in the PAA solution. After 
that, the powders were then washed twice by deionized water to remove the remaining 
polymers. However, FESEM images for the two sample powders after encapsulation 
show a big difference. For S-15, the shapes and the sizes of the powders remains 
unchanged, suggesting that the powders could not be successfully coated with PAA. 
However, after OPS-15 was encapsulated with PAA, it can be clearly observed that the 
















































Figure 7.4 FESEM images of S-15: a- before PAA encapsulation and b- after PAA 
encapsulation and OPS-15: c- before PAA encapsulation and d- after PAA encapsulation. 
Figure 7.5 shows the TEM images of OPS-15 before and after being encapsulated 
with PAA. It can be seen that after being encapsulated with PAA, the parallel channels 
of OPS-15 are covered by PAA (Figure 7.5c), and from a cross-sectional view of 
Figure 7.5d, a thick layer of PAA (around 10 nm) could be observed on the outer 
surface of SBA-15. As PAA is less charged at pH 5.35, the polymer chains tend to be 






















































Figure 7.5 Plan-view and cross-sectional TEM images of OPS-15 unencapsulated (a and 
b) and encapsulated with PAA (c and d). 
 
7.3.3 In vitro Release Studies 
The release studies of BSA from unencapsulated or PAA-encapsulated BSA/OPS-
15 were conducted either in HCl-KCl buffer solutions (pH 1.2) or in phosphate buffer 
solutions (pH 7.4). It is interesting to note from Figure 7.6 that the release rate of BSA 
from PAA-encapsulated BSA/OPS-15 into HCl-KCl buffer solution (pH 1.2) is 
extremely slow as compared with those from unencapsulated BSA/OPS-15. In this 
acidic medium, BSA is hardly released from PAA-encapsulated BSA/OPS-15 samples 
within 5 hours and only around 10% is released in 36 hours. However, in phosphate 
buffer solution (pH 7.4), the release profile of BSA from PAA-encapsulated OPS-15 is 
similar to that from unencapsulated OPS-15. These results indicate that after 
BSA/SBA-15 has been encapsulated with PAA, BSA can only be released under 
certain pH conditions, i.e. at the higher pH value of 7.4. In addition, it is also worth 
mentioning that the release rate of BSA from unencapsulated OPS-15 at pH 1.2 is 
higher than that at pH 7.4 due to the higher electrostatic replusion between BSA and 
OPS-15. As it can be seen in Figure 7.2, at pH 1.2, OPS-15 is highly positively 
d 
 7 / A Smart pH-Controllable Drug Delivery System Based on Removable PAA Encapsulated SBA-15 
 151


























charged, and BSA is also positively charged; as a consequence, BSA could be easily 








Figure 7.6 Release profiles of BSA from: a- PAA-encapsulated OPS-15, at pH 1.2; b- 
PAA-encapsulated OPS-15, at pH 7.4; c- unencapsulated OPS-15, at pH 7.4 and d- 
unencapsulated OPS-15, at pH 1.2. 
At the end of the release studies, all of the above solid samples were separated 
from the release mediums by centrifugation and further dried for TGA analysis to 
measure the amount of BSA still remaining on the samples. Table 7.2 summarizes the 
TGA results for these samples together with the original samples. For amine-
functionalized SBA-15 prepared by one-pot synthesis (OPS-15), the weight loss 
between 100-800ºC is mainly due to the remaining copolymer template, which can not 
be completely removed by ethanol extraction. It can be seen that the weight loss 
increased after SBA-15 was loaded with BSA and the resulting BSA/OPS-15 was 
encapsulated with PAA. It also can be estimated from the TGA analysis that the 
loading amount of BSA on PAA-encapsulated OPS-15 is 16.3%. It is interesting to 
note from Table 7.2 that the weight loss of PAA-encapsulated BSA/SBA-15 (86.6%) 
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after the release test at pH 1.2 is higher than that of other samples (around 50%), 
indicating that there is more BSA remaining on PAA-encapsulated SBA-15 after the 
release test at pH 1.2. The TGA results further confirm that BSA could be entrapped 
inside the mesopores at lower pH conditions. 
Table 7.2 TGA results for SBA-15 samples. 





BSA loading, 20.2 
PAA-encapsulated BSA/OPS-15 34.5 PAA coating, 6.3 
PAA-encapsulated BSA/OPS-15  
after the release testing at pH 1.2 
29.8 Remaining BSA, 86.6 
PAA-encapsulated BSA/OPS-15 
after the release testing at pH 7.4 
22.6 Remaining BSA, 56.0 
Unencapsulated BSA/OPS-15 
after the release testing at pH 1.2 
22.2 Remaining BSA, 49.4 
Unencapsulated BSA/OPS-15  
after the release testing at pH 7.4 
22.8 Remaining BSA, 45.8 
(Note: BSA loading amount can not be directly obtained through the weight loss as shown in TGA results, but 
estimated by the equation of: (31.6-14.2)/(1-0.316)/[100+(31.6-14.2)/(1-0.316)]. Other estimated results are 
obtained in the similar way. For OPS-15 samples encapsulated with PAA, BSA weight loss during encapsulation 
process was estimated to be around 2.9%) 
The interesting release result obtained above is believed to be due to the pH-
induced alteration of the configuration of PAA coating on the surface of SBA-15.Since 
it is known that PAA is a weak polyelectrolyte and has a dissociation constant pKa 
between 4.5 to 5, therefore PAA will be partially dissociated and become negatively 
charged at certain pH value (Equation 7.1). Its shrinking and swelling behaviors thus 
depend on the nature of the ionizable side chains as well as the pH of aqueous medium.  
 





At the pH of 1.2 (pH < pKa 4.5), because the side carboxylic groups cannot be 
dissociated, PAA remains collapsed or contracted and SBA-15 remains encapsulated 
by PAA coatings, resulting in the entrapment of BSA in SBA-15 mesopores. However, 
at the pH of 7.4 (pH > pKa 5.0), the carboxylic groups undergo dissociation and the 
charges on a linear PAA chain repel each other, causing PAA to swell and finally 
dissolve into the release medium of higher pH value. PAA coating is then removed 
from the outer surface of SBA-15, hence resulting in the release of BSA from SBA-15. 
Comparing with the published work which used multilayers of polyelectrolyte pairs 
whereby drugs or proteins were released more at a lower pH value rather than at a 
higher pH value (Zhu et al., 2005; Yu et al., 2005), our results presented here have 
more therapeutical significance, because on most occasions drugs - especially protein 
drugs - are desired to be protected from release into the stomach (at pH 1-3) but only 
released to the intestine which has pH of 6-8. It is therefore believed that this pH-
responsive drug delivery system could have a potential application for oral delivery of 
drugs. 
7.3.4 Cytotoxity Studies 
The cytotoxicities of materials are measured by MTT assay by observing the 
viability of 3T3 mouse fibroblasts after incubated with samples at 37˚C for 24 hrs. The 
3T3 mouse fibroblasts are also identified with optical microscope and the general 
morphology of the fibroblasts incubated with S-15, OPS-15 and PAA-encapsulated 
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shows that the cells incubated with S-15, OPS-15 and PAA-encapsulated OPS-15 are 
well spread and there is no distinct change in the morphology after 24-hour incubation 
with samples relative to control cells. However, when the particle concentration is 
increased to 0.5 mg/ml, the morphology of the cell incubated with S-15 shows a clear 
difference from that of the control cell, revealing that exposure of the cells to S-15 at a 
high concentration (e.g. 0.5 mg/ml) could induce toxicity. This is not surprising as the 
component of S-15 is silica, and it is widely accepted that silica-induced cytotoxicity at 
high concentration is due, in part, to the disruption of phagolysosomal membrane 
integrity. After phagocytosis of silica, reactive particle surfaces may interact with 
phagolysosomal membranes leading to the release of lysosomal enzymes into the 
cytosol and cell death (Nadler and Goldfischer, 1970; Erdogdu and Hasirci, 1998; 






























Figure 7.7 Morphology of 3T3 mouse fibroblasts incubated with samples for 24 hrs at 37˚
C. (A) at concentration of 0.1 mg/ml: a- control, b- S-15; c- OPS-15 and d- PAA-
encapsulated OPS-15. And (B) at concentration of 0.5 mg/ml: e- control, f- S-15; g- OPS-
15 and h- PAA-encapsulated OPS-15. 
Figure 7.8 shows the cell viability of S-15, OPS-15 and PAA-encapsulated OPS-
15 at two different concentrations of SBA-15. The results show that the cytotoxicity of 
all of three samples increases in relation to the increase of the sample concentration (p 
< 0.05). The results also demonstrate that the cytotoxicity effects of OPS-15 and PAA-
encapsulated OPS-15 are lower as compared with that of pure SBA-15. The cell 
viability of OPS-15 and PAA-encapsulated is more than 80% even at a high 
concentration of 0.5 mg/ml, suggesting that introduction of amine groups could 
attenuate the cytotoxicity induced by pure silica. Additionally, it is interesting to note 
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that, after 24 hours of incubation with OPS-15 at particles concentration of 0.1 mg/ml, 
the fibroblasts were found to be more than 100% viable as compared to control cells, 
indicating that the introduction of amine group on SBA-15 surface could induce the 








Figure 7.8 Cytotoxicity of S-15, OPS-15 and PAA-encapsulated OPS-15 as measured by 
MTT assay. The results (n=3) are expressed as mean ± SD and the differences between 
samples and control were considered significant at p<0.05, * p < 0.01, ** p <0.05.  
 
7.4   Conclusions 
Using a simple and fast method, by properly choosing the right combination of a 
pair of hydrogel and SBA-15, we have successfully encapsulated SBA-15 with PAA 
through electrostatic assembly method, and successfully prepared a smart pH-
responsive drug delivery system which could have a potential application for oral 
delivery of protein drugs at a higher pH value of intestine. It is found that surface 
charge and hydrophilicity determine the encapsulation process. Due to the fact that 
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amine-functionalized SBA-15 prepared by one-pot syntheis is of hydrophilic nature 
and positive charge, it has been successfully encapsulated with PAA. In vitro release 
studies show the entrapped protein can be released at neutral medium rather than at 
acidic medium. In vitro cytotoxicity studies show that amine-functionalized SBA-15 
encapsulted with PAA has little toxicity effect even at a high concentration of 0.5 
mg/ml. This novel drug delivery system is believed to have potential application in 
targeted oral delivery of therapeutic proteins, which can release drugs to the ideal site 
like small intestine or colon while protecting them from the acidic condition in the 
stomach. 
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CHAPTER 8 - CONCLUSIONS AND FUTURE 
RECOMMENDATIONS 
8.1   Conlusions 
An extensive study on fine-tuning the properties of ordered mesoporous silicas 
SBA-15 and their application in controlled drug delivery for both small molecule 
model drug of IBU and large protein drug of BSA has been carried out in this research. 
In the preparation of controlled drug delivery system for IBU, mesoporous SBA-
15 materials were functionalized with amine groups through post synthesis and one-pot 
synthesis. The results show that the adsorption capacities and release behaviors of IBU 
were highly dependent on the different surface properties of SBA-15 materials. The 
release rate of IBU from SBA-15 functionalized by post synthesis is found to be 
effectively controlled as compared with that from pure SBA-15 or from SBA-15 
functionalized by one-pot synthesis due to the stronger ionic interaction between the 
carboxyl groups of IBU and the amine groups on the surface of SBA-15 functionalized 
by post synthesis. 
In contrast to small molecular drug IBU, the fabrication of the controlled drug 
delivery system for large protein model drug BSA was more complicated as it involved 
not only the properties of protein matrix itself but also the stability of protein drug. 
Three sections of research work related to the protein drug delivery systems are 
contained in this thesis: 
In the first section of the work, the adsorption isotherms of BSA on SBA-15 were 
determined at various conditions in order to find the favorable conditions for large 
adsorption capacities. Based on their plateau adsorptions values, it is observed that 
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higher BSA adsorption capacities could be obtained on SBA-15 with higher amine 
group content and larger pore size and at the condition near the isoelectric region of 
BSA. Electrostatic interaction is suggested to be the driving force that prompts mild 
adsorption of BSA on hydrophilic surface of amine-functionalized SBA-15. In vitro 
release studies conducted in phosphate buffered saline (PBS, pH 7.4, ionic strength 
0.25 M) show that the amine group content and pore size of functionalized SBA-15 
could also affect the release rates. The release rates slow down when BSA molecules is 
adsorbed on SBA-15 of higher amine contents; this result has been attributed to the 
stronger electrostatic interaction between BSA and amine-functionalized SBA-15. For 
SBA-15 of smaller pore size, a relatively larger amount of BSA is believed to be 
adsorbed on the external surface rather than inside the mesopores; hence the overall 
release rate of BSA from SBA-15 of smaller pore is faster than that from SBA-15 of 
larger pores. 
In the second section of the work, the conformational changes of BSA under 
various process conditions are examined. It is found that BSA has reduced α-helix 
content after it has been released from amine-functionalized SBA-15 prepared by post-
synthesis. This result is resulted from the hydrophobic interaction between BSA and 
the hydrophobic surface of the material. For SBA-15 of different pore sizes, the 
percentage of α-helix of BSA secondary structure is more likely to be reduced on those 
of smaller pore size. For adsorption process occurred at different temperatures, it is 
found that the high thermal stability of native BSA can not be preserved after its 
adsorption and subsequent desorption from SBA-15, which is attribute to entropically 
driving adsorption resulting from the unfolding of protein molecules. In BSA 
adsorption process, the pH value of medium is also observed to be one of important 
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factors affecting the conformational change; the results show that there is more loss of 
α-helix at higher pH values.   
Finally, the novelty of the research is that a smart pH-controllable drug delivery 
system has been successfully prepared through encapsulation of amine-functionalized 
SBA-15 with PAA by electrostatic assembly. Surface charge and hydrophilictiy are 
found to be two important surface properties of SBA-15 which affect the encapsulation 
process. Thus, hydrophilic and positively charged amine-functionalized SBA-15 
prepared by one-pot synthesis could be successfully encapsulated with PAA. The 
results show that the entrapped BSA on the resulting system can be released at neutral 
medium (pH 7.4) rather than at acidic medium (pH 1.2). Cytotoxicity studies show that 
such pH-sensitive system has little toxicity effect even at a high concentration of 0.5 
mg/ml. This novel drug delivery system is believed to have potential application in 
targeted oral delivery of therapeutic proteins, which can release drugs to the ideal site 
like small intestine or colon while protecting them from the acidic condition in the 
stomach. 
 
8.2   Future Recommendations 
In recent years, a spurt of research and development has been conducted 
involving a wide range of protein therapeutics for various conditions. Most of the 
proteins have been successfully applied in therapy, mainly as parenterals. An oral 
dosage form is the preferred form of delivery because of ease of administration, patient 
compliance, and lower cost. Major hurdles must be overcome before the oral delivery 
of a protein becomes a reality. Among the proteins, althrough oral delivery of insulin 
has received the most attention, currently there is yet no oral insulin formulation 
commercially viable and available. 
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Insulin is a polypeptide hormone made of, after elimination of peptide C by 
hydrolyses, two chains of 21 and 30 amino acids, connected by two disulphides 
bridges (Figure 8.1). Insulin was isolated from bovine pancreas in 1922 by Banting and 
Best, who received the 1923 Nobel Prize with Mcleod. In early years, insulin was 
isolated mostly from the pancreases of bovine cadavers. This method of isolation led to 
several immunological reactions as a result of impurities present in the isolated protein. 
The synthesis of insulin by recombinant DNA technology represented an important 
scientific milestone and made large quantities of protein available at an affordable 
price - a factor that led to insulin becoming one of the most popular proteins to be 







Figure 8.1 Insulin structure 
One of the challenges for oral delivery of insulin is that, upon ingestion, insulin is 
subjected to acid-catalyzed degradation in the stomach. Based on the nature of insulin 
and the results obtained in this research, the chemical and physical properties of the 
matrix material can be tuned to make an effective pH-sensitive insulin oral delivery 
system. One of the most important aspects of the future research should be directed to 
characterize the change of insulin related to its conformation, size, shape, surface 
properties, and bioactivity upon formulation processing.  
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However, it should be noted that successful oral delivery of insulin involves 
overcoming the barriers of enzymatic degradation, achieving epithelial permeability, 
and taking steps to conserve bioactivity during formulation processing. A synergistic 
collaboration among biomaterials, analytical biochemistry, immunoassays and 
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